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CHAPTER 1
REVIEW OF THE LITERATURE

1.1

Research Goals
The research goal of my thesis is to develop an in-cell fluorescence technique to

study the in situ protein structure and function inside living mammalian cells. To achieve
this goal, our rationale is to label a protein of interest in vitro with small molecule
fluorophores, either at specific residues or at surface located lysine residues. We will
then deliver this fluorescence labeled protein into the correct intracellular compartment
of living mammalian cells using our newly developed QQ-protein delivery technology.
This will generate a special mammalian cell population that only contains one
fluorescent labeled protein, whereas the other intracellular background proteins are
unlabeled. We anticipate that this strategy will allow us to study structure, intracellular
trafficking and in situ function of this fluorescent labeled protein inside the living cell
using either confocal fluorescence imaging or fluorescence spectroscopy.
To gain structural information of a protein inside living cells, we will develop an
in-cell FRET technique that allows us to measure the distance between the specifically
labeled fluorescence donor and acceptor at atomic resolution. Our strategy is to utilize
the intrinsic fluorescence of the tryptophan residue in a protein as the fluorescence
donor and label the protein with a fluorescence acceptor at a cysteine residue with a
thiol-reactive small molecule fluorophore, such as IAEDANS. This provides a
fluorescence donor and acceptor with minimal disturbance of the structure of the
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protein of interest. In addition, this also generates a specifically labeled protein with
site-specific labeled fluorescence donor and acceptor, allowing us to accurately measure
the distance between the donor and acceptor at atomic resolution. Thus, this technique
enables us to gain structural information of a protein inside cells at atomic resolution.
To solve the problem of disturbance of protein-protein interactions between the
protein of interests and intracellular proteins that also contain tryptophan residues, we
will label the protein of interest with a tryptophan analog, 5-hydroxy-L-tryptophan (5HT), to generate a specific 5-HT labeled protein. Since a 5-HT labeled protein can be
excited at 310 nm to generate emission spectra, where minimal excitation of regular
tryptophan residues at this wavelength, this will allow us to eliminate any contribution
of intracellular proteins to the FRET due to protein-protein interactions. Thus, the in-cell
FRET measurement using this special labeled protein sample will be only intra-protein
FRET between the labeled 5-HT donor and the acceptor. Therefore, this strategy will
allow us to obtain accurate distance measurements between the fluorescence donor
and acceptor within the labeled protein.
An important aspect of this project is to develop an innovative FRET technique
that allows us to obtain multiple distances within a protein via a single FRET
measurement. To achieve this goal, we will prepare a protein sample that contains
multiple fluorescence donors (multiple 5-HTs) and a single acceptor. We will develop a
fluorescence technique for FRET measurement using the synchronous fluorescence
spectroscopy for these FRET measurements of these protein samples for the purpose to
simultaneously obtain multiple distances via a single FRET measurement.
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In summary, this thesis pioneers a novel in-cell fluorescence technology to study
the in situ structure, intracellular trafficking and functions of a protein of interests inside
the cells. This is a very challenging project, since the intracellular environment is
extremely complex. However, any success of this project shall generate an innovative incell fluorescence technology that enables the study of the cellular physiology of roles
played by a protein of interest. This review of literature begins with a look at available
high-resolution structural biology techniques as well as low-resolution cell biology
techniques in order to explain why fluorescence spectroscopy was the chosen method
for this study.

1.2

High-resolution structural biology and Low-resolution cell biology
After the invention of the microscope, scientists in the cell biology field have

consistently pushed the optical resolution limits (Figure 1-1). With the advent of the
light microscope, one could study at the tissue level and visualize individual cells. As the
lenses improved, the subcellular compartments became apparent. Until the utilization
of fluorescent proteins in the 1990s, individual proteins could not be elucidated within
cells or even when purified and in solution. Other techniques were developed to
determine the structure of a protein at the atomic level.
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Figure 1-1: Optical resolution scale from the tissue level to atomic resolution. Reprinted
from Sun 2011 [1].

1.2.1 High-resolution structural biology techniques
Structural biology is a combination of methods from the fields of molecular
biology, biochemistry and biophysics. Various technologies have been developed to
elucidate protein structure and the top three methods are X-ray crystallography, nuclear
magnetic resonance (NMR) and cryo-electron microscopy (cryo-EM).

1.2.1.1 X-ray crystallography
The field of X-ray crystallography has a long, rich history. Several milestones
were achieved in the early 20th century as shown in Table 1-1 [2, 3].
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Table 1-1: Important milestones in the history of X-ray crystallography
Year

Achievement

Achieved by

1912

Observation of X-ray diffraction

Friedrich, Knipping
& von Laue

1912-13

Bragg’s law developed

Bragg

1912-50s

Minerals, organic and small biological molecules
structures solved used X-ray crystallography

1934

First X-ray diffraction picture taken of pepsin protein

Bernal

1958

First protein structure solved by X-ray crystallography

Kendrew & Perutz

1970-80s

Utilization of synchrotron X-ray radiation

1990s

MAD Phasing

Hendrickson

The first step to obtaining X-ray data is the production, purification and
crystallization of the target protein.

The most important part of any protein

crystallography studies is protein crystallization. Without perfect crystals of protein (or
any other biological samples) it is impossible to carry out any crystallographic structural
studies. The aim of protein crystallization is to produce well-ordered protein monocrystals without any inclusion and large enough to diffract X-Ray beam. Despite very
wide knowledge about protein crystallization it is still impossible to predict any
conditions for protein crystallization. The protein crystallization process is still empiric
and the biggest part of success is hidden in the hand and experience of the scientist who
performed the protein crystallization and pure luck.

However, recent structural

genomics projects developed high-throughput screening methods using robots for
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different crystallization conditions significantly accelerate the success rate of protein
crystallization [4, 5].
Once a decent sized crystal is produced, it can be mounted on a goniometer and
gradually rotated while being bombarded with X-rays, producing a diffraction pattern of
regularly spaced spots known as reflections. However, the information at this point only
contains the intensities of the diffracted rays. In order to continue with structure
calculation, the phase must be determined as this information is lost during the X-ray
data collection.
The phase can be determined in a number of ways.

The first method is

isomorphous replacement where a crystal is soaked in a solution containing heavy
atoms or co-crystallized with that heavy atom. The native crystal X-ray diffraction is
then compared to the crystal containing the heavy atom and the differences allow for
phase determination [6]. The second method is molecular replacement. Many proteins
are similar to other proteins with a known structure. The new protein’s structure can be
solved by using the intensities and phases of the known structure and can give a general
orientation guideline [7].

The third and most commonly used method is multi-

wavelength anomalous dispersion [8]. Typically, selenomethonine is incorporated into
the protein during translation. Data is collected at a variety of wavelengths, the various
diffraction patterns are compared allowing for phase determination.

Since its

introduction in 1990, this has become the most standard method for solving X-ray
crystal structures [9].
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Once the phase has been determined, electron density maps can be calculated.
At this point, the atoms of the known molecules can be fit into the electron density
map. X-ray data processing is a key stage for protein crystallography. The final quality of
X-Ray data is related with the data processing procedure, which includes integration of
the crystallographic data and scaling. The first step between experimental X-ray data
and protein structure is the structure solution procedure. Structure solution can be
based on the many different techniques, depending on the data available. The final
stage of protein crystallography is the structure refinement. At this stage it is necessary
to do a lot of visual graphics work with the model together with structure refinement
[10]. Figure 1-2 displays a summary of all the steps needed to determine protein
structure from a crystal: (1) crystallization, (2) collect x-ray diffraction data, (3)
determine phase and create electron density map, (4) fit protein and produce an atomic
model.

8

Figure 1-2: Summary of steps needed to determine structure of protein based on x-ray
crystal data.

X-ray crystallography suffers from a few drawbacks when using this technique to
determine protein structure. First, flexible regions of a protein cannot be seen in an
electron density map and therefore cannot be seen in the final structure. Second,
occasionally there are artifacts from the crystallization process such as protein
dimerization when the protein in solution does not dimerize.

1.2.1.2 Nuclear magnetic resonance (NMR) spectroscopy
Nuclear magnetic resonance spectroscopy, most commonly known as NMR
spectroscopy, is a research technique that exploits the magnetic properties of certain
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atomic nuclei to determine physical and chemical properties of atoms or the molecules
in which they are contained. It relies on the phenomenon of nuclear magnetic
resonance and can provide detailed information about the structure, dynamics, reaction
state, and chemical environment of molecules [11].
Most frequently, NMR spectroscopy is used by chemists and biochemists to
investigate the properties of organic molecules, though it is applicable to any nucleus
possessing spin. This can range from small compounds analyzed with 1-dimensional
proton or

13

C NMR to large proteins or nucleic acids using 3 or 4-dimensional

techniques.
The first step to collecting NMR data is the expression and purification of the
target protein. Depending on the size of the protein, it can be single or double-labeled
with 13C and/or 15N. For large proteins, they can be triple-labeled with 2H, 13C and 15N.
Once the protein has been purified and a powder is obtained, it is then dissolved in
buffer at around a 1 mM concentration. The solution is placed in a slim, cylindrical tube
and taken to the NMR spectrometer. The main subsystems of an NMR spectrometer
are: (1) superconducting magnet (300-950 mHz), (2) probe, (3) pulse programmer and rf
transmitter, (4) receiver and (5) data acquisition and processing computer [12]. When
placed in a magnetic field, the NMR active nuclei (1H/13C/15N) absorb electromagnetic
radiation at a frequency characteristic of the isotope. The resonant frequency, energy of
the absorption and the intensity of the signal are proportional to the strength of the
magnetic field [11-13].
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There is a variety of NMR experiments that can be performed and depending on
the size of the protein. One-dimensional 1H-NMR spectral analysis is only useful for
elucidating the structures of small organic molecules. More complex samples require
two and three-dimensional analysis using

13

C and

15

N nuclei. Two-dimensional analysis

basically measures the spectra of two different nuclei in a sample and plots them
against each other. The different local electronic environments of each of the nuclei
within a folded structure give rise to unique spectral shifts. Each crosspeak represents a
unique proton-nitrogen pair within the protein. Well-folded proteins typically give
better resolved spectra with distinct peaks. Unstructured proteins give spectra with
poor resolution between peaks. This type of analysis is useful as a rapid screen for the
“foldedness” of a given peptide/protein and can be used to screen for optimal
conditions for good “foldedness” [13].
Complex protein samples will have significant spectral overlap with 2D-NMR,
thereby complicating the downstream assignments and structure determination. Threedimensional analysis extends the spectra into one further dimension, to resolve these
ambiguities. An example of a typical experiment is the 3D 1H-15N NOESY correlation
spectrum. This experiment, like the 2D NMR spectroscopy described above, correlates
amide hydrogens to their resident nitrogens. The experiment extends into another 1H
spectral dimension and contains 1H-1H NOE correlations between the amide hydrogens
and other nearby hydrogens [14].
Another example of a 3D-NMR experiment is the 3D HNCACB (1H-15N, 13Cα-13Cβ).
This experiment can give unambiguous assignments of residues to the NMR shifts. Each
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amide 1H-15N pair is coupled to the 13C nuclei in backbone of its own residue and those
of the one before it in the primary sequence. The result of this phenomenon is that
each amide strip contains four shifts (two strong peaks for its resident carbons and two
weak peaks for the carbons of the residue before it). Shifts from alpha vs. beta carbons
are identified by having opposite signs. These data strips can then be used to determine
which residues correspond to which shifts, a process called sequential assignment. Once
the assignment is complete, other NMR experiments like the 3D-NOESY-correlation can
be performed to determine which atoms are nearby in space (< 6Å), the basis of NMR
solution structure determination.

Figure 1-3 illustrates all the steps needed to

determine protein structure based on an NMR sample: (1) isotopically labeling protein
samples, (2) NMR data collection using specific pulse sequences depending on the 2-D
or 3-D experiment performed, (3) process data and assign peaks with NMR software, (4)
perform structural calculations and produce an NMR structure of the protein.
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Figure 1-3: A summary of all the steps needed to determine a protein structure using
NMR spectroscopy.

NMR can be complimentary to or more advantageous than X-ray crystallography
in several ways. First, comparisons can be made between a protein’s structure that has
been crystallized and the same protein solved by solution NMR. Second, NMR can
provide structural information for proteins that do not crystallize. Third, the solution
conditions can typically vary widely allowing a protein to be studied under various
conditions that include changes in pH and denaturing conditions. On the other hand,
proteins tend to crystallize under strict conditions and changing those conditions may
result in the protein not crystallizing. Finally, NMR is conducive to the study of protein
dynamics [13]. One major drawback for NMR is that it is limited to smaller proteins (<
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40 kD) for high-resolution NMR structural determination because there is too much
spectral overlap and significantly enhanced linewidths for large proteins that
compromise signal-to-noise.

1.2.1.3 Cryo-electron microscopy
There are times when a protein or protein complex is too difficult to form a
consistent crystal and too large for solution NMR techniques, cryo-electron microscopy
(cryo-EM) presents a possible solution. Cryo-electron microscopy is a form of
transmission electron microscopy (EM) where the sample is studied at cryogenic
temperatures (generally liquid nitrogen temperatures) [15].
The popularity of cryo-electron microscopy stems from the fact that it allows the
observation of specimens that have not been stained or fixed in any way, showing them
in their native environment, in contrast to X-ray crystallography, which generally
requires placing the samples in non-physiological environments, which can occasionally
lead to functionally irrelevant conformational changes. In practice, the resolution of
cryo-electron microscopy maps is not high enough to allow for unambiguous model
construction on the basis of EM maps only, and models obtained by protein
crystallography are used to interpret the cryo-EM maps [16]. However, the resolution of
cryo-EM maps is improving steadily, and some virus structures obtained by cryo-EM are
already at a resolution that can be interpreted in terms of an atomic model.
A version of electron cryo-microscopy is cryo-electron tomography (CET) where a
3D reconstruction of a sample is created from tilted 2D images. Electron tomography is
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comparable to medical tomographic techniques like CAT, PET and MRI in the sense that
it provides a 3D view of an object, yet it does so at a cellular scale and with nanometer
resolution. Electron tomography has the unique ability to visualize molecular
assemblies, cytoskeletal elements and organelles within cells. The three-dimensional
perspective it provides has revised our understanding of cellular organization and its
relation with morphological changes in normal development and disease. Cryo-electron
tomography of vitrified samples at cryogenic temperatures combines excellent
structural preservation with direct high-resolution imaging [15]. Current resolutions of
ET systems are in the 5-20 nm range, suitable for examining supra-molecular multiprotein structures, although not the secondary and tertiary structure of an individual
protein or polypeptide.

1.2.1.4 Limitations and challenges of current structural biology techniques
Each of the major methods used to determine protein structures has its own
unique limitations and disadvantages.

X-ray crystallography has generated more

structures in the PDB database than any other technique and accounts for 87% of the
total structures. X-ray crystallography has a long history and has become a highthroughput method for obtaining structures.

However, it still suffers from a few

disadvantages: crystal formation is more of an art than science, membrane proteins are
extremely difficult to crystallize, artifacts from crystallization may negatively affect
structure, and flexible regions are not visible.
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NMR accounts for 12% of the structures in the PDB database. Since NMR is
solution-based, the key advantage of protein NMR is the option to study protein
dynamics under changing conditions. Proteins that have been unable to crystallize have
been studied using NMR. However, for the most part, NMR is still only used to study
proteins under 30 kD, despite available techniques to study larger proteins.
Cryo-EM, or CET, is advantageous in the fact that it can provide a snapshot into
subcellular level structure. In combination with other structural techniques, Cryo-EM
can aide in the final structure determination of proteins. Cryo-EM is especially helpful
with modeling structures for membrane proteins. The main disadvantages to this
technique are its nanometer resolution and frozen state of the sample which could
produce artifacts.

1.2.2 Low-resolution cell biology techniques
Although there have been numerous advances in the field of cell biology, it is still
considered low-resolution as protein structures cannot be elucidated. Listed below are
various technologies available that have pushed the lower boundaries of optical
resolution. The majority of the techniques are fluorescence based.

1.2.2.1 Fluorescence imaging
Fluorescence imaging is a broad category that covers many available
fluorophores: small organic dyes, quantum dots and fluorescent proteins. There are a
number of techniques available, including immunolabeling and genetic tagging.
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Depending upon the fluorophore chosen and technique used, a number of passive and
active applications can be elucidated from mammalian cells. Some of the passive
applications include protein expression and localization in primary cells and fixed
tissues, Active applications include protein diffusion and trafficking, conformational
changes, protein-protein interactions, protein synthesis and turnover, manipulation of
protein activity, seeing endogenous enzyme activity [17, 18].
Small organic dyes or fluorophores (< 1 kD) can covalently bond to a protein and
have been designed to be much brighter, photostable and have reduced self-quenching.
Since they do not have the capability to specifically bind to a target protein within a cell,
they must be first attached to secondary antibodies that will specifically bind to primary
antibodies for the target protein [17].
Quantum dots are inorganic nanocrystals that are thought to be superior to
small organic dyes in several ways. One of the most obvious differences is brightness
due to the high extinction coefficient combined with a comparable quantum yield to
fluorescent dyes. The second difference is their high photostability, allowing much less
photobleaching [19]. It has been estimated that quantum dots are 20 times brighter and
100 times more stable than traditional fluorescent reporters [20].
The improved photostability of quantum dots, for example, allows the
acquisition of many consecutive focal-plane images that can be reconstructed into a
high-resolution three-dimensional image [21]. Another application that takes advantage
of the extraordinary photostability of quantum dot probes is the real-time tracking of
molecules and cells over extended periods of time [22]. Antibodies, streptavidin,
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peptides, nucleic acid aptamers, or small-molecule ligands can be used to target
quantum dots to specific proteins on cells [23-25].

1.2.2.2 Immunohistochemistry
The goal of immunohistochemistry is to provide color and contrast to
microscopic images. The field uses different techniques to accomplish the specific
labeling of biological structures. Histochemists pioneered the use of small-molecule
cellular stains, labeled molecules such as antibodies, and enzyme mediated detection
and signal amplification. Historically, however, histochemistry involves the imaging of
fixed cells and tissues. The advent of genetic manipulation techniques has greatly
expanded histochemical methods to living cells [26].
The fundamental concept behind immunohistochemistry is the demonstration
of antigens (Ag) within tissue sections by means of specific antibodies (Abs). Once
antigen–antibody (Ag-Ab) binding occurs, it is demonstrated with a colored
histochemical reaction visible by light microscopy or fluorochromes with ultraviolet light
[27].
Immunolabeling is a technique that involves identifying endogenous proteins
with primary antibodies, followed by detection with secondary antibodies conjugated
with small organic dyes or quantum dots. Alternatively, the primary antibodies can be
directly conjugated with a fluorophore itself. Both methods depend on the specificity of
the primary antibody [17].
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1.2.2.3 Fluorescent proteins
The Green Fluorescent Protein was first discovered in 1962 alongside aequorin, a
chemiluminescent protein from Aequorea jellyfish [28]. Since then, it has been studied
in numerous biochemical ways including crystallization and the phenomenon of energy
transfer. However, the major breakthrough did not occur until 1992, when Prasher et al
cloned the gene and then by Chalfie et al and Inouye et al who demonstrated that the
protein fluoresced when expressed in other organisms [29-32].
The Green Fluorescent Protein was first crystallized in 1974 and diffraction data
collected in 1988, but it was not until 1996 that two independent groups determined
the structure of the protein [32-34]. Figure 1-4 shows the two crystal structures, Panel
A by Ormo et al and Panel B by Yang et al.

A

B

Figure 1-4: Panel A shows X-ray crystal structure of GFP solved by Ormo et al, PDB#
1EMA. Panel B shows X-ray crystal structure of GFP solved by Yang et al, PDB# 1GFL.
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The structure is an 11-stranded β-barrel with an α-helix running through the
middle of the structure and attached to the chromophore. Based on the X-ray crystal
structure, it became clear that the chromophore is buried almost perfectly in the center
of the protein. It also became obvious that there was no way to truncate the protein in
order to make it smaller.
The GFP has a major peak excitation at 395 nm and a minor peak excitation at
475 nm, with corresponding peak emissions at 508 nm and 503 nm respectively. As a
result of various mutations, different variants of green fluorescent protein can be
produced that are excited and emit at different wavelengths and can be classified as
yellow, cyan and blue fluorescent proteins [32].
Although the chromophore is protected inside the barrel of the protein and is
typically insensitive to changes in the chemical environment, there are a few overall
stability issues that inevitably affect fluorescence. It was found that after raising the
temperature of the solution above room temperature, wild type GFP was unable to
properly fold. Subsequent mutations of GFP allow for it to be folded properly at 37 °C
[32]. In addition, changing to a high pH decreases excitation amplitude at 395 nm and
gains amplitude at 470 nm, although pH > 11 is physiologically irrelevant and only
interesting biochemically.
There are quite a few techniques available to study intracellular process in live
and fixed cells using fused fluorescent proteins.

There are a number of passive

applications that utilize fluorescent proteins as spatial or temporal markers. The protein
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trap strategy fuses fluorescent proteins to a library of cloning DNA sequences and based
on their localization pattern, interesting proteins can be cloned and identified. Fusion of
fluorescent proteins can also yield information about the production of small molecule
messengers and gene activity/transcripts [18].
Fluorescence can serve as a temporal marker in several ways. First, fused
proteins can serve as an indicator of gene expression. In addition, they can provide a
temporal history by using a specifically designed fluorescent protein, DsRed, that
changes from green to red fluorescence over a 24-hour period. The ratio of green to red
fluorescence will provide the temporal history of the promoter activation [18].
Accumulation and degradation of fluorescent protein fused substrates can provide
dynamic information about intracellular complexes.

Finally, protein diffusion and

trafficking can be monitored over time with the use of fused fluorescent proteins [17].

1.2.3 Is an in-cell structural biology technique possible?
With all of the available structural and cell biology techniques available, it is still
impossible to obtain structural information from proteins inside living cells. X-ray
crystallography cannot be used since that requires a solid crystal consisting of a purified
protein at a high concentration. Cyro-EM is excluded for similar reasons. Although a
pure sample is not required, there is the problem of flash freezing a sample to cryogenic
temperatures that may result in artifacts. In addition, although in theory cryo-EM can
reach Angstrom resolution, in practice, it still has nanometer resolution.
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In-cell NMR is still in the infant stages of development. There are several
challenges to overcome concerning in-cell NMR [35, 36]. The first challenge is the
introduction of an isotopically labeled protein into the cell. Protein transduction is
highly inefficient with currently available methods and using the cells themselves to
produce the isotopically labeled protein results in native proteins being labeled as well.
The second problem is the millimolar concentration requirement. In order to achieve a
good signal to noise ratio, the concentration of protein must be high to the point it
becomes physiologically irrelevant.
As far as the available cell biology techniques are concerned, they all share the
common problem of low-resolution. Of course, there have been advances made with
single molecule studies and super-resolution fluorescence imaging.

But the fact

remains, that many of these techniques are in their infant stages and/or require
expensive equipment not available to most labs [37, 38]. Fluorescent proteins are not
sufficient to calculate intra- or intermolecular distances with angstrom resolution.
Figure 1-5 illustrates the differences between fluorescent proteins and small
molecule fluorophores in terms of sensitivity to changes in the environment. In the top
half of the figure, a fluorescent protein is shown fused to an unfolded target protein.
Since the chromophore is shielded by the barrel of the protein and is far removed from
any changes that the target might be undergoing, be it folding, post-translational
modification or protein-protein interactions, the fluorescent protein is insensitive to
these changes. Small molecule fluorophores on the other hand are small enough to be
bonded to the target protein itself, in various spots if necessary. Since they are bonded
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to the sidechain of the target protein, any changes in its chemical environment caused
by folding or modifications can be detected.

Figure 1-5: Comparison between GFPs and SMFs concerning sensitivity of fluorophore to
changes in its environment.

In order for atomic-resolution information to be gained from inside living cells
and have the technology be easily accessible to the average structural biology lab, we
need to utilize a few unrelated techniques. First, bacteria could be used to produce
large quantities of recombinant protein. This will be followed by specific labeling with
small molecule fluorophore donor and acceptors. Next, the protein will be transfected
into living mammalian cells. This will generate live mammalian cells that contain only
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one protein that is labeled with a fluorescence donor and acceptor. Such a specifcallly
labeled mammalian cell allows us to perform FRET experiments. We think that by
introducing exogenously produced proteins labeled with small molecule fluorophores
into living cells, it will be possible to obtain structural information using FRET. The next
review section takes a closer look at the history and applications of FRET.

1.3

Förster resonance energy transfer (FRET)

1.3.1 History and mathematics behind FRET
Theodore Förster published the first paper concerning Förster (or Fluorescence)
resonance energy transfer in 1946 [39]. FRET is defined as the physical phenomenon in
which there is a non-radiative transfer of energy via long-range dipole-dipole coupling
between a donor and acceptor molecules [40]. There are three basic requirements in
order for FRET to occur (Figure 1-6):
(1) The donor and acceptor molecule must be within 1-10 nm of each other
(Figure 1-6, Panel A).
(2) The emission spectrum of the donor must overlap the absorption spectrum of
the acceptor (Figure 1-6, Panel B).
(3) The dipoles of the donor and acceptor molecule cannot be perpendicular
(Figure 1-6, Panel C).
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Figure 1-6: Panel A – donor emission spectrum must overlap acceptor absorbance
spectrum. Panel B – donor and acceptor dipoles must not be perpendicular to one
another. Panel C – donor and acceptor molecules must be between 10 and 100 Å of one
another.
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The rate of transfer (kt) is proportional not only to the distance between the
donor and acceptor (r), but also the unperturbed lifetime of the donor (τo) and the
Förster distance (Ro – the distance at which energy transfer is 50%):
[1]

kt = *( )
The efficiency of energy transfer (E) is a quantitative measure of the number of

quanta that are transferred from donor to acceptor. E is also known as the quantum
yield of energy transfer. To determine the efficiency of energy transfer, we can multiply
the rate of transfer (kt) by the first excited singlet state lifetime (τ):
[2]

E = kt*τ =

where

= kf + knr + kisc + kpb

and

=

+ kt

We can also determine E by measuring the steady-state donor fluorescence
intensity from a sample containing only the donor and another sample containing the
donor-acceptor pair [40].
[3]

E=1-

Where QD is the quantum yield of the sample containing only a donor and QDA is the
quantum yield of the sample containing both the donor and acceptor.
By setting equation [2] equal to equation [3] and solving for r, we can now
calculate the distance between the donor and acceptor on our protein:
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[4]

r = Ro (

)

These calculations can be greatly simplified by using a donor-acceptor pair with a known
Förster distance (Ro). Calculations are still possible without having a known Ro value, but
you must use equation [5] to determine this value:
[5]

= coκ2Jn-4kf τo

Where co = 8.8 x 10-28 nm, κ2 is the orientation parameter, typically valued at , J is the
overlap integral of the donor emission and acceptor absorption spectra, n-4 is the
refractive index, typically valued between

and , and kf is the radiative deactivation

rate constant [41].
When deciding on a donor-acceptor pair, the effective range must be taken into
consideration. Organic fluorophores and fluorescent proteins typically have an R0 value
around 5 nm yielding an effective range of 3 – 8 nm which corresponds to the 5 – 95 %
range of E where changes can still be detected sensitively [38]. However, due to
experimental limitations, such as noise, the useful range is around 4 – 7 nm. Therefore,
when choosing a donor-acceptor pair with a known R0 value, it is necessary to calculate
the effective/useful ranges to ensure the likelihood of obtaining observable FRET
efficiencies.
Another consideration when deciding upon a donor-acceptor pair is the type of
FRET experiment to be performed. There are four general categories FRET experiments
can fall into: (1) methods that monitor changes in donor fluorescence, (2) methods that
examine changes in acceptor fluorescence, (3) methods that simultaneously measure
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changes in both donor and acceptor fluorescence and (4) methods that monitor changes
in the orientation of the fluorophores [42]. Depending upon which type of experiment
is chosen, the photostability of the fluorophore may need to be high or low.

1.3.2 Discovery of fluorescent proteins (FPs) and FRET applications
After it was demonstrated that the GFP could be fused to target proteins and
expressed inside other organisms, a number of both intramolecular and intermolecular
FRET applications became possible [32]. One active application of intramolecular FRET
monitors conformational changes and involves sandwiching a protein between two
fluorescent proteins, typically CFP and YFP [17]. For example, a target protein may be
oriented in a way that keeps CFP and YFP more than 80 Å from one another or oriented
in a certain way, but upon binding of a ligand or phosphorylation there is a subsequent
conformational change that brings the two fluorescent proteins closer together or
changes the orientation of the chromophores and FRET becomes observable.
Another active application of intramolecular FRET is the monitoring of protease
activity within a cell. This is achieved by linking two fluorescent proteins with a short
region with the known protease cut site. At first, FRET should be observed since the two
fluorescent proteins are near to one another, but depending upon the rate of protease
activity, the FRET signal should slowly lessen as the active site is cut and the two
fluorescent proteins drift apart from one another [18].
One of the most common active applications of intermolecular FRET is the study
of protein-protein interactions, provided the fluorescent proteins get within 6 – 8 nm of
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one another [17, 18, 42]. Two target proteins are independently fused with different
fluorescent proteins (i.e., CFP and YFP) and if FRET is observed it can be assumed that
the two proteins interact with one another.

The big problem with studying

intermolecular FRET is that the ratio of donor and acceptor expression is no longer fixed
since they are not fused to the same protein. Endogenous proteins can also interact
with the fused proteins and reduce the amount of target proteins available for FRET
[18].

1.3.3 Limitations of FPs
There are several limitations of the fluorescent protein technology. First, GFP
contains only one fluorophore and it is not very bright. For low expressing fusion
proteins, this becomes a problem since the fluorescence signal is weak and difficult to
detect. Another limitation is the innate environmental insensitivity of the chromophore
caused by the shielding of the barrel structure. This prevents detection of minor
changes of the proteins environment as it is trafficking or undergoing conformational
changes [32]. The fluorescent proteins large size and possibility that fusion may affect
the protein’s function is another consideration [17].
When performing FRET experiments there are additional concerns.
colocalization does not necessarily indicate protein-protein interaction.

First,

Resolution

limits of conventional light microscopy prevents accurate determination of nearness
versus protein-protein interactions. FRET efficiencies measured in cells are often an
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ensemble measurement arising from both specific protein-protein interactions and from
random associations [42].

1.3.4 Advantages of small molecule fluorophores in FRET
Small molecule fluorophores are advantageous to use in FRET experiments for
several reasons [37]. As mentioned previously, these fluorophores are small (<1 kD) and
covalently attached to proteins without disturbing the structure. There are also much
brighter than fluorescent proteins are more easily detected when performing FRET
experiments.

Since they are so small, accurate distance measurements can be

calculated. Another major advantage to small molecule fluorophore is that they can be
attached to small proteins that would otherwise be overwhelmed by a large fluorescent
protein.

1.3.5 Synchronous fluorescence scanning spectroscopy
Synchronous scanning fluorescence spectroscopy is a technique that takes
advantage of the ability to vary both the excitation and emission wavelengths
simultaneously during data collection. In this technique, the fluorescence signal is
recorded when excitation and emission wavelengths are simultaneously scanned
keeping in between a fixed wavelength interval (called the offset value, Δλ) throughout
the spectrum. As a result, the selectivity for individual fluorescent components is
considerably improved; additionally, much more information on mixtures of fluorescent
compounds is gained [43, 44].

30

The tryptophan residues of a protein could be considered “fluorescent
components” as they are each in their own unique environment and could possibly have
unique spectral patterns. The immediate chemical environment of tryptophan residues,
such has being involved in hydrogen bonding or hydrophobic interactions, can have
effects on its fluorescent properties. These interactions could result in slight red or blue
shifts of its emission spectrum, causing different wavelengths of the FRET-peaks for
different tryptophan donor/IAEDANS acceptor pairs [45].
It might become possible to create a protein with multiple donors and a single
acceptor and obtain information about each donor/acceptor pair from one
measurement. These wavelength differences may possibly allow us to assign the FRETpeaks to an individual FRET donor/acceptor pair, if these synchronous scanning
fluorescence spectra can separate the individual FRET-peaks.

1.3.6 Can we use a small molecule fluorophore labeled protein for in-cell FRET
measurements to obtain atomic resolution distances between fluorescence
donors and acceptors?
Ideally, in order to obtain structural information from proteins inside living cells,
using fluorescence spectroscopy or imaging, they need to be labeled with small
molecule fluorophores since fluorescent proteins are large, independently folded
proteins separate from the target protein. However, currently there is no available
technique that allows specific labeling of a particular protein inside the cells with small
molecule fluorophores. Small molecule fluorophores may specifically adhere to a single
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amino acid in vitro, like cysteine or lysine, but they are unable to specifically label a
target protein while ignoring the other intracellular proteins. A few advances have been
made, with respect to targeting small molecule fluorophores to specific proteins within
a cell (i.e., “FlAsH” and “ReAsH”) but this requires a genetic insertion of a specific
sequence into the target protein that these fluophores can target [17].
On the other hand, if there was a way to label purified target protein in vitro and
introduce them efficiently into the target compartment of living mammalian cells at a
sufficient concentration, then performing in-cell FRET measurements should be
possible. Since proteins only perform their function inside the correct intracellular
compartment, the target capability of the protein delivery into the correct intracellular
compartment is essential for this approach.

In-cell FRET would require specific

excitation of a donor molecule on the target protein, followed by an observable
emission of the acceptor molecule also on the target protein. In recent years, there
have been several advances made in the field of exogenous protein delivery making this
application possible.

1.4

Exogenous protein delivery inside mammalian cells
The ability to deliver exogenous proteins into the specific intracellular

compartment of mammalian cells is of great interest for several reasons. First, protein
based therapy would be available for patients suffering from genetic diseases resulting
in non-functional proteins. It would be more beneficial and less risky than viral gene
delivery. In my case, I would like to selectively label bacterially produced proteins with
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probes and then deliver this specifically labeled protein into the correct intracellular
compartment of mammalian cells and perform live cell fluorescence spectroscopic
studies. This allows me to gain structural information of the labeled proteins within live
mammalian cells.

1.4.1 The CPP-based protein delivery technology and its limitations
Protein transduction is a technique that delivers proteins into living cells. It
emerged after the discovery of the cell penetrating peptides (CPP) [46, 47]. These CPPs
are small peptides with the ability to enter cells via an unconventional way, although
their transduction mechanism is still debatable [48, 49]. Fusion of a CPP with
proteins/DNAs/RNAs allows their intracellular delivery [48-50]. Protein transduction was
galvanized by a report on the ability of CPP to deliver β-galatosidase to multiple tissues,
including the liver, spleen, lung, heart and brain, in mice [51]. Efforts have been made to
pursue non-peptide protein delivery reagents. Polyethyleneimine (PEI) is found to have
the ability to deliver protein and DNA intracellularly [8, 52]. A small-molecule mimic
(SMoCs) of CPP has been reported to have a similar protein delivery property [53].
Despite these notable successes, protein delivery technology has yet to become
commonplace for biomedical applications [46, 47]. The CPP-fused proteins share
common problems. The CPP-fusion changes protein sequence and intracellular
proteases likely degrade the delivered proteins, if they are not folded properly, before
they reach their target intracellular compartment. The CPP-fusion also lacks targeting
capability to specific intracellular compartments, significantly restricting their
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applications. It remains unknown if the intracellular folding machinery can refold the
CPP-delivered bacterial expressed proteins. Blobel’s “signal theory” guides the fate of
endogenous proteins, dictating their intracellular locations and trafficking [54, 55].
Questions remain regarding whether the CPP-delivered proteins follow the same
intracellular trafficking/secretion pathway inside cells. These are critical questions
regarding the physiological relevance of protein delivery technology.

1.4.2 The QQ-protein delivery technology
Recently, our lab has developed a QQ-reagent based protein delivery technology
that has solved the problems related to the CPP-based technology [Li 2011]. The QQprotein delivery has several novel features, including non-covalently association with
proteins, protection from intracellular protease degradation and the target capability to
specific intracellular compartments. These features enable the delivered proteins to be
indistinguishable from their endogenous counterparts by the cell machinery. It is further
demonstrate that the intracellular folding machinery properly refolds the delivered
proteins and the refolded proteins follow the same trafficking pathway as their
endogenous counterparts. Indeed, QQ-protein delivery provides new tools in cell
biology studies, allowing one to introduce specific labeled proteins inside the cells for
high-resolution biophysical studies of these proteins at the molecular level.
The QQ-reagent is a cocktail of several commercially available compounds,
making this protein delivery technology easily accessible and affordable. The QQ-protein
delivery only requires an incubation step of the QQ-modified proteins with cells. It
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enables delivering multiple proteins either simultaneously or consecutively. This allows
one to study protein-protein interaction in a consecutive way once these proteins are
labeled in different methods and consecutively QQ-delivered into the correct
intracellular compartment of the mammalian cells. The second novel feature of the QQreagent is its high delivery efficiency and the delivered proteins can be easily detected
by a SDS-PAGE. Although the mechanism of the QQ-protein delivery is unknown, this is a
significant result since high delivery efficiency is critical for applications of a protein
delivery technology.
The intracellular toxicity of the QQ-protein delivery is minimal. Another novel
feature of the QQ-reagent is the non-covalent modification feature, allowing for
dissociation of the QQ-reagent from the delivered proteins inside cells. The QQ-reagent
protects the delivered proteins from intracellular protease degradation, solving the
major problem of the current protein delivery techniques. Since the delivered proteins
are coated with non-covalently associated QQ-reagent, they are initially camouflaged
from the intracellular proteases and cellular machinery even if they are misfolded. Once
inside the cells, the non-covalent association nature permits QQ-reagent dissociation
from proteins, thus, the QQ-delivered proteins become “naked” proteins similar to the
endogenous proteins. Therefore, the QQ-delivered proteins can reach their target
compartment based on their sequence localization signals. This allows the cellular
folding machinery to properly refold the misfolded, QQ-delivered proteins inside the
mammalian cells. More importantly, this design of non-covalent association allows the
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QQ-protein delivery to have a targeting capability to specifically deliver proteins into
their intracellular destinies.
These novel features of the QQ-protein delivery enable the delivered proteins to
be indistinguishable from the endogenous proteins by the cell machinery. Once inside
cells, the cell’s machinery functions as if the QQ-delivered proteins were the
endogenous counterparts. The development of this critical technology is the necessary
step needed to introduce a model protein labeled with a FRET donor and acceptor pair
to obtain in-cell FRET measurements. The model protein, MESD, is reviewed in the
following section.

1.5

MESD

1.5.1 LDLR Family
The low-density lipoprotein (LDL) receptor (LDLR) family members are utilized in
many biological processes, including cholesterol homeostasis, neuronal migration and
pattern formation during development. LDLR members act in two main ways – as
endocytic receptors or as receptors in signaling pathways. Variant LDLRs or their ligands
can contribute to several major human diseases, including hypercholesterolemia,
atherosclerosis, bone diseases and developmental and neurodegenerative disorders
such as Alzheimer’s disease.

In the Wnt/Wingless (Wg) signaling pathway, the

mammalian LDLR-related proteins 5 and 6 (LRP5/LRP6) are essential co-receptors for
binding to Wnts, controlling many aspects of animal development [56].
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1.5.2 The modular organization of the LDLR family
The structural organization of the LDLR family is complex and contains several
common modular structures, including: (1) complement-type repeats (Type A repeats),
(2) epidermal growth factor repeats (EGF) and (3) YWTD repeats which display a sixblade β-propeller structure. The receptors are anchored in the plasma membrane by a
single trans-membrane domain, followed by a cytoplasmic domain that contains signal
sequences for endocytosis and interaction motifs, such as the NPXY motifs, for binding
to cytoplasmic adaptors and scaffolding proteins.
The modular structures are complex and provide a challenging task for the cell in
regards to their correct folding. Specifically, they contain many cysteines which form
specific intramolecular disulfide bonds which contribute to the overall 3-dimensional
structure; in addition to the hydrophobic residues of the ligand binding region that
could potentially cause aggregation. Failure to achieve the native conformation or
protein aggregation can cause many diseases. The presence of molecular chaperones in
the ER prevent these problems from occurring.

1.5.3 Specific chaperones
Like most transmembrane and secreted proteins, LDLR family members enter
the secretion pathway as they are translated by endoplasmic reticulum (ER)-associated
ribosomes. These proteins fold and mature inside the ER and traffic from the ER
through the Golgi apparatus on their way to the cell membrane. Effective quality
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control systems in mammalian cells ensure that only the properly folded and matured
proteins can be exported from the ER and the misfolded proteins will be retained in the
ER and removed by ER-associated degradation (ERAD) [57]. Numerous chaperones and
folding enzymes function in the ER to ensure proper folding and maturation of most
proteins [58]. For the LDLR family, two specialized chaperones have been identified.
The receptor-associated protein (RAP) is an ER-resident chaperone that is
necessary for efficient folding and ER export of some LDLR family members [59]. RAP
also escorts the receptor trafficking from the ER to the Golgi and prevents premature
association of ligands that are also expressed in the same compartment with the
nascent receptor and thus may interfere with proper folding and trafficking of the
receptors [57].
Another specialized chaperone, termed mesoderm development protein (MESD)
in the mouse and boca in the fly, is essential for the Wg/Wnt signaling [60, 61]. Flies or
mice with nonfunctional boca or mesd gene die during embryogenesis and display
phenotypes that are consistent with an inability to transduce a Wg/Wnt signal.
Interestingly, MESD/Boca does not function as a direct component of the Wg/Wng
signaling pathway.

Instead, it functions as a molecular chaperone inside the ER

specifically for proper folding and export of the LDLR family, including LRP5 and LRP6
[57]. In the absence of MESD, LRP5/LRP6 fails to reach the cell surface and remains
sequestered as insoluble aggregates due to misfolding.
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1.5.4 MESD: Sequence, structure, mechanism
Our laboratory recently solved the NMR structure of MESD (Figure 1-7), which
includes two structural domains: a central core domain and a C-terminal flexible helical
domain [62]. Mutagenesis and functional data indicates that the central core domain is
the chaperone domain which promotes LRP5/6 folding and maturation inside the ER,
whereas the C-terminal flexible helical domain is the escort domain that safe-guards the
properly folded receptor trafficking from the ER to the Golgi.

Figure 1-7: NMR structure of MESD (solved by Chen 2011, PDB# 2KGL).

Looking at Figure 1-8, we can see that residue W32 is highly conserved amongst
all species. Mutation of this residue is fatal and development does not get past the
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embryonic stage. In addition, all species have conserved lysine residues in both the Cand N-termini that are important for MESD’s chaperone and escort functions. Finally,
each species ends in an ER retention signal (KDEL for the fly and C. elegans species and
RDEL for mammals) [62].

Figure 1-8: Sequence Alignment of MESD from Four Species. The secondary structure of
MESD is displayed under the sequence based on our NMR structure. In the sequence
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alignment, the critical receptor-binding residues in both the central core domain and the
C-terminal flexible helical domain are highlighted in green. For residues that are
involved in the binding pocket of W32 are highlighted in yellow. The other conserved
Lys/Arg residues are highlighted in grey. The sequence of MESD(60-155) is shown in blue
with the helical residues colored in red and β-strand residues in green.

1.5.5 MESD promotes folding of BP domain of LRP5 and LRP6
A cell biology picture of the MESD/LRP5/6 pathway, shown in Figure 1-9 suggests
that it is the specialized chaperone MESD that determines proper folding of the BP
domain of LRP5/6, whereas the BP domain strategically regulates structural switches of
the two structural domains of MESD in a unique fashion to ensure both proper folding
and safe trafficking of the receptor along the secretory pathway, as well as the ERretrieval of MESD protein. Chen et al suggest that the escort function may be a recent
evolutionary acquisition of these chaperones, since Boca, the Drosophila ortholog of
MESD, lacks the C-terminal escort domain. By strategically placing fluorescent probes to
serve as donor and acceptors, it might be possible to prove the exact point of
interaction between MESD and the BP domain of LRP6/6.
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Figure 1-9: The MESD/LRP5/6 Pathway. The rigid chaperone domain (Ch) of MESD binds
to the newly synthesized BP domain of LRP6, serving as a folding template. After BP
domain properly folded, MESD switches the binding from the rigid chaperone domain to
the flexible escort domain (Es), safely guarding the mature receptor traveling from the
ER to the Golgi, preventing premature ligand (Lig) binding. The acidic environment of
the Golgi activates the histidine switch in the BP domain that leads to the dissociation of
MESD from the receptor. MESD will be retrieved back to the ER by the KDEL-receptor.
The properly folded receptor will be properly post-translationally modified and further
reach the cell membrane for activation of canonical WNT pathway. RAP goes through a
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similar cycle for promoting the ligand-binding domain folding and trafficking as
described before [57].

1.5.6 Unanswered biological questions
1.5.6.1 MESD ER concentration versus LRP5/LRP6 folding
As mentioned previously, chaperones and folding enzymes are present in the ER
to prevent misfolding and subsequent degradation by ERAD. During the unfolded
protein response (UPR), protein translation is halted and there is upregulation of the
production of molecular chaperones. It is unknown at what concentration MESD exists
in the ER of cells or to what level it is elevated during the UPR. How much MESD is
necessary to ensure LRP5/LRP6 are folding efficiently? Currently, there are no methods
available to determine the intracellular concentration of a protein inside live cells.

1.5.6.2 MESD ER and Golgi structures versus NMR structure
MESD has two distinct domains that serve as a chaperone and then as an escort.
It is thought that the change of environments from the ER to the Golgi causes the
change from chaperone to escort [62]. Since the Golgi is a more acidic environment than
the ER it is possible that there is a structural change. There are inhibitors available that
will inhibit transport from the ER to the Golgi and vice versa. It is possible, therefore, to
create a batch of mammalian cells with a strict population of MESD located in the ER
only and a separate population of MESD located in the Golgi only. Measurements could
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be taken in these separate compartments to determine if there is a difference in
distance calculations indicated a structural change between the ER and Gogli.

1.5.6.3 MESD serves as a model protein for our technique to address unanswered
questions
MESD serves as an excellent model protein for this thesis due to a number of
reasons. First, it has three tryptophan residues that can act as FRET donors. By using a
native residue, there will be no need to add an additional probe to serve as the donor.
It is also easy to mutate one or two tryptophan residues at a time to reduce the number
of donors, since the simplest measurement involves one donor and one acceptor.
Second, the sequence contains one cysteine residue.

There are a number of

commercially available small molecule fluorophores that are thiol reactive and will
covalently bind to the cysteine residue and serve as the FRET acceptor. Third, the MESD
sequence contains an “RDEL” ER-retention signal. This ensures that after the protein
has been delivered inside the mammalian cell using the QQ-protein delivery technique,
it will traffic to the ER and remain there.
Once several basic methodologies have been established, we can also use the
MESD protein to answer several questions pertaining to MESD’s structure and function
within the ER and Golgi. The first step into answering these questions is the production
of a large quantity of pure protein to be used in these structural studies. Bacterial
expression is still one of the best methods for protein production on a large scale.
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1.6

Bacterial protein expression

1.6.1 Recombinant protein production
Recombinant protein expression allows for the production of large quantities of
protein to be used for laboratory study or industrial purposes, typically therapeutics.
Depending upon the final purpose of the protein, scientists choose a host organism to
insert recombinant DNA into that will ultimately produce their target protein in a
controlled fashion. There are many options available for host organisms, including both
prokaryotic and eukaryotic cells, and there are advantages and disadvantages of each
type of host.

1.6.1.1 Prokaryotic expression systems
Bacterial expression systems are the most attractive organisms for heterologous
protein production for a number of reasons. The ability to reproduce rapidly and grow
at high densities results in high yield protein production, as compared to eukaryotic
systems. In addition, bacteria can generally be grown in inexpensive medium and a
large amount of protein can be produced in one day. Bacterial hosts typically have well
characterized genetics that can be manipulated to create even better hosts. Finally, due
to all of the mentioned advantages, there are a multitude of commercially available
products, including bacterial strains, bacterial expression vectors and protein
purification materials, to aid in heterologous protein production utilizing bacterial
expression systems [63-66].
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Escherichia coli remains the most commonly used bacterial host for all the above
mentioned reasons. Expression of eukaryotic proteins inside a prokaryotic cell does not
always result in a properly folded and active protein. However, techniques to optimize
heterologous protein overproduction in E. coli have been explored that significantly
enhanced the yield of the foreign eukaryotic proteins. Two recent excellent reviews
summarized these optimizations (Table I in Refs. 2 and 3). Some empirical “rules,” for
host strain selection, plasmid copy numbers, promoter selection, mRNA stability, and
codon usage, have been derived from these optimizations that can be used to guide the
design of expression system and to limit the unpredictability of protein expression in E.
coli [64, 65]. However, an important optimization is cell growth conditions and media,
which seems to be target protein dependent and there does not seem to be any
empirical rules reported to date in this aspect [5].
Although E. coli is the most popular host, other bacteria have been utilized as
well. Kay Terpe provided an informative review of all the various bacterial systems that
have been used over the years [66]. Gram-positive bacteria such as Bacilli strains,
Streptomyces, and Staphylococcus carnosus have been used since they typically have
lower protease activity, high secretion capacity and have produced protein in a soluble
form when E. coli was unable to do so. Gram-negative bacteria such as Caulobacter
crescentus, Methylobacterium extorquens, Pseudomonas fluorescens and Ralstonia
eutropha have been used to take advantage of their unique properties.

These

properties include the ability to secrete target proteins into media, growth on a single
low cost substrate, production of highly enriched proteins with stable isotopes and
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remarkably high yields of target proteins. These bacteria provide several advantages
over an E. coli system, but due to their rare use, E. coli still proves to be a more
economical choice.

1.6.1.2 Eukaryotic expression systems
In contrast, eukaryotic expression systems are utilized when a full length,
properly modified and active protein is required. A eukaryotic host, such as mammalian
cell culture systems, has the necessary machinery to properly fold and posttranslationally modify target proteins. Mammalian cells lines produce proteins most
closely resembling those made by human cells in the body. However, maintenance of
mammalian cell lines is complicated, costly and protein yield is typically low [4, 67, 68].
In recent years, yeast systems such as Saccharomyces cerevisiae and Pichia pastoris
have been utilized with moderate success. Yeast has the advantages of both prokaryotic
and eukaryotic expression systems. They rapidly grow and are of lower maintenance
and cost, like prokaryotic systems, while having the added advantage of improved
folding and post-translational modifications [67]. However, there are problems that
include but are not limited to hyperglycosylation and reduced secretion [68].
Protein production can also be performed in insect cells using the baculovirus
system. The target gene is inserted into the baculovirus genome and insect cells or
larvae are infected with the mutated virus [69]. Protein production is similar to that of
mammalian cells, in that the insect cells will properly fold and post-translationally
modify the protein. The main advantage of the insect system is the robust nature and
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inexpensive cell culture [4].There are a few disadvantages of the insect system that
prevent it from being more widely used. Specifically, there are complications from the
baculovirus that lead to proteolytic activity and impaired protein production [68].
Filamentous fungi and plants have also been utilized for recombinant protein
productions with limited success. Filamentous fungi have a more advanced posttranslational modification complex, similar to mammals. However, little is known about
their genome and metabolic pathways that there has been successful production of only
a few proteins [68]. Plants cells have also been used sparingly as they have problems
with glycosylation and proteolysis [64].

1.6.1.3 Cell-free expression systems
Another alternative to bacterial expression is the utilization of cell-free systems.
In order to create a cell-free system, cells of bacterial, plant or mammalian origin are
grown to a certain optical density. Afterwards, the cells undergo a series of
centrifugation and lysis ending in the isolation of the subcellular protein producing
machinery [70]. Cell-free systems are advantageous for a number of reasons. First, they
solve the problem of eukaryotic proteins that are toxic to bacterial cells. Second, they
have increased production since all the metabolic resources will be singly focused on
protein production [71].

Finally, cell-free systems that have been isolated from

eukaryotic cells have the ability to post-translationally modify the target protein [4].
Another recent advancement has shown that by addition chaperonins and glutathione
redox buffer improved the folding yields of recombinant proteins produced with a
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bacterial cell-free system [71]. Many of the problems associated with cell-free systems,
such as low protein yield, have been solved by optimizing lysate preparation and
experimental conditions.

The last remaining hurdle is the expensive nature of

purchasing commercially available kits or creation of in-house lysates and reaction
buffers [4, 70, 71].

1.6.2 Heterologous protein expression in Escherichia coli
Once the decision has been made to produce a target protein in a lab, several
decisions must be made. First, should the target protein be produced in bacteria, yeast
or mammalian cells? Second, what type of vector should be used? It is suggested that E.
coli be used as the expression host when first attempting expression due to its rapid
results and inexpensive nature [5]. In order to express recombinant proteins inside of
bacteria, a gene construct must be made that includes the target gene inserted in a
plasmid containing a regulated promoter region. The plasmid also contains an affinity
tag that will be attached to the target protein that allows for purification after
expression.
The pET expression vector is a powerful system developed for the cloning and
expression of recombinant proteins in E. coli. Based on the T7 promoter-driven system
originally developed by Studier and colleagues, Novagen's pET System has been used to
express thousands of different proteins [72-74]. In pET vectors, target genes are cloned
under control of strong bacteriophage T7 transcription and translation signals, and
expression is induced by providing a source of T7 RNA polymerase in the host cell. The
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host cell typically has the T7 RNA polymerase gene in the host chromosome under
lacUV5 control and therefore is not expressed until an inducer is added. The lacUV5
promoter is a mutated version of the lac operon promoter with decreased basal activity.
Inducing expression of the T7 RNA polymerase with lactose, or a lactose analog like
IPTG, results in over-expression of the target gene.
In addition to efficient vectors, several bacterial strains have been developed to
facilitate large quantity production of recombinant proteins and they are commercially
available. For example, a BL21(DE3) bacterial strain, developed by Brookhaven National
Laboratory, knocks out intracellular protease expression inside this bacterial strain [75].
This solved the problem associated with protease digestions of the expressed
recombinant protein, significantly enhancing the yield of recombinant proteins. To
overcome codon bias and intracellular toxicity of the recombinant proteins, several BL21(DE3) bacterial strains, including BL-21(DE3)pLys and BL-21(DE3) CodonPlus, have
been developed [65, 66].
If the target protein is produced without any biophysical probes, the bacteria are
grown in rich medium to a desired optical density. The inducer is added and the culture
continues to grow for a specific period of time. The cells are harvested and the protein
can be purified based on the affinity tag used.

1.6.3 Protein production in minimal medium
Structural biologists often need to specifically label recombinant proteins with
biophysical probes for their studies. Proteins may be labeled with selenomethionine for
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X-ray crystallography studies or stable isotopes (2H/13C/15N) for NMR studies amongst
other possibilities. Using any expression system besides a bacterial expression system is
highly inefficient and expensive.
The standard protocol for specifically labeling proteins with biophysical probes
involves first growing bacterial cells in a rich medium, followed by transfer to minimal
medium.

Minimal medium has one specific carbon source (glucose) and a single

nitrogen source (ammonium chloride or ammonium sulfate) in addition to various salts,
minerals and metals. The culture is grown until a desired density is reached, then an
inducer is added that allows for expression of the target protein. However, expression
in minimal medium often results in lower protein yields as compared to growth and
expression in rich medium. This is especially true when attempting to make triplelabeled proteins for NMR studies, which requires growth in D2O-based minimal medium.
Minimal medium is also necessary to specifically label proteins with amino acid
analogues or isotopically labeled amino acids. The problem of “scrambling” arises since
bacteria have the ability to synthesize all twenty amino acids. To ensure that bacteria
do not synthesize their own amino acids, auxotrophic bacterial strains are used.
Auxotrophic bacterial strains usually contain some type of genetic mutation inhibiting
biosynthesis of a specific amino acid(s). Minimal medium supplemented with the
specific amino acids must be used even when working with an auxotrophic strain since
rich medium will contain the standard amino acids.
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1.6.4 Auto-induction method
Recently, Studier introduced an auto-induction bacterial expression method,
which provides several advantages over the standard IPTG induction method, including:

(1) Achieving a high cell density (leading to higher target protein production and
(2) Minimal handling as there is no need to monitor cell growth for induction
[76].

In order for auto-induction to occur, the growth medium must contain varying
amounts of glucose, glycerol and lactose. The bacteria will utilize glucose initially as its
energy source and naturally repress induction despite the presence of lactose. Once the
glucose has been depleted, induction will occur since the bacteria will use glycerol as its
energy source and lactose will remove the repressor protein that is preventing
induction. An inducer molecule, like IPTG, is not needed since the lactose metabolite,
allolactose, is the native molecule necessary to remove the repressor protein from the
lac operon. This method is extremely low maintenance, as it is only necessary to
inoculate the culture medium and wait for the culture to saturate.
Studier and others devised various recipes for different auto-induction medium,
depending on the final use of the target proteins, including auto-induction minimal
medium for proteins to be used for structural studies. This method has been used to
prepare 13C/15N double-labeled proteins for NMR studies and selenomethionine-labeled
proteins for X-ray crystallographic studies, both produced a moderate yield of target
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proteins (~40 mg/L) [77, 78].

Our lab also developed a modified recipe for the

production of triple-labeled proteins (2H/13C/15N) in D2O-based auto-induction minimal
medium [79].
When using the auto-induction method to produce isotopically labeled proteins
in our lab, we noticed a few problems. First, a high cell density culture did not
guarantee high yield protein production. Second, when expressing proteins in the autoinduction minimal medium, expression times could take up to several days, especially
with D2O-based medium. Another issue was the expensive

13

C-glycerol that is a key

ingredient in auto-induction method. All of these problems lead us to re-evaluate our
expression method and develop a method that produced a consistently high yield of
target proteins [79].

1.6.5 High cell-density bacterial expression method
In order to solve the problems we encountered while using the auto-induction
method, we developed a bacterial expression method that maintains the advantage of
the tightly controlled induction by IPTG and utilizes both rich and minimal media to
achieve a very high cell density for production of a very high yield of recombinant
proteins. Unlike the auto-induction method that incorporates minimal medium, our
high-cell-density method does not require long time durations for achieving a high cell
density, which is much more time efficient. This method starts with a cell culture grown
in rich medium that allows for a significantly enhanced initial cell density at the OD600
values of 3–7 before IPTG induction, depending on the rich medium used. After
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switching the cells into the minimal medium, the bacterial cells are cultured at a
previously optimized temperature for 1.0–1.5 h and induced with IPTG for protein
expression. With both auto-induction and the high cell density IPTG-induction methods,
the final cell density before cell harvest can reach to OD600 of 10–20, resulting in very
high yields of protein production [79].

1.6.6 Three critical protocols to ensure a very high yield production of pure
recombinant proteins
During the course of developing our new hybrid expression method, we
developed three critical protocols that would ensure consistent, high yield protein
production. First, expression must begin with a proper starting culture. Typically,
starting cultures are grown in rich medium overnight ending in a saturated culture that
will be diluted in minimal medium for expression. We found that the best results were
obtained when a starting culture was only allowed to grow to mid-log phase of its
growth curve. Second, double colony selection must be performed to ensure a colony
with a stable, high expressing plasmid has been chosen. It is standard practice to screen
colonies after transformation to choose a high expressing colony, but we found that
performing a second round of selection resulted in a more reliable glycerol stock. Third,
optimization of induction temperature, time and IPTG concentration must be performed
on every protein as all of the variables are protein dependent and can vary widely.
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1.6.7 High level expression as used in my research
In order to perform in vivo FRET experiments, my target protein must be labeled
with an amino acid analogue which requires growth in minimal medium. The first
advantage to using our new hybrid method is the repeatability of the results. We found
that after performing double colony section, we never had a problem repeating the high
yield expression as compared to the auto-induction method. The second advantage is
the extremely high yield of protein production directly due to the high cell density of the
culture. Third, since we first grow the culture in rich medium before transferring to
minimal medium, we can obtain a high yield of protein production typically in a single
day. The auto-induction method using minimal medium can take up to three or four
days. The hybrid method we developed provides us with consistent, high yield target
protein. High level expression ensures that I could efficiently produce enough protein to
be used in both the in vitro and in vivo experiments.

1.7

Selective labeling of amino acids in recombinant proteins

1.7.1 Uses for selective labeling of amino acids
In structural biology, two of the atomic resolution techniques take advantage of
selective labeling.

When performing X-ray crystallography, the multi-wavelength

anamolous diffraction [8] method requires the target protein to be labeled with an atom
that will absorb or scatter X-rays in a specific way [80]. Most commonly this is achieved
by incorporating selenomethionine (Se-Met) into the protein. Se-Met is identical to the
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original amino acid structure except for the replacement of the sulfur atom with
selenium.

Selenium shares chemical properties with sulfur, but causes unique

diffraction patterns at various wavelengths. Incorporation of Se-Met into a protein does
not change the protein’s structure or function. However, the selenium atom that has
been incorporated into the amino acid helps determine the phase of the crystal
structure by measurable changes in the diffraction pattern and therefore allows for
structure determination [80]. Prokaryotic expression systems are the most commonly
used to produce proteins labeled with Se-Met and can typically achieve 90-100% Se-Met
incorporation. Yeast and insect cells systems have been used, but Se-Met incorporation
is much lower and the selenomethione can be toxic to the host cell [9].
NMR experiments require target proteins to be isotopically labeled with isotopes
containing NMR active, nuclear half spins (i.e., 1H, 13C, 15N and 19F). Depending upon the
size of the protein and what structural information is desired, a protein can be uniformly
labeled with general isotopes, like 13C and 15N. This is achieved by growing the bacterial
culture in minimal medium that contains a 13C-carbon source, typically 13C-glucose, and
a

15

N-nitrogen source, typically

15

N-ammonium chloride.

This ensures that all the

carbon and nitrogen atoms have an active spin that can be utilized by specific pulse
sequences.
If the target protein is over 25 – 30 kD, suffers from severe spectral overlap or if
you want to only see specific changes in a particular region of a protein, like an active
site, the protein can be selectively labeled with isotopic amino acids. There are several
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methods available to achieve this goal. Originally, selective labeling was achieved by
growing the auxotrophic bacterial cells in a defined minimal medium, excluding the
nitrogen source and supplementing with all 20 amino acids including the labeled amino
acid of interest [81]. More recently, cell-free systems are being widely used as well as
alternative bacteria, like Brevibacillus choshinensis [82].

Selective “unlabeling” is

another alternative which allows the protein to be uniformly labeled with

13

C and

15

N

with the exception of certain unlabeled amino acids that are supplemented in the
medium [83]. Spectra collected from a selectively unlabeled sample is compared to a
uniformly labeled sample, the missing crosspeaks can then be assigned.

1.7.2 Potential problems for amino acid selective labeling
Whether the protein will be used in an X-ray experiment or an NMR experiment,
there are a few problems involved with selective labeling. First, the protein yield will be
reduced when grown in the required defined minimal medium. This is especially true
when selectively labeling with amino acid analogues. The analogues do not fit as well
into the specific pocket of the tRNA synthetase.
A second problem is the fact that E. coli can produce all 20 amino acids and the
biosynthetic pathways are redundant at times (Figure 1-10), this can lead to one of two
results: (1) the breakdown of the labeled amino acid and incorporation into another
amino acid, called “scrambling” or (2) the production of the native amino acid from
other supplemented native amino acids.

The first result occurs either because a
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particular amino acid is a direct metabolic precursor to another amino acid or is
susceptible to aminotransferase [84]. For example, if you were trying to label a protein
with an isotopic asparagine residue, that residue could be broken down and
incorporated into aspartate (and all the other amino acids it is related to) or the bacteria
could use the normal aspartate that is provided in the defined minimal medium and
produce non-labeled asparagine itself.
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Figure 1-10: Amino acid biosynthesis pathways [85].

1.7.3 Auxotrophic bacterial strains
One way to prevent scrambling is to inhibit the biosynthetic production of the
amino acid in question during induction [86].

However, inhibition is not 100%;

therefore incorporation of the amino acid analogue is not 100% but can be as high as
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greater than 90% [9]. In order to achieve 100% incorporation and prevent scrambling,
auxotrophic bacterial strains have been developed by various labs [9, 84].
Auxotrophic bacteria strains are typically created by altering the genome in
some way that an important enzyme in an amino acid’s biosynthetic pathway is
rendered nonfunctional. Depending upon where the enzyme acts in the pathway,
several amino acids could be affected or a single amino acid is affected. Using the
asparagine residue as a simple example, it was found that by creating a lesion in the two
genes (asnA and asnB) responsible for converting aspartate into asparagine, a bacterial
strain auxotrophic for asparagine could be created [84].
When using auxotrophic bacterial strains, the bacteria culture is grown in
minimal medium supplemented with the necessary amino acids, but the standard
carbon and nitrogen source can once again be used. Since the bacteria cannot produce
the amino acid it is auxotrophic for, there is no chance of scrambling the label.

1.8

Summary of the literature review
In order to perform protein structural studies using biophysical techniques, pure

protein samples have to be made and these proteins have to be specifically labeled with
probes. In many cases, bacterial expression of proteins in minimal media with labeled
components significantly reduced protein yield and in some cases, result in no protein
production. In this literature review, I reviewed current literature of protein production
using different host systems, including mammalian cells, insect cells, yeast and bacterial
cells. I then focused on bacterial protein expression methods with emphasis on our
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newly developed high cell-density method and the three practical protocols that ensure
this high cell-density bacterial expression method to routinely produce large quantities
of pure recombinant proteins.
In order to develop a novel method to study protein structure inside living cells, I
then reviewed the literature of current structural biology techniques, including X-ray
crystallography, NMR and cryo-EM which are atomic resolution structural biology
techniques and fluorescence imaging and spectroscopy which are lower resolution
techniques. I discussed the advantages and disadvantages of each structural biology
technique and pointed out the possibility of applications for in-cell structural biology
studies of proteins using these techniques. With this discussion, I concluded that the
fluorescence technique may provide the best solution to study protein structure inside
the living cells under a physiological concentration. I further discussed the challenges in
developing an in-cell fluorescence technique that can be used to study protein structure
inside living mammalian cells under a physiological concentration.
The first challenge is to generate a pure, specifically labeled mammalian cell
population that contains only one protein, which is fluorescently labeled. I reviewed the
current in-cell fluorescence labeling techniques in the literature and discussed the
problems of using GFP for in-cell structural biology studies. I further pointed out that
small molecule fluorophores might solve the problem since these fluorescence probes
are sensitive to the changes in the chemical environment of the labeled protein, thus
they could to report any structural changes of this labeled protein inside living cells.
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However, there is no method in the literature that could specifically label a protein
inside mammalian cells with these small molecule fluorophores.
To solve this challenge, I proposed a novel strategy that labels a protein with a
small molecule fluorophore and then delivers this labeled protein into the correct
intracellular compartment of a living cell for structural studies of this protein. I further
proposed to use a tryptophan analog, 5-hydroxy-L-tryptophan (5-HT), as the
fluorescence donor for this proposed strategy, since 5-HT labeled protein might allow us
to separate the labeled protein from intracellular background proteins that contain
regular tryptophans. To achieve this novel strategy, I reviewed the literature of protein
labeling techniques with small molecule fluorophores and with specific amino acid
analogs. I also reviewed current protein delivery techniques and pointed out that our
newly developed QQ-protein delivery technique might serve as a physiological relevant
protein delivery technique to achieve this proposed novel strategy.
To gain protein structural information inside the cells under a physiological
condition, I proposed to develop an in-cell FRET technique to measure the distance
between a specifically labeled fluorescence donor and acceptor either within a protein
or between proteins. I reviewed the literature of the current FRET theory and its in vitro
applications. I further proposed to use a protein called MESD as a model protein for my
study. I reviewed the literature of MESD with the focus on the unsolved questions about
this protein for its structure and biological functions.
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CHAPTER 2
HIGH CELL DENSITY IPTG-INDUCTION BACTERIAL EXPRESSION FOR
PRODUCTION OF GRAM/LITER PURE RECOMBINANT PROTEINS

2.1

Introduction
In order to perform in vivo FRET experiments, the target protein must be labeled

with an amino acid analogue which requires growth in minimal medium with
auxotrophic bacterial strains. High level expression in minimal medium ensures that I
could efficiently produce enough proteins to be used in both the in vitro and in vivo
FRET experiments.
Bacterial expression systems are the most attractive organisms for heterologous
protein production for a number of reasons. The ability to reproduce rapidly and grow
at high densities results in high yield protein production, as compared to eukaryotic
systems. In addition, bacteria can generally be grown in an inexpensive medium and a
large amount of protein can be produced in one day. Bacterial hosts typically have well
characterized genetics that can be manipulated to create even better hosts. Finally, due
to all of the mentioned advantages, there are a multitude of commercially available
products, including bacterial strains, bacterial expression vectors and protein
purification materials, to aid in heterologous protein production utilizing bacterial
expression systems [63-66].
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Escherichia coli remains the most commonly used bacterial host for all the above
mentioned reasons. Expression of eukaryotic proteins inside a prokaryotic cell does not
always result in a properly folded and active protein. However, techniques to optimize
heterologous protein overproduction in E. coli have been explored that significantly
enhanced the yield of the foreign eukaryotic proteins [87].
Structural biologists often need to specifically label recombinant proteins with
biophysical probes for their studies. Using any expression system besides a bacterial
expression system is highly inefficient and expensive. However, bacterial expression in
minimal medium often results in lower protein yields as compared to growth and
expression in rich medium such as LB and 2X YT.
However, minimal medium is necessary to specifically label proteins with amino
acid analogues or isotopically labeled amino acids. The problem of “scrambling” arises
since bacteria have the ability to synthesize all twenty amino acids. To ensure that
bacteria do not synthesize their own amino acids, auxotrophic bacterial strains are
developed. Auxotrophic bacterial strains usually contain a certain type of genetic
mutation(s) inhibiting or knocking out biosynthesis of a specific amino acid(s). Minimal
medium still must be used even when working with an auxotrophic strain since rich
medium will contain all the standard amino acids. Minimal medium supplemented with
isotopically labeled amino acid(s) or amino acid analogues allows the auxotrophic
bacterial strain to grow and produce labeled proteins without scrambling.
Recently, Studier introduced an auto-induction bacterial expression method,
which provides several advantages over the standard IPTG induction method, including:
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(1) Achieving a high cell density and
(2) Minimal handling as there is no need to monitor cell growth for induction
[76].

However, we were unable able to obtain consistent results using this method. In
addition, protein yields were not very high using the auto-induction method although
the cell density could get quite high. Following the idea of auto-induction, we developed
a bacterial expression method that maintains the advantage of the tightly controlled
induction by IPTG and utilizes both rich and minimal media to achieve a very high cell
density for production of a very high yield of recombinant proteins. Unlike the autoinduction method, our high-cell-density method does not require longer time durations
for achieving a high cell density, which is much more time efficient. Most importantly,
we developed several practical protocols, to ensure high yield protein production at
high cell density. These protocols allow us to use regular incubator shakers and original
bacterial expression vectors. Our high cell density IPTG induction method is able to
produce nearly gram quantity of pure recombinant proteins from a liter bacterial cell
culture.

2.2

Materials and Methods

2.2.1 Bacterial strains, plasmids and media
Seven different proteins were tested, including two different constructs of
receptor-associated protein, RAP (1-210), RAP (91-323), truncation mutants of the
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human apolipoprotein E, apoE (1-183) and apoE (1-214), full-length apoE, a truncation
mutant of mouse apolipoprotein AI, apoAI (1-216), and full-length human apoAI. The
genes of these proteins were subcloned into different expression vectors as follows:
RAP (1-210)/pET30a, RAP (91-323)/pET30a, human apoE (1-183)/pET22b [88], human
apoE (1-214)/pTYB1 [89], apoE/pET30a-sHT [90], mouse apoAI (1-216)/pET30a [91]and
human apoAI/pET30a-sHT [92]. The pET vectors were from EMD Biosciences and the
pTYB1 vector was from New England BioLabs, MA. We engineered the pET30a vector to
introduce a Factor Xa site between the long his-tag and the target gene. The pET30asHT is also an engineered pET30a vector in which the long his-tag was replaced by a
short his-tag containing a six histidine tag plus a two serine linker. The pET30a and
pET30a-sHT are kanamycin resistant vectors whereas the pET22b and pTYB1 vectors are
ampicillin resistant vectors. The expression vectors were transformed in to BL-21(DE3)
bacterial strains.

2.2.2 Creating a proper starting culture
To find the best cell density to prepare proper starting cultures, we added
glycerol stock to a 5 mL LB culture containing the appropriate antibiotic and measured
the OD600 every 30 minutes for 10 hours. After plotting time vs. OD 600, we could
determine the various phases of bacterial cell growth: lag, exponential/log and
stationary. Once the mid-log phase could be determined, we will use the OD600 of the
mid-log phase as our starting culture. We noticed that different bacterial strains display
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different growth curves, thus have to be tested when a new bacterial strain is used for
the first time.

2.2.3 Traditional IPTG-induction bacterial expression method
We use this expression method to either check protein expression levels of
different colonies during double colony selection or serve as an expression control.
For double colony selection, we used a small-scale expression with the following
procedure: 2 mL of LB media was inoculated with a single colony from a freshly
transformed plate as the starting culture and cultured at 37°C. When the OD 600 reached
the middle of its growth curve (usually between 3 and 5), 50 µl of the starting culture
was added to 5 mL of the minimal M9 medium to obtain an initial OD 600 between 0.05
and 0.1. When the culture reached an OD600 of ~1.0, it was induced with 0.5 mM IPTG
and incubated at 20°C overnight [Human apoE (1-215), full-length apoE, mouse apoAI,
human apoAI, RAP (1-210), RAP (91-323)] or at 28°C for 16 - 18 h [human apoE (1-183)].
Two hundred fifty microliters of cell suspension was collected and spun down at 3300g
for 5 - 10 min. The cell pellet was resuspended in 50 µL of 2X SDS gel loading buffer and
heated at 90°C for 30 min. Cell debris and DNA molecules were pelleted by centrifuging
at a maximum speed for 10 min in a benchtop microcentrifuge. Finally, 10 µL of the
supernatant was loaded into the SDS-PAGE gel to check the expression level.
For the IPTG method as an expression control, we used a 50 mL expression with
the following procedure: 10 mL of LB media was inoculated with glycerol stock (after
double selection) as the starting culture and cultured at 37°C. When the OD600 of the
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starting culture reached between 3 and 5, 500 µl of the starting culture was added to 50
mL of the minimal M9 medium to obtain an initial OD 600 between 0.05 and 0.1. When
the culture reached an OD600 of ~1.0, it was induced with 0.5 mM IPTG and incubated at
20°C overnight [Human apoE (1-215), full-length apoE, mouse apoAI, human apoAI, RAP
(1-210), RAP (91-323)] or at 28°C for 16–18 h [Human apoE (1-183)]. The cells were
harvested and the cell pellet was used for protein purification.

2.2.4 Double colony selection
First, LB agar plates were prepared either in H2O or in 70% D2O (for triple-labeled
protein expression). For 70% D2O plates, the agar medium was not autoclaved, but
microwaved until the agar dissolved. Three milliliters of agar was poured into a 35 mm x
10 mm petri plate (Corning, NY). Bacterial cells, either from a glycerol stock or 5 µL of a
starting culture that has been diluted to an OD 600 of ~0.05 - 0.1, were streaked onto the
LB agar plates. Several colonies were picked from the plates next morning, and the
expression levels of these colonies were checked using the traditional IPTG induction
expression. Glycerol stocks were prepared for each colony. We chose the colony with
the highest protein expression and went through another round of selection, following
the procedure described above. The colonies selected from the double selection were
used for preparation of glycerol stocks and were stored in a –80°C freezer. Once the
double colony procedure is completed and high protein production is achieved, we
recommend making at least 10 glycerol stocks to be stored in a –80°C freezer. Our
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experience is that these glycerol stocks can be used even after two years storage and
will still produce a similar high protein yield.

2.2.5 High-cell density IPTG-induction bacterial expression method
This expression method uses rich medium to achieve an initial high cell density
before switching to minimal medium for expression. We started bacterial expression
using a rich medium, such as LB or 2X YT, at 37°C. Once the cell density reached a cell
density that was in the middle of its exponential phase, we switched the cell culture by
gently spinning down cells and resuspending the pellet into the same volume of minimal
medium. After switching the medium, we cultured bacterial cells for another 1.0 - 1.5
hours without adding IPTG, at the optimized temperature that is used for the cell
culture after IPTG induction. During this period, the OD 600 of the cell culture should
increase by 0.5 - 1 unit. IPTG was then added to induce protein production. The cell
culture was incubated at the same temperature for a period that is optimized for
different proteins before cell harvest. Usually, we found that the OD 600 value at the end
of the cell culture increased by 2 to 3 fold compared with the OD 600 value from the start
of IPTG induction. Therefore, before harvesting the cells, the bacterial culture can reach
an OD600 of 10 - 15 with LB as the starting rich medium and an OD600 of 15 - 20 using 2X
YT. This is about a 5 to 10 fold increase in OD 600 compared to that of the regular IPTG
induction bacterial expression in minimal medium.
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2.2.6 Optimization of various conditions
Another important step for high level protein production using high-cell density
bacterial expression is to optimize the expression conditions such as culture
temperature, IPTG concentration and induction time. These steps are critical for the
initial expression of a protein using the high cell density expression method.

2.2.6.1 Temperature Optimization & Time Course
We prepared several 10 mL starting cultures in a rich medium at 37°C. Usually
three cultures were started to check induction temperatures at 15, 20 and 37°C;
however, if space and time permitted, we also checked induction temperatures of 18,
room temperature and 28°. Once the optimal OD600 was reached, we gently spun down
the culture and resuspended the cell pellet in 10 mL minimal M9 medium. We placed
each flask in the appropriate incubator shaker and let the culture grow for 1 – 1.5 hours.
At this point, we checked the OD600 to make sure the culture had adapted to the
minimal medium. An OD600 increase of 0.5 to 1.0 units is a good indication that the
bacterial cells have adapted well to the minimal M9 medium. We then added 0.5 mM
IPTG to each culture and put the flasks back into the appropriate incubator shakers.
For the cultures growing at temperatures below 25°C, we allowed the cultures to
grow overnight (14 – 16 hours). The following morning, we began collecting 500 µL
samples and monitoring the OD600 every two hours for the remainder of the day
(collected samples 14 – 28 hours after induction).

For the cultures growing at

temperatures above 25°C, we collected 500 µL samples and monitored OD 600 every 2
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hours after induction for a total of 8 hours. Once all the samples had been collected, we
performed SDS-PAGE analysis to determine at which temperature the bacteria produce
the highest protein yield.
During the time course, we closely monitored the pH of the medium, OD600 and
protein yield. This allows us to obtain the best pH of the starting minimal medium, best
cell culture temperature after IPTG induction and the best time to harvest bacterial cells
for the highest protein yield.

2.2.6.2 IPTG concentration optimization
Once the optimal induction temperature and time were determined, we will
determine the optimal IPTG concentration. We prepared several 2 mL starting cultures
in a rich medium at 37°C. Once the optimal OD600 was reached, we gently spun down
the culture and resuspended the cell pellet in 2 mL minimal M9 medium. We placed
each tube in the incubator shaker set at the optimized induction temperature and let
the culture grow for 1 – 1.5 hours. At this point, we checked the OD600 to make sure the
culture had adapted to the minimal medium. We then added various amounts of IPTG:
0.1, 0.25, 0.5, 0.75 and 1.0 mM. We put the tubes back into the appropriate incubator
shaker and let the culture grow for the optimized induction time. Finally, we collected
500 µL from each culture and performed SDS-PAGE analysis to determine the optimal
IPTG concentration.
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2.2.7 Aeration and medium pH
A bacterial culture grown to a high cell density results in a decrease in available
dissolved oxygen and a large release of metabolites that will lower the culture pH [76].
In order to increase the available dissolved oxygen, we tested various culture volumes
to flask size ratios, in addition to shaker speed. We also added NaOH to increase the
starting medium’s pH to various levels to determine the best starting pH.

2.3

Results

2.3.1 High cell density IPTG induction bacterial expression method
Figure 2-1 shows a comparison of the procedures and final OD600 before cell
harvest for three different bacterial expression methods used in our studies. The
traditional IPTG induction method we used in the laboratory uses minimal medium for
bacterial expression. This is because we frequently prepare isotopically labeled proteins
for NMR studies, which requires minimal medium with 13C-glucose and 15NH4Cl in either
H2O for double-labeled proteins or in D2O for triple-labeled proteins.
As Figure 2-1 indicates, the final OD600 of the traditional IPTG induction
expression before cell harvest is usually about 2 – 3.

We tested auto-induction

expression for both unlabeled and triple-labeled proteins. Direct application of Studier’s
protocols using the C750501 recipe lead to inconsistent results [76]. For some proteins,
the yield was a two to three-fold increase compared with the traditional IPTG method,
whereas for other proteins, bacteria either did not grow or only a poor yield was
obtained. This is especially true when we grow bacteria in D2O for triple-labeling, which
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is not very surprising because different growth patterns for bacteria in D 2O and H2O are
expected. In addition, we frequently observed a phenomenon during auto-induction
experiments: using minimal media, the OD600 reached quite high levels (usually 8–20),
but no protein production was observed. Due to these inconsistences, we developed the
third bacterial expression method. The hybrid high cell density method uses rich
medium, such as LB and 2X YT, to reach a high cell density before IPTG-induction. We
then switch the culture medium by gently spinning down the cells and resuspending to
an equal volume of minimal medium.
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Figure 2-1: A schematic diagram of thee expression methods used in this study.
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A similar method was reported previously by Cai et al. and by Marley et al. for
making double-labeled protein with

13

C-glucose and

15

NH4Cl [93, 94]. The procedure

carried out by Cai et al. used a fermentor with a carefully controlled O2 level and pH,
whereas our method uses a regular incubator shaker that is commonly used in many
laboratories for bacterial expression [93]. Marley et al. generated a cell mass with
unsaturated LB medium (OD600 = 0.7) [94]. They then concentrated the suspension (2X,
4X, and 8X) and transferred the bacteria into isotopically labeled minimal medium for
expression. The cells were incubated for 1 h at 37°C to allow for the discharge of
unlabeled metabolites and then induced with IPTG. They discovered that the 4X
concentrated LB medium conferred maximal protein expression.
We found that a bacterial culture should not be saturated in the rich medium,
because a saturated bacterial expression would not result in a high yield of protein
production [76]. Instead, the OD600 of the bacterial cell culture in the rich medium
should be an intermediate value, preferably in the middle of its log phase, to ensure
high level protein expression. This will also avoid the problems associated with cells
going into stationary phase, such as induction of proteases [5]. For example, our
experience suggested that an OD600 at 3–5 in LB medium and an OD600 at 5–7 in 2X YT
medium were adequate before switching to minimal medium. After switching the
medium, the bacterial cells were cultured at a previously optimized temperature for
another 1.0 – 1.5 hours before IPTG induction, to allow bacterial cells to adjust to
minimal medium and to the new culture temperature. Using this high cell density
method, we can easily achieve IPTG induction within a ‘‘normal’’ working day, making
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this method time efficient when comparing with the auto-induction method.

For

isotopic labeling of proteins using the high cell density method, a slightly longer period
of medium exchange time, such as 1.5 – 2.0 hours, at a lower temperature might be
preferred, because this not only allowed for the clearance of the unlabeled metabolites
but also slowed down the bacterial growth during the exchange period, preserving the
labeled nutrients for protein synthesis after IPTG induction. At the end of this short
period of medium exchange time, the OD600 of cell culture should increase, normally, by
~ 0.5 – 1.0 units. After IPTG induction, the bacterial cells are cultured at an optimized
temperature for an optimized time period before harvest. With this method, the final
cell density before harvest can reach OD600 of 10–20, which significantly enhances the
protein yield.
It is important to point out that there is no guarantee that a high cell density cell
culture results in a high protein yield. As we described earlier, several drawbacks occur
at high cell density bacterial expression, including plasmid loss, reduced medium pH,
and limited dissolved molecular oxygen, causing either no protein production or a low
protein yield. Indeed, when we initially worked with high cell density bacterial cultures,
we frequently encountered a situation that even though cell density became quite high,
the protein yield was either very low or no protein production could be seen at all. In
addition, the protein expression yield was not always repeatable. We sometimes
obtained an intermediate protein yield when we started with a freshly transformed
colony. The other times we obtain a very low protein yield or no protein production at
all even with a freshly transformed colony. When we started expression with freshly
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prepared glycerol stocks, most of the times we only obtained a very low protein yield.
To solve these problems, we further developed the following practical protocols that
ensure repeatable very high yield protein production using these high cell density
bacterial expression methods.

2.3.2 A proper starting culture
The general practice in most labs is to make a starting culture by growing an
overnight culture using rich medium, such as LB, at 37°C.

We observed that an

overnight starting culture in rich medium at 37°C usually reached saturation by the next
morning. A saturated overnight culture might result in plasmid instability because of
the basal leakage of the T7 expression system [95]. This usually resulted in a poor yield
of target protein. We found the best time to utilize a starting culture, with the least
amount of plasmid instability, was in the middle of the exponential growth phase. For
all expressions hereafter, we grew a starting culture in a rich medium (H2O or D2O
based) for several hours at 37°C until the OD600 was in the middle of its exponential log
phase; typically an OD600 between 3 and 5 for cultures grown in LB medium and 5 and 7
for cultures grown in 2x YT medium. For example, Figure 2-2 shows the growth curve
for LCAT (lecithin:cholesterol acyl transferase) using a pET30a-sHT vector inside
BL21(DE3) cells. The optimal OD600 for LCAT is ~2.5 and is reached after 7 hours of
growth in a 50 mL cell culture. If the culture was grown in D2O based rich medium, the
growth rate was much slower. This method for obtaining a proper starting culture is
used in both the traditional IPTG method and our new high cell density method.
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Figure 2-2: Plot of E. coli growth with the middle of the log phase at an OD600 value of ~ 2.

2.3.3 Double colony selection
We observed that colony selection was one of the most important factors for
high level protein production using high density bacterial expression methods. This is
especially true for bacterial expression in D2O when making triple-labeled proteins. As a
common laboratory practice for high level protein production of proteins, we routinely
select high level expressing colonies. However, we often found that a low yield of
protein was obtained using the glycerol stock made with a selected colony, even though
this glycerol stock previously produced high yield protein. Such a situation happened
quite often when we worked with human proteins that were toxic to the bacterial cells.
This situation is also often observed when bacterial expression is carried out in D 2O. To
solve this problem, we have developed a double colony selection protocol. In this
protocol, the LB medium was inoculated with a single freshly transformed colony for a
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starting culture, which was grown to an OD600 of 0.7–0.9. The medium was then spread
onto a plate, followed by selection of colonies from the plate. The selected colonies
were checked for protein expression levels using the traditional IPTG-induced
expression. After expression, 200–500 µL of cell suspension was spun down and the cell
pellet was treated with SDS loading buffer for 20 min at 70°C. An SDS-PAGE was carried
out to check the expression level. Only those colonies that displayed high level
expression will be used for the second selection. The second selection repeated the
aforementioned procedure. If this double colony selection is used for selecting high
level protein expression colonies in D2O, we will carry out all the aforementioned
experiments in D2O, including D2O plates.
With this double colony selection procedure, we were able to select several
colonies for high level expression of a protein, whereas our previous experiments
showed very low protein production in D2O. An example can be seen in Figure 2-3,
showing SDS-PAGEs of expression levels of apoE (1-215), using an apoE (1-215)/pTYB1
expression vector, in D2O before (Panel A), during (Panel B), and after (Panel C) double
selections. Panel A shows a lower protein production yield for all four colonies that were
picked from a freshly transformed plate. However, colony 2 seemed to give a higher
protein expression level (Lane 2), thus was selected for the next round of colony
selection. Panel B shows a comparison of three different colonies from colony 2 selected
in Panel A (Lanes 1–3) and another three different colonies from a double-colony
selection (Lanes 4–6), suggesting that Colony 3 (Lane 3) gave the best protein expression
level after the first-colony selection. Using Colony 3, we made a plate and picked three
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more colonies, Colonies 4–6. The second colony selection indicated that Colony 6 gave
the best protein expression level. With Colony 6, we made another plate and picked six
colonies.

Figure 2-3: SDS-PAGEs of protein expression of apoE (1-215)/pTYB1 in D2O before (Panel A), during (Panel
B), and after (Panel C) double-colony selections. Arrows indicate the expected protein band (~80 kDa,
apoE (1-215) + intein + CBD). Panel A shows four different colonies before colony selection. Panel B shows
results of three different colonies selected from the single-colony selection (Lanes 1–3) and another three
colonies selected from the double-colony selection (Lanes 4–6). The second-colony selection was based
on Colony 3 (Lane 3) in the single-colony selection, because this colony gave a higher protein production.
Panel C shows the results of six colonies from the double-colony selection, indicating a high protein
expression level of all six colonies. Molecular weight markers are labeled with kDa.

It clearly demonstrates that all six colonies after double selection indeed solved
the problem of low expression of apoE (1-215), resulting in a very high-level expression
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of target protein in D2O (Panel C). In contrast to single colony selection, a glycerol stock
prepared using a colony from double colony selection can pass on for many generations
and always give a consistent reproducible high level protein production. Therefore, a
double colony selection procedure is recommended for colony selection of high level
expressing colonies.

2.3.4 Optimization of bacterial expression in D2O
Protein expression and purification is a routine practice in many NMR labs, but it
is not uncommon to see a drastic reduction in protein yield when isotopically labeling
the proteins, especially when D2O must be used. If the bacteria did not grow well in 7099% D2O, we found that training the bacteria to adapt to D2O-based medium and
performing double colony selection upon D2O plates solved the problem. First, we
performed double colony selection (as outlined in section 2.2.4) utilizing 70% D2O
plates. Next, we trained the bacteria by picking a colony off a D 2O plate and starting a 5
mL bacterial culture of LB medium in 25% D2O. Once the OD600 of the culture reached
1.0 at 37 oC, we transferred 100 µL of the cell culture into 5 mL of LB medium in 50%
D2O. The starting OD600 of this new culture is about 0.1. We let the cell culture grow at
37 oC until the OD600 reached 1.0 and transferred 100 µL of the cell culture into 5 mL of
LB medium in 75% D2O. The culture grew at 37 oC until the OD600 reached between 2
and 3. At this point, we set some aside to be used to make glycerol stock and the
remaining culture was used as a starting culture for expression. Figure 2-3 shows an
example of double colony selection on D2O plates. After training the bacteria, we
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consistently obtained 15 mg triple-labeled protein per 50 mL cell culture, as opposed to
0.6 mg per 50 mL cell culture using the traditional IPTG method.

2.3.5 Optimization of high cell-density IPTG-induction bacterial expressions
2.3.5.1 Temperature and Time optimizations after IPTG-induction
Another important step for high level protein production using a high cell density
bacterial expression culture is to optimize expression conditions, such as culture
temperature and the time after IPTG induction. This step is critical for the first time
expression of a new protein using the high cell density expression method. First, we
carry out time courses at different temperatures, such as 15, 20, 23 (room
temperature), 28, 30, and 37°C. We closely monitor the following parameters: OD 600,
pH, and target protein production. We normally make a 10 mL culture, either D 2O or
H2O-based, for the temperature and time course. To check target protein yield, we take
500 µL from the culture every 2 hours after IPTG induction (depending on the
temperature), spin down, treat the cell pellet with SDS loading buffer for 30 min at 90°C,
and take 10 µL to run SDS-PAGE. As an example, Figure 2-4, Left Panel shows an SDSPAGE gel of a time course of triple-labeled human apoAI expression in D2O at room
temperature and Panel B shows a Western blot of the same time course. At each time
point, we also checked pH of the expression medium and OD 600. This figure clearly
demonstrates the importance of the time course, indicating that either apoAI does not
have enough time to be expressed under 30 hours or the expressed apoAI starts to
degrade after 40 hours, both resulting in low protein production. In contrast, bacterial
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expression at 36 hours gave the highest protein yield as confirmed by the Western blot
in the right panel of Figure 2-4.

Figure 2-4: Left Panel: An SDS-PAGE showing a time course of triple-labeled human apoAI expression in
D2O at room temperature. The expected apoAI band is indicated by an arrow. Lane 1:24 h, Lane 2:28 h,
Lane 3:32 h, Lane 4:36 h, Lane 5:40 h, Lane 6:44 h, and Lane 7:54 h. Right Panel: Western blot of the same
time course using an anti-human apoAI monoclonal antibody, 5F6.

Table 2-1 lists the OD600, pH, and protein yield at each time point, suggesting
that OD600 has indeed reached its maximum at 36 hours (OD600 = 9.1), resulting in the
highest protein yield. In contrast, the pH of the expression drops from the starting
pH.7.2 to 6.01 after 36 hours. Further reduction of pH may lead to significant instability
of the plasmid, resulting in plasmid loss and significant reduction of the protein yield.
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Table 2-1: Parameters of the time course of human apolipoprotein A-I expression
Time

24h

28h

32h

36h

40h

44h

54h

OD600

2.5

3.9

7.2

9.1

8.4

8.0

8.1

pH

6.6

6.5

6.3

6.0

6.0

6.0

6.1

-

+

++

+++

++

++

-

Protein yield

For the seven proteins we tested, we found that different proteins require
different temperatures for the optimized yield. For example, we expressed the two
fragments of RAP, RAP (1-210) and RAP (91-323) at 37°C. For human apoE N-terminal
domain, apoE(1-183), expression was carried out at 28°C. For apoE(1-215)/pTYB1,
optimal expression temperature was 20°C after IPTG-induction and for the two apoAI
proteins, experiments at room temperature provided the best yields. Nevertheless, time
course experiments at different temperatures allow us to quickly optimize expression
conditions for a high level production of proteins.

2.3.5.2 Optimized media
2.3.5.2.1 13C-glucose optimization for high cell density bacterial expression
High density bacterial cells require more nutrition in the minimal medium, which
usually uses NH4Cl as the nitrogen source and glucose as the carbon source. For making
isotope-labeled protein, we use

15

NH4Cl and

13

C-glucose to replace normal NH4Cl and

glucose for double-labeling the proteins. We intended to optimize both 15NH4Cl and 13C-
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glucose amounts for a low cost of production of isotope-labeled proteins. In most cases,
our laboratory used 0.2 – 0.4% of

13

C-glucose and 0.1% of

15

NH4Cl for regular IPTG

induction bacterial expression. We found that this recipe did not work well with a high
cell density IPTG induction method, simply because of limited nutrition in the minimal
medium, which limited bacterial cells to reach a high cell density and significantly
reduced protein yield. We optimized different nutrition in the minimal medium for high
cell density expression (Table 2-2).

Table 2-2: Optimized High Cell Density Minimal Medium
50 mM

Na2HPO4·7H2O

25mM

KH2PO4

10mM

NaCl

5mM

MgSO4

0.2mM

CaCl2

0.25X

Trace metals

0.25X

Vitamins

0.1%

NH4Cl or 15NH4Cl

1.0%

Glucose or 13C-glucose

As an example, Figure 2-5 shows glucose optimization of high cell density IPTG
induction expression of human apoE in D2O. These expressions started with a glycerol
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stock of apoE after double colony selection and are carried out with an optimized time
course and temperature.

Figure 2-5: A 12% SDS-PAGE of glucose optimization of human apoE expression in D 2O at 20°C using high
cell density IPTG induction bacterial expression: Un-induced (Lane 1), with 0.4% (Lane 2), 0.6% (Lane 3),
0.8% (Lane 4), and 1.0% glucose (Lane 5). Molecular weight marker is shown in left lane. Small-scale time
course experiments with different glucose concentrations were also carried out to find the optimum
protein expression time after induction of the culture.

A cell culture containing 0.4% glucose could reach an OD 600 of only 4.2 and the
expression yield was also low. Increasing the glucose concentration increases the
culture cell density and protein yield. With 1.0% glucose, the OD600 reached to 7.4 and
protein yield seems enhanced by ~10-fold (Table 2-3). Marley et al. previously showed
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that increasing the amount of glucose to 0.8% only improved the protein yield modestly.
They suggested that glucose concentration is not a critical factor in enhancing protein
yield. Our results seemed to be different, indicating that the amount of glucose is critical
for high cell density IPTG induction expression. Our high cell density expression is based
on several optimizations as described earlier, which may make a significant difference.
We believe that at a high cell density bacterial culture, more nutrients, especially the
carbon source, are required for healthy cell growth, thus, the culture can reach to a high
cell density, resulting in a higher protein production.

Table 2-3: Glucose Optimization of High Cell Density IPTG Induction Bacterial
Expression of Human apoE in D2O
Glucose (%)

0.4

0.6

0.8

1.0

OD600 at IPTG induction

2.0

2.5

3.0

3.3

OD600 at harvest

4.2

5.1

6.1

7.4

pH at harvest

6.7

6.6

6.4

6.3

Time after IPTG induction

12

19

23

36

Protein yield

+

++

+++

++++

2.3.5.2.2 Optimization of the starting pH of the M9 medium
Bacterial cultures grown to a high cell density typically result in a drastic drop in
pH. This drop in pH is largely due to the increased glucose concentration in the minimal
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medium and subsequent metabolism of the glucose. Medium with a low pH may cause
stress to the bacterial cells, which results in plasmid loss from the high density bacterial
cells [95]. We chose to modify the pH of the culture medium to 8.2 using NaOH, so that
the medium has a larger buffer capability. Our result confirmed that an enhanced pH of
the expression medium indeed helped to control medium pH at high cell density, thus at
the end of bacterial expression, pH maintained at pH >6.0 for the cell culture of OD600
between 8 and 14 (Table 2-1).

2.3.6 Culture volume: flask size ratio – proper aeration
To solve the problem of limited availability of dissolved oxygen in the high cell
density culture, we used a smaller expression volume with a larger culture flask. For
example, a 250 mL high cell density expression culture was divided into 5 x 50 mL
cultures, and each culture used a 250 mL flask. This resulted in better aeration in a small
culture compared with a large culture, thus more molecular O2 will be dissolved in the
medium. In addition, the shaker speed was kept for 175 – 225 rpm. Our results were
similar to Studier’s findings with his auto-induction studies [76].

2.3.7 A very high yield of pure recombinant proteins
With these protocols, we routinely produced 14–25 mg of triple-labeled proteins
and 17–34 mg of unlabeled proteins from 50 mL cell cultures for all the proteins we
tested. Table 2-4 lists the final yields of unlabeled and triple-labeled proteins using high
cell density bacterial expressions and compared with the yields of the traditional IPTG

88

induction methods, which is also fully optimized, in a 50 mL cell culture, suggesting a 9
to 85 fold enhancement in protein yield.

Table 2-4. Final yields of unlabeled and triple-labeled proteins: high cell-density vs
traditional IPTG method.
High cell
densityb (mg)

IPTGb
(mg)

M.W. [45]
(Dalton)

M.W. (MS)
(Dalton)

%Dc

RAP(1-210)

20 ± 3

0.5

33,801

33,525 ± 195

~92

RAP(91-323)

25 ± 3

0.8

36,633

36,376 ± 200

~93

ApoE(1-183)a

18 ± 4

2

22,866

22,686 ± 116

~89

Mouse apoAI(1-216)

15 ± 2

0.8

28,014

27,732 ± 125

~90

Human apoAI

14 ± 1

0.6

32,814

32,401 ± 150

~88

Human apoAI

34± 1

1.0

Human apoE

17± 2

0.2

Protein
Triple-labeled

Unlabeled

M.W.: molecular weight.
a

b

ApoE(1–183) was expressed in 40% D2O, the rest are expressed in 99.7% D2O.
High cell density (50 mL culture volume): high-cell-density expression methods, including auto-induction
and high cell-density IPTG-induction; IPTG: the optimized traditional IPTG-induced expression. We
repeated the expressions at least three times for all proteins, the yield shown is the average ± standard
deviation.

c

13

15

Estimated percentage of deuteration, assuming 100% C and N-labeling. For apoE(1–183), the %D is
the estimated percentage of deuteration based on 40% D2O. For the other four proteins, the %D is the
estimated percentage of deuteration based on 99.7% D 2O.

89

It is worth noting that we repeated the expressions of each protein more than
three times and Table 2-4 gives the average yields with standard deviations. This
indicates that the protocols described earlier produce a consistent, high level, triplelabeled protein production and that is always reproducible. Table 2-4 also gives the
mass spectroscopic data of the triple-labeled protein, indicating that the efficiency of
deuteration for triple-labeled protein using high cell density expressions. Overall, the
deuteration efficiency is around 90% if we assume that the
100%. This is because we used 99.7% D2O and

13

13

C and

C-glycerol or

15

N-labeling are

13

C-glucose (not

deuterated) in the high cell density expressions. For the apoE (1-183) case, we only used
40% D2O and 13C-glycerol or 13C-glucose (not deuterated), the 89% deuteration level was
based on 40% D2O (Table 2-4). This result is comparable with the deuteration efficiency
of the traditional IPTG induction expression with single-labeled 13C-glucose.

2.3.8 Protein structure integrity is maintained using high cell density IPTG-induction
bacterial expression
To confirm the efficiency of triple-labeling by high cell density expressions, we
carried out NMR experiments of these proteins. Figure 2-6 shows an example of the 1H15

N HSQC experiments of human apoE (1-183), for which the NMR samples were

obtained using high cell density IPTG induction expression (Panel C), auto-induction
expression (Panel B), and traditional IPTG induced expression (Panel A).
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1

15

Figure 2-6. H- N HSQC spectra of triple-labeled human apoE (1-183) obtained using high cell density
IPTG induction expression (Panel C), auto-induction expression (Panel B), and traditional IPTG induction
expression (Panel A). All three samples contained 1.0 mM triple-labeled human apoE (1-183) in 100 mM
phosphate buffer, 10 mM EDTA, 0.5 mM NaN 3, 90 mM DTT, and 0.02 mM DSS, pH 6.80. The spectra were
collected at 30°C on a 600 MHz NMR spectrometer with a cold probe.

This figure demonstrates that all three NMR samples produce an identical HSQC
spectrum. In addition, with the proteins obtained using our high cell density IPTG
method for apoE and apoAI, we have carried out NMR studies allowing us to completely
assign NMR spectra of lipid-free apoE, lipid-free mouse apoAI (1-216), and human
apoAI/preβHDL [92, 96, 97]. In addition, we also determined NMR structures of lipidfree apoE (1-183) and mouse apoAI (1-216) (manuscript in preparation)[98]. Thus, we
conclude that the high cell density expression produces a very high yield of triplelabeled, well folded proteins for NMR studies (14–25 mg/50 mL for triple-labeled
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proteins; 17–34 mg/50 mL for unlabeled proteins). Table 2-4 also indicates that the
principles we described here for optimization of high cell density bacterial expression
methods can be directly applied to other proteins, including membrane proteins in
either H2O or D2O to obtain very high level production of target proteins.

2.4

Conclusions
We have developed a hybrid bacterial expression method that combines the

advantages of the traditional IPTG method and Studier’s auto-induction method. We
have combined the tight control allowed by a timed IPTG induction and the high cell
density nature of the auto-induction method. To achieve this, we developed three
critical protocols to ensure consistent and high level protein production:

(1)

A proper starting culture must be used before transfer to minimal medium which
ensures plasmid stability. By transferring a culture growing in rich medium in the
middle of its growing phase, we have eliminated the problems caused by
allowing a culture to reach saturation (low pH, plasmid instability, antibiotic
degradation).

(2)

Double colony selection must be performed to generate a reliable glycerol stock
needed for future high level expressions.

This is especially critical when

expressing proteins in D2O or labeling with amino acid using auxotrophic
bacterial strains.
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(3)

Optimization of induction temperature, time and IPTG concentration is critical
since all of these variables are protein dependent. Very few of the proteins we
tested optimized in the same manner – some proteins required low induction
temperature and a long induction time, while others required high induction
temperatures for a short period of time.

After performing these three critical protocols, we have found that we can
obtain consistent high level expression for all of the proteins we tested in our lab.
Compared to the traditional IPTG induction method we used previously, we observed a
9 to 85 fold enhancement in protein production:

(1)

Unlabeled proteins: 17-34 mg/50 mL cell cultures

(2)

Triple-labeled proteins: 14-25 mg/50 mL cell cultures

In summary, following the practical protocols developed in this study, this high
cell-density IPTG-induction bacterial expression method allows for production of gram
quantity of pure recombinant proteins from one-liter bacterial expression.

2.5

Discussion
E. coli offers a mean for the rapid and economical production of recombinant

proteins. In recent years, the number of recombinant proteins used for therapeutic
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application increased dramatically. These demands drive the development of a variety
of strategies for achieving high level bacterial expression of proteins using E. coli.
Optimizations in expression vector design, gene dosage, promoter strength
(transcription regulation), mRNA stability, translation initiation and termination, E. coli
host strain design, and codon usage have been performed, which result in significant
enhancement of protein production and different commercial products [63], such as the
pET expression vectors and pLysS plasmid by EMD Biosciences. The pLysS plasmid
carries the gene for T7 lysozyme, which is a natural inhibitor of T7 RNA polymerase and
serves to suppress basal expression of T7 RNA polymerase prior to induction, thus
stabilizing recombinants encoding target proteins that may also affect cell growth and
viability [63, 66]. In addition, empirical selection yields E. coli strains that are superior to
the traditional BL21(DE3) host strain by overcoming the toxic effects associated with the
overproduction of membrane and globular proteins under T7 transcriptional control [66,
87]. Based on the BL21(DE3) strain, another strain was developed to overcome the
problem of rare codons. Many eukaryotic proteins may contain codons that are not
typically used in E. coli, therefore the BL21 CodonPlus-RIL and BL21 CodonPlus-RP
strains were engineered to enhance expression of eukaryotic proteins that use these
rarely used codons in E. coli [65, 66].
In contrast, optimization of bacterial expression conditions seems to be protein
dependent [99]. The general consideration is to increase cell density of bacterial
expression for the purpose of enhancing recombinant protein production. Much of the
efforts have been centered on enhancement of cell density in a fermentation setting,
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rather than in a general laboratory setting, because bacterial expression conditions,
such as O2 level, pH, and nutrients, can be much better controlled using a fermentor to
achieve a high cell density [95, 100]. In contrast, these expression conditions are
difficult to control using a regular incubator shaker, and thus a much lower cell density
can be achieved using this general laboratory setting.
We aimed to develop a novel bacterial expression method for high yield
recombinant protein production in a general laboratory setting using a regular incubator
shaker without changing the expression vector. The biggest challenge to achieve this is
to obtain high yield recombinant protein production using a high cell density bacterial
expression since bacterial cells experience stress at a high cell density using a regular
incubator shaker which does not control the O2 level, pH and nutrients of the expression
medium. To achieve high cell density of bacterial expression in a general laboratory
setting, we first utilized the auto-induction method developed by Studier [76]. We
obtained inconsistent results which sometimes produced a higher yield (2 – 5 fold
enhancement), but many times did not produce recombinant protein at all. We found
that although the auto-induction method produced much higher cell density as
compared with traditional IPTG-induction method in minimal medium, this high cell
density often caused the plasmid to be dropped from the bacterial cells, thus no protein
production was observed. This is because high cell density of bacterial expression often
changed medium conditions, such as acidity and limited dissolved oxygen, causing
significant stress to the bacteria cells. Under such a stressed condition, the expression
vector could be easily dropped by the bacterial cells.
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This result encouraged us to develop a better high cell density bacterial
expression method, so that we can maintain a high cell density without plasmid drop
and also take the advantages of the tightly controlled IPTG induction for better
recombinant protein expression. This will allow us to take advantage of the optimized
features of the commercially available bacterial expression vectors for high yield
production of recombinant proteins. We developed a hybrid bacterial expression
method that utilizes rich medium to achieve a high cell density before IPTG induction,
while maintaining the advantage of the tightly controlled induction by IPTG in minimal
medium. Our hybrid expression method allows us to reach a high cell density with a
final OD600 that is 5 to 10 fold higher than that of the regular IPTG induction method.
High cell density culture systems, especially under the non-fermentation,
laboratory conditions, frequently suffer from several drawbacks, including plasmid loss,
limited availability of dissolved oxygen, and increased carbon dioxide levels in the
medium which causes significant reduction of medium pH [63, 101]. These problems
often cause a low or even no protein production with a high cell density culture. Indeed,
we frequently observed a low protein production from a high cell density bacterial
expression before we implemented our protocols to solve these problems. The common
practices in general laboratories to solve these problems are as follows: selecting high
expressing colonies and optimizing growth temperatures and time. We found that these
common practices sometime produce inconsistent results that are not always
repeatable. This is especially true for protein expression in D 2O for production of the
triple-labeled proteins.
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We have designed several modifications to these common laboratory practices
specifically for bacterial expression at high cell densities in a routine laboratory setting.
The major modifications include:

(1) Double colony selection
(2) Proper preparation of a starting culture

By performing a double colony selection, we ensure that we have chosen a
stable colony with a high level of expression. We found that it is not enough to only
perform one round of colony screening.

In the past, we have seen inconsistent

expression results from a single glycerol stock based on one round of colony selection.
Once we started performing double colony selection on all proteins, we obtained much
more consistent results.
Many labs start with an overnight culture in rich medium before switching to
minimal medium for expression.

A saturated culture reaches a high cell density

overnight and therefore experiences a drop in pH and limited dissolved oxygen. This
stress can cause some of the bacteria in the culture to drop the plasmid. Thus, by using
this overnight culture as the starting culture for expression, the end result will be lower
protein production since many of the bacteria have already dropped their plasmids. By
monitoring the growth of the starting culture and capturing the bacterial cells in their
mid-log phase, we have eliminated the stressors that will ultimately cause plasmid loss.
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Using these modifications, we have obtained repeatable very high yield of
protein production for all the proteins tested, especially for triple-labeled proteins in
D2O. Our data indicated a 9 to 85 fold enhancement of protein yields. Importantly, such
a high protein yield used the same DNA constructs and the same bacterial strains that
we previously used for regular IPTG induction method. This provides a critical advantage
of our method/protocols – a simple optimization in bacterial expression conditions can
result in 9 to 85 fold enhancement of protein yields. Indeed, we routinely obtain 14–25
mg of triple-labeled proteins and 17–34 mg of unlabeled proteins from a 50-mL cell
culture for all the proteins tested.
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CHAPTER 3
IN VITRO FRET MEASUREMENTS, FRET PEAK ASSIGNMENT AND SELECTIVE
LABELING OF MESD WITH 5-HYDROXY-L-TRYPTOPHAN

3.1

Introduction
The goal of this thesis is to develop an in-cell fluorescence technique that allows

for measurement of the distances between fluorescence acceptors and donors within a
protein or between two proteins inside the correct intracellular compartment of living
cells. The successful achievement of this goal will allow us to obtain high-resolution
structural information within a protein or between two proteins inside the cells, one key
step towards high-resolution structural biology of proteins inside the living cell.
To achieve this goal, we will apply the fluorescence resonance energy transfer
(FRET) technique to the specifically labeled proteins inside the cells. Our rationale is to
specifically label the protein(s) of interest in the test tube with a small molecule
fluorophore and then deliver the labeled protein(s) into the correct intracellular
compartment of living cells for in-cell FRET measurement. The QQ-protein delivery
technique can specifically deliver a protein to its intracellular destiny based on its signal
sequence [102, 103]. This will result in special mammalian cells that contain a
fluorescence labeled target protein with unlabeled intracellular endogenous proteins as
the background. The FRET measurement will be performed on this specifically labeled
protein and the calculated FRET-distance will be between the donor and acceptor of the
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protein(s) of interest, thus, high-resolution structural information of a protein inside
living cells can be obtained using this novel approach.
To minimally disturb the protein, we intend to use tryptophan residues of a
protein as the fluorescence donor and IAEDANS as the acceptor, which is a thiol-reactive
fluorophore and can bind to a cysteine residue [104]. We use MESD, a specialized
chaperone protein for the LDLR super family members, as the model protein for this
approach [57, 62]. MESD contains one cysteine (C142) and three tryptophan residues
(W32, W98 and W130). We prepared several tryptophan mutants, including single and
double tryptophan mutants. We first labeled MESD single tryptophan mutants with
IAEDANS at C142, and performed in vitro FRET measurement to verify our FRET
technique. Our lab recently determined the NMR structure of MESD and we could
accurately measure the distances between the C142 bound IAEDANS and the
tryptophan residues. Our data indicated that our FRET-measured distances are nearly
identical to the distances in the NMR structure. This confirmed validity of our in vitro
FRET technique.
We also explored a fluorescence approach to determine multiple FRET-distances
with a single FRET-measurement using MESD samples that contain multiple
fluorescence donors (tryptophans) and a single acceptor. The key steps of this approach
are to separate FRET signals of these multiple donors to the acceptor and to assign the
separate FRET signals as the FRET peaks that come from each individual tryptophan
residue. We utilized synchronous fluorescence scanning technique that has the ability
to separate individual FRET peaks. We were also able to assign these separated FRET-
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peaks when we compared single and double tryptophan mutants with the wild-type
MESD that contains three tryptophan residues. This is an important step towards
development of a FRET-technique for efficient measurement of inter-residue distances
within a protein or between proteins inside living cells, thus allowing us to develop a
high-resolution in-cell structural biology technique to study protein structures and
structural changes caused by intracellular events.
To eliminate intermolecular FRET contributions between the tryptophan of
intracellular background proteins and the labeled IAEDANS inside the protein of
interest, we will specifically label MESD with 5-hydroxy-L-tryptophan (5-HT) using an
auxotrophic bacterial strain. 5-HT labeled proteins can be excited at 310 nm, whereas
proteins with regular tryptophan residues cannot be excited at this wavelength [105].
This ensures that the in-cell FRET measurement at 310 nm is from the labeled 5-HT in
MESD and IAEDANS labeled at C142, whereas the tryptophan residues within
intracellular background proteins will not be excited, thus to eliminate any possible
protein-protein interactions. This chapter also describes our results of specific labeling
of MESD with 5-HT and IAEDANS.
In summary, this chapter works on technical development of a successful in-cell
FRET technique for simultaneous measurement of multiple distances using a FRET
protein sample with multiple tryptophan donors and one IAEDANS acceptor. Our goal is
to develop a structural biology technique to study protein structure and structural
changes inside living cells at high-resolution.
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3.1.1 FRET-based distance calculations
FRET is defined as the physical phenomenon in which there is a non-radiative
transfer of energy via long-range dipole-dipole coupling between a donor and acceptor
molecules [40]. There are three basic requirements in order for FRET to occur:
(1) The donor and acceptor must be within 10 – 100 Å of each other.
(2) Emission spectrum of the donor must overlap with the absorption spectrum
of the acceptor.
(3) The dipoles of the donor and acceptor molecule cannot be perpendicular.
The rate of transfer (kt) is proportional not only to the distance between the
donor and acceptor (r), but also the unperturbed lifetime of the donor (τo) and the
Förster distance (R0: the distance at which energy transfer is 50%). The efficiency of
energy transfer (E) is a quantitative measure of the number of quanta that are
transferred from donor to acceptor. E is also known as the quantum yield of energy
transfer. To determine the efficiency of energy transfer, we can multiply the rate of
transfer (kt) by the first excited singlet state lifetime (τ):

[1]

E = kt*τ =

We can also determine E by measuring the steady-state donor fluorescence intensity
from a sample containing only the donor and another sample containing the donoracceptor pair [40].
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[2]

E=1-

Where QD is the quantum yield of the sample containing only a donor and QDA is the
quantum yield of the sample containing both the donor and acceptor.
By setting equation [1] equal to equation [2] and solving for r, we can now
calculate the distance between the donor and acceptor on our protein:
⁄

[3]

r = R0 (

)

3.1.2 Donor-Acceptor Pair
These calculations can be greatly simplified by using a donor-acceptor pair with a
known Förster distance (R0). For example, the tryptophan-IAEDANS donor-acceptor pair
is used in my study and has an R0 = 22 Å with an effective range of 13.2 – 35.2 Å.
Another consideration when deciding upon a donor-acceptor pair is the type of
FRET experiment to be performed.

Since distances will be calculated based on

differences in intensity, the donor-acceptor pair must be bright and photostable. Small
molecule fluorophores are advantageous to use in FRET experiments for several
reasons. The fluorophores are small (<1 kD) and covalently attached to proteins with a
minimal disturbance to the protein structure.

They are also much brighter than

fluorescent proteins and are more easily detected when performing FRET experiments.
In contrast to GFP which is a large protein (~ 28 kD), small molecule fluorophores are
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less than 1 kD, therefore, accurate distance measurements between the donor and
acceptor can be accurately calculated.
Ideally, in order to obtain structural information from proteins inside living cells,
they need to be labeled with small molecule fluorophores. However, currently there is
no in vivo method available to only label a protein of interest without labeling the
intracellular background proteins. This imposes a major challenge in specific labeling of
a protein inside cells for fluorescence studies of a protein of interest.
On the other hand, if we can label the purified target protein in vitro and then
deliver the labeled protein efficiently into the correct intracellular compartment of living
mammalian cells at a sufficient concentration, this will allow us to generate a specific
labeled mammalian cell population for in-cell FRET measurements. In recent years,
there have been several advances made in the field of exogenous protein delivery
making this approach possible.

3.1.3 Synchronous scanning fluorescence spectroscopy
Synchronous scanning fluorescence spectroscopy is a technique that takes
advantage of the ability to vary both the excitation and emission wavelengths
simultaneously during data collection. In this technique, the fluorescence signal is
recorded when excitation and emission wavelengths are simultaneously scanned
keeping in between a fixed wavelength interval (called the offset value, Δλ) throughout
the spectrum. As a result, the selectivity for individual fluorescent components is
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considerably improved; additionally, much more information on mixtures of fluorescent
compounds is gained [43, 44].
The tryptophan residues of a protein could be considered “fluorescent
components” as they are each in their own unique environment and could possibly have
unique spectral patterns. The immediate chemical environment of tryptophan residues,
such has being involved in hydrogen bonding or hydrophobic interactions, can have
effects on its fluorescent properties. These interactions could result in slight red or blue
shifts of its emission spectrum, causing different wavelengths of the FRET-peaks for
different tryptophan donor/IAEDANS acceptor pairs [45].
It might become possible to create a protein with multiple donors and a single
acceptor and obtain information about each donor/acceptor pair from one
measurement. These wavelength differences may possibly allow us to assign the FRETpeaks to an individual FRET donor/acceptor pair, if these synchronous scanning
fluorescence spectra can separate the individual FRET-peaks.

3.1.4 MESD as a model protein
In order to test the ability to collect FRET experiments from inside living cells,
MESD was chosen as the model protein. MESD is a specialized chaperone essential for
the folding of LRP5/LRP6 which are the critical co-receptors of the Wg/Wnt signaling
pathway [60, 61]. It functions as a molecular chaperone inside the ER specifically for
proper folding and export of the LDLR family, including LRP5 and LRP6 [57]. In the
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absence of MESD, LRP5/LRP6 fails to reach the cell surface and remains sequestered as
insoluble aggregates due to misfolding.

A

B
W98

W130
26.10
20.49
W32
23.48

C142

Figure 3-1: Panel A shows the ribbon structure of MESD with W32 highlighted in purple,
W98 highlighted in yellow, W130 highlighted in red and C142 highlighted in green.
Panel B is a slightly enlarged version of Panel A without the backbone ribbon structure.
The blue dashed lines and corresponding numbers indicate the distance between the
Nε1 atom of the tryptophan residues and the Sγ atom of the cysteine residue. This figure
is based on the NMR structure of MESD (PDB code: 2KGL) [62].
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MESD serves as an excellent model protein for a number of reasons. First, it has
only three tryptophan residues that can act as the FRET donors (Figure 3-1). By using a
native amino acid of MESD as the fluorescence donor, there will be no need to label the
protein with an additional fluorescence probe to serve as the donor. This will also cause
minimal structural changes of MESD for the fluorescence labeling. It is also easy to
mutate one or two tryptophan residues at a time to reduce the number of donors, since
the simplest measurement involves one donor and one acceptor. Second, the sequence
contains one cysteine residue. There are a number of commercially available small
molecule fluorophores that are thiol reactive (e.g., IAEDANS) and will covalently bind to
the cysteine residue and serve as the FRET acceptor. Third, the MESD sequence
contains an “RDEL” ER-retention signal. This ensures that after the protein has been
delivered into the ER of living mammalian cells, it will stay in the ER and traffic between
the ER and Golgi. This is critical for our in-cell FRET-measurement since we would like to
measure the FRET distances between the donor and acceptor of MESD in its
physiological intracellular locations, thus making our FRET-measured distances
physiologically relevant.

3.1.5 5-Hydroxy-L-Tryptophan labeling and fluorescence spectroscopy
Since tryptophan is the chosen donor for the future in-cell FRET experiments, it is
essential to develop a novel method to distinguish the tryptophan of MESD from all the
other tryptophans of the intracellular background proteins. A tryptophan analogue, 5hydroxy-L-tryptophan, was chosen based on its different fluorescent spectral properties
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from normal tryptophan [105].

The 5-HT analogue has an extended absorbance

spectrum that allows for specific excitation at 310 nm (Figure 3-2), whereas under this
wavelength, the native tryptophan residues are not excited.
There have been a number of methods introduced that have allowed for the
incorporation of tryptophan analogues. Some labs have simply synthesized peptides
using the analogue [106]. Other labs have created new orthogonal pairs (analog-RS and
) and taken advantage of rare codons or amber stop codons [107, 108].
Another method involves an OXYPRO promoter that induces protein production once
oxygen levels have fallen below a certain level [109].

Several labs have used

auxotrophic bacteria to incorporate 5-HT and in order to selectively label MESD with 5HT with near 100% incorporation, we chose to utilize a bacterial strain auxotrophic for
methionine and tryptophan, DL21 (DE3) – a generous gift from Dr. Carl Frieden.
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Figure 3-2: Absorbance spectra of free tryptophan versus 5-hydroxy-L-tryptophan (5-HT)
(λem = 336 nm).

3.1.6 Can multiple FRET-distances be obtained from a single FRET-measurement?
The current in vitro FRET technique usually uses a protein that is labeled with a
single donor and a single acceptor, thus this technique can only generate a single
distance between a donor and an acceptor of the protein with each FRET measurement
[110]. This is the major bottleneck for developing the FRET technique as a highresolution structural biology tool. Indeed, the FRET-measured distances are accurate at
angstrom resolution, this technique certainly has the potential to determine a protein
structure at atomic resolution.
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To determine a protein structure at atomic-resolution using the FRET technique
though, hundreds of FRET-distances are required for structural simulation using the
FRET-measured distances as the experimental restraints. This would require an
enormous effort including mutagenesis, fluorescence labeling and FRET-measurement,
representing the major challenge that limits this technique from becoming a highresolution structural biology technique.
Comparing to the current atomic resolution structural biology techniques
including X-ray crystallography, NMR and cryo-EM, the FRET technique has several
major advantages for physiologically relevant in-cell experiments. First, FRET is a
sensitive technique and only requires a micromolar protein concentration which is
similar to the intracellular protein concentration. In contrast, NMR requires a millimolar
concentration that is not a physiologically relevant concentration. Second, the FRETtechnique does not have the line-broadening problem of large proteins under an
intracellular environment, whereas NMR does. This is another key property that
distinguishes FRET from NMR for in-cell experiments. Indeed, the macromolecular
crowding effect of the intracellular environment significantly broadening the NMR
signals to significantly reduce the signal-to-noise, making in-cell NMR a very challenging
subject [111]. Third, although large amounts of mutagenesis and fluorescence labeling
are required, the FRET-measurements are quick and multiple scans of the same sample
take less than ten minutes. This is the third advantage of FRET for in-cell experiments.
Since we have to collect biophysical experiments in a tube or cuvette, the longer the
experiments are, the more cell viability will become a problem. A few hours inside a
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cuvette without the optimized cell culture conditions, the mammalian cells will still
remain healthy. Thus the experiment data collected will be true reflection of the protein
structure inside the cells under physiological conditions.
In this thesis, we also address a key question: Can we obtain multiple FRETdistances via a single FRET-measurement? We will explore new techniques to achieve
this goal. Usually, a protein contains multiple tryptophan residues. Our strategy is to
develop a technique that allows us to obtain multiple distances between these
tryptophan donors and a single acceptor. If we can achieve this goal, we can simply
change the single cysteine position to prepare new samples for new FRETmeasurements. This approach will allow us to minimize the mutagenesis work and to
efficiently obtain many FRET-based distances used for structural simulation to generate
protein structure inside the cell at atomic resolution. This shall have a revolutionary
impart on structural biology.

3.2

Materials and Methods

3.2.1 Strain, plasmid and mutants
The MESD gene was subcloned into a pET30a vector from EMD Biosciences. We
engineered the pET30a vector to introduce a Factor Xa site between the long his-tag and
the MESD gene. The pET30a-sHT is also an engineered pET30a vector in which the long
his-tag was replaced by a short his-tag containing a six histidine tag plus a two serine
linker. The pET30a and pET30a-sHT are kanamycin resistant vectors. The expression
vectors were transformed in to BL-21(DE3) and DL-41(DE3) bacterial strains.
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MESD contains three tryptophans at residues 32, 98 and 130. In order to make
double tryptophan mutants of MESD, each tryptophan residue was mutated to an
alanine using the Site Directed QuickChange Mutagenesis Kit (Stratagene). The resulting
mutants are identified as MESD_W32A, MESD_W98A and MESD_W130A as the double
tryptophan mutants. In order to make the single tryptophan mutants of MESD, the
MESD_W32A mutant was used as a template to mutate W98 to A98, resulting in
MESD_W32/98A. The MESD_W32A mutant was also used as a template to mutate
W130 to A130, resulting in MESD_W32/130A. The final single tryptophan mutant was
made by using the MESD_W98A template to mutate W130 to A130, resulting in
MESD_W98/130A. Finally, a “no tryptophan” mutant was made using MESD_W32/98A
as a template and mutating W130 to A130 resulting in MESD_W32/98/130A. Table 3-1
lists all the mutants and their corresponding number of tryptophan residues.
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Table 3-1: MESD and Tryptophan Mutants
Mutant

Referred
to as

#
TRP

TRP
positions

Mutations

MESD_wt

WT

3

W32, W98, W130

No mutation

MESD_W32A

32A

2

W98, W130

W32A

MESD_W98A

98A

2

W32, W130

W98A

MESD_W130A

130A

2

W32, W98

W130A

MESD_W32/98A

130W

1

W130

W32A, W98A

MESD_W32/130A

98W

1

W98

W32A, W130A

MESD_W98/130A

32W

1

W32

W98A, W130A

MESD_W32/98/130A

NoW

0

No TRP

W32A, W98A, W130A

3.2.2 Protein expression and purification
In order to produce unlabeled MESD, glycerol stock was added to 50 mL LB broth
and 50 μL KAN in a 250 mL flask and placed in a 37 °C incubator shaker. The culture was
grown until OD600 reach ~ 2 – 2.5. The culture was spun down at 5,000 x g for 7 minutes
and the supernatant was poured out. The conical tube was inverted for 1 minute on a
paper towel to remove all traces of LB broth. To resuspend the pellet, 50 mL of minimal
M9 medium was added to the pellet and poured into a new 250 mL flask. The flask was
placed in a 37 °C incubator shaker for 1 hour. The OD 600 was measured to confirm
growth, then 0.5 mM IPTG was added to the culture and placed back in the 37 °C for 4
hours. The cells were harvested by spinning the culture down in two 50 mL conical
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tubes at 10,000 x g for 10 minutes. The supernatant was removed and the pellet was
either store in a -80 °C freezer or used immediately for purification.
In order to purify the MESD proteins, the cell pellets collected after harvesting
were re-suspended in 20 mL 1X binding buffer (recipe modified slightly from His-Bind
Resin manual and all buffers containing 6 M urea). The solution was sonicated 3X for 1
minute each time at 10 V. The lysate was spun down at 10,000 x g for 10 minutes. The
supernatant was poured into a second container and stored on ice. The pellet went
through two more rounds of sonication adding 10 mL of 1X binding buffer each time to
resuspend the pellet. The clear lysate was loaded twice onto the previously charged
and equilibrated His-Bind resin. The resin was then rinsed with 100 mL 1X binding
buffer and 100 mL 1X wash buffer (25 mM imidazole). Finally, the protein was eluted
with 60 mL 1X elution buffer (200 mM imidazole).
The elution was poured into a dialysis bag (MWCO 10,000 kD) and placed in 4 L
of distilled water containing ~20 mM NaHCO3. The solution stayed on dialysis for at
least three days with three water changes per day. Once dialysis was complete, the
solution was poured into a thick glassed beaker and place in a small container of liquid
nitrogen to freeze. Once frozen, the beaker was placed on a lyophilizer and only the
powder of the protein remained. The protein was weighed and a small sample was
taken to check the purity of the protein powder.
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3.2.3 Labeling MESD with IAEDANS
The protocol provided by Invitrogen was used to label MESD with IAEDANS.
First, MESD protein powder was dissolved in buffer (25 mM NaCl, 25 mM sodiumphosphate buffer, 10 mM EDTA, pH 7.6) at a concentration of ~ 80 μM (2 mg/ml). To
disrupt the intermolecular disulfide bonds that have possibly formed, 20X molar excess
of TCEP (1.6 mM) was added to the solution and was placed on a rocker at room
temperature for 1 hour. Next, the solution was divided evenly into two microcentrifuge
tubes and were labeled “unlabeled” and “IAEDANS”. To the IAEDANS tube, 40X molar
excess of IAEDANS (3.2 mM) was added. Both tubes were wrapped completely in foil
and placed on the rocker at room temperature for at least 2 hours. Finally, to both
tubes, 20X molar excess of DTT (1.6 mM) was added to stop the reaction. The tubes
were once again wrapped in foil and placed on the rocker at room temperature for 1
hour. In order to remove the free IAEDANS, the solution underwent size exclusion gel
chromatography with a molecular weight cut off of 10 kD.
We optimized the concentration of IAEDANS to ensure efficient labeling. During
this optimization, step 2 of the protocol (20X molar excess was suggested) was changed
and various amounts of IAEDANS were added: 20, 30, 40 and 50X molar excess. Once
the free IAEDANS was removed, emission scans were collected on each sample. The
samples were excited at 290 and 336 nm and the emission range collected was 300 –
600 nm and 350-600 nm, respectively.
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3.2.4 In vitro FRET
After labeling the protein with IAEDANS, the sample protein concentration must
be determined as they need to be the same in order to correctly calculate FRET
distances. BCA or Lowry assays are used to determine concentrations and the samples
are diluted with buffer to equilibrate the concentrations between the two samples.
Next, emission scans are collected on each sample by pipetting 350 μL of the
protein solution into a 4-sided quartz cuvette.

The cuvette is placed into the

QuantaMaster-6 Spectrometer (Photon Technology International, South Brunswick, NJ)
and the data is collected using the Felix32 software provided by PTI. After opening a
new data acquisition file, “Emission Scan Method” is selected and the following
information is inputted: excitation wavelength is set at 295 nm, emission range is set at
305 – 600 nm, step size is set at 0.5 nm, integration time is set at 0.5 sec and average is
set at 5. The buffer spectrum is collected for baseline correction.

3.2.5 Synchronous scanning fluorescence spectroscopy of IAEDANS labeled MESD
and its tryptophan mutants
The samples that were prepared for the in vitro FRET experiments were also
used for the synchronous scanning experiments. Using the Felix32 software package,
new data acquisition file is opened, “Synchronous Scanning Method” is selected and the
following information is inputted: excitation wavelength range is set at 240 – 370 nm,
emission range is set at 450 – 580 nm, step size is set at 0.5 nm, integration time is set at
0.5 sec and average is set at 5. The buffer spectrum is collected for baseline correction.
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3.2.6 MESD expression using auxotrophic bacteria and 5-HT labeling
In order to produce MESD selectively labeled with 5-hydroxy-L-tryptophan (5HT), glycerol stock (DNA transformed into DL41 (DE3) competent cells) was added to
500 mL M9 minimal medium supplemented with 25 mg/L of MET and TRP and allowed
to grow overnight for at least 20 hours. After overnight growth, the OD 600 reached ~ 1.0
before spinning down the culture at 5,000 x g for 7 minutes. The supernatant was
removed and the container was inverted for 1 minute on a paper towel. The pellet was
re-suspended with 25 mL 1X PBS and vortexed briefly in order to remove any remaining
TRP. After spinning down and removing the supernatant, the pellet was re-suspended
with 500 mL defined M9 minimal medium (not containing any glucose, ammonium
chloride or tryptophan, but supplemented with 50 mg/L of the other 19 amino acids).
The re-suspended culture was poured into a 2 L flask and placed back in the 37 °C
incubator shaker for 2 hours. After 2 hours, 25 mg 5-HT was added to the culture and
placed back into the incubator shaker for an additional hour. At this point, 0.5 mM IPTG
was added to the culture and grew for 5 hours at 37 °C. Cells were harvested by
spinning the culture down at 10,000 x g for 10 minutes.

After removing the

supernatant, the pellet was either stored in the -80 °C freezer or used immediately for
purification. The purification procedure is the same as unlabeled MESD (3.2.2).
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3.2.7 Characterizations of 5-HT labeled MESD
In order to confirm the incorporation of 5-HT into the protein, fluorescence
emission and excitation scans of both 5-HT labeled and unlabeled MESD protein samples
were collected using a fluorescence spectrometer. Protein powders of MESD containing
regular tryptophan and 5-HT were dissolved in buffer (25 mM NaCl, 25 mM sodium
phosphate buffer, 10 mM EDTA, pH 7.6) at a concentration of 50 μM. Using a 4-walled
quartz cuvette, 350 μL of the protein solution was added and the cuvette was placed in
the fluorescence spectrometer.

Using the Felix32 software package, new data

acquisition file is opened, “Excitation Scan Method” is selected and the following
information is inputted: excitation wavelength range is set at 250 – 320 nm, emission
wavelength point is set at 336 nm, step size is set at 0.5 nm, integration time is set at 0.5
sec and average is set at 5. The buffer spectrum is collected for baseline correction.

3.2.8 Assignment of the FRET peaks
Standard emission scans were collected using MESD mutants containing multiple
donors and one acceptor (IAEDANS) with an excitation wavelength set at 295 nm. After
baseline correction, analysis of the emission spectra revealed that the emissions of the
multiple tryptophan donors coalesced into one uniform spectrum and effects from
individual donors could not be determined. Synchronous scanning, on the other hand,
is designed to detect subtle differences amongst a mixture of fluorescent components in
a solution and is therefore used to collect fluorescence spectra of these MESD samples.
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After collecting all the data, it was imported into an excel file and baseline
corrected, by subtracting the buffer spectrum from each protein spectrum. Next, the
data was divided into three subgroups: W32, W98 and W130 groups. For example, the
W32 group includes: MESD_wt, MESD_W98A, MESD_W130A, and MESD_W98/130A.
The “no tryptophan” mutant spectrum was included in each subgroup to be used as a
reference spectrum.
After generating a chart containing all the protein spectra, each region of the
spectra was analyzed. The first region includes the emission wavelength ranging from
465 – 485 nm, this region coincides with an excitation wavelength range of 255 – 275
nm. Both tyrosine and phenylalanine residues may be excited by this wavelength range.
Although typically the emission intensity of both tyrosine and phenylalanine is much less
than that of tryptophan, there are 4 tyrosine residues and 7 phenylalanine residues in
MESD. Their combined emission could be exciting IAEDANS and might explain the first
region of this spectra.
The second region includes the emission wavelength ranging from 485 – 510 nm,
which coincides with an excitation wavelength range of 275 – 300 nm. This excitation
range fully overlaps the absorption range of tryptophan. Therefore, this region may be
the “FRET peak” region. Once a donor is excited, its emission can excite the acceptor
and cause the acceptor to emit its own emission. The peak emission of an acceptor
caused by excitation from a donor’s emission is called the “FRET peak”.

When

comparing the FRET peak of MESD samples containing one donor and one acceptor
using an excitation wavelength of 290 nm, we found that the corresponding FRET peaks
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display maximum intensity at 480 – 490 nm (Figure 3-4). The FRET peaks observed in
region 2 of the synchronous scanning spectra overlap the same region found in Figure 34, providing additional spectroscopic confirmation for our assignment.
It is this region that can be used to assign tryptophan residues. By comparing all
the different mutants and wild-type proteins, subtle changes in this region of the
spectra should be due to the contributions to the FRET peaks of different tryptophan
residues. Therefore, such a comparison may allow us to assign the FRET peaks of each
individual tryptophan residue.
The first comparison is between the “no tryptophan” mutant and the single
tryptophan mutants of MESD. The peak in the single tryptophan mutant spectra is
assigned as the tryptophan residue that the mutant contains. This is done for each
single tryptophan mutant, allowing us to tentatively identify the FRET peak position of
each tryptophan residue. By identifying the tentative FRET peak of each tryptophan
residue, these FRET peak assignments can be confirmed using double tryptophan
mutants. This can be done by comparisons of the FRET peaks of the double tryptophan
mutants in the FRET region. For example, a double tryptophan mutant containing W32
and W130 should contain two individual FRET peaks of W32 and W130, if there is no
FRET peak overlap between these two tryptophans. An observation of the FRET peaks of
W32 and W130 in the FRET spectrum of this double tryptophan mutant will be a
confirmation of assignment of the FRET peaks of W32 and W130. This comparison will
also allow us to tentatively assign the FRET peak for the second tryptophan residue.
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The third region includes the emission wavelength ranging from 510 – 580 nm
with a peak emission at 546 nm. After subtracting the Δλ of 210 nm, that leaves a λex =
336 nm. Since the peak excitation wavelength of IAEDANS is exactly 336 nm, therefore,
this third emission region is a result of the direct excitation of IAEDANS.

3.3

Results

3.3.1 MESD tryptophan mutants
Wild-type MESD was successfully mutated into single and double tryptophan
mutants containing varying number and placement of tryptophan residues using
Stratagene’s Site Directed QuickChange Mutagenesis Kit. The ds-plasmid DNA was sent
out for sequencing and the results were confirmed. Each plasmid was successfully
transformed into bacterial strain BL21 (DE3) and underwent double colony selection
[79]. Once a stable colony was formed, the high cell density method was used for
expression and an affinity chromatography column was used for purification. Figure 3-3
shows purified protein samples of wild-type MESD and all the MESD tryptophan
mutants.
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M

WT

DM1

DM2

DM3

SM1

SM2

SM3

NoW

50kD

20kD

Figure 3-3: 12% SDS-PAGE of 8 MESD proteins. M – Marker, WT – wild-type MESD, DM
– double tryptophan mutant (1: W32A, 2: W98A, 3: W130A), SM – single tryptophan
mutant (1: W98/130A, 2: W32/130A, 3: W32/98A) and NoW: no tryptophan mutant.

3.3.2 Optimization of IAEDANS-labeling
During the initial experiments with IAEDANS labeled MESD, widely varying
spectra were obtained for the same mutant and the distance calculations were far off
from the observed distances between the donor and acceptor observed in the NMR
structure of MESD. Invitrogen supplied a protocol for labeling proteins with IAEDANS,
but suggested optimizations may be necessary. The concentration of each reagent for
each step was increased two-fold, therefore the new protocol used 20X molar excess of
TCEP, 40X molar excess IAEDANS and 20X molar excess of DTT. The FRET spectra of the
mutants labeled in this manner displayed consistent FRET spectra. Using these FRET
spectra, the distances between the single tryptophan donor and IAEDANS acceptor
provided consistent distances that are close to the observed distances between the
various tryptophan residues and C142 in the NMR structure of MESD. To eliminate any
artifacts of this approach, multiple FRET spectra were collected and used to calculate
the FRET-distances. The calculated distances were nearly the same as the distance in the
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NMR structure of MESD with small variations. Based on this result, the TCEP and DTT
concentrations were maintained at 20X molar excess.
In order to ensure that all the MESD proteins were labeled with IAEDANS,
various concentrations of IAEDANS were tested to determine the optimal amount of
IAEDANS that was needed when labeling. Samples were treated with: 20, 30, 40 and
50X molar excess of IAEDANS and emission scans were collected in the range of 300 –
600 nm and 350 – 600 nm with the excitation wavelength (λex) equal to 290 and 336 nm,
respectively. When λex = 290 nm, we will observe the tryptophan emission peak
(decrease in intensity) and when λex = 336 nm, we will observe the IAEDANS emission
peak (increase in intensity).
As seen in Panel A of Figure 3-4, the tryptophan emission peak continues to
decrease until the IAEDANS concentration is 40X molar excess of the MESD
concentration. After that point, the intensity of the peak does not change indicating
that 40X molar excess of IAEDANS sufficiently labels all the MESD proteins in the
sample. Panel B shows a similar response to direct excitation of IAEDANS. The IAEDANS
emission peak continues to increase until the IAEDANS concentration is 40X molar
excess of the MESD concentration. From this point, all labeling of MESD with IAEDANS
used 40X molar excess of the label.
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Figure 3-4: Panel A shows emission range 300 – 400 nm at λex = 290 nm. Panel B shows
emission range 400 – 600 nm at λex = 336 nm. W32/130A-UN designates the unlabeled
protein while W32/130A-I designates the IAEDANS labeled protein.
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3.3.3 In vitro FRET measurements and calculation of FRET-distances
One method to calculate intramolecular distances between a donor and
acceptor within a protein is to determine the intensity difference of the donor emission
peak with a protein containing only a donor (tryptophan) and a protein containing both
a donor and acceptor (tryptophan-IAEDANS). The two samples were prepared for each
mutant and their concentrations were equilibrated since intensity is also concentration
dependent. Emission scans were collected in the range of 305 – 600 nm with an
excitation set at 295 nm. The same fluorescence spectra were collected using the buffer
that was used to dissolve the fluorescence labeled protein, serving as the baseline.
After the data has been collected, it is exported to an excel file. Each of the
collected FRET spectra was baseline corrected by removing the buffer spectrum from
each mutant’s spectrum. After baseline correction for each mutant, the tryptophan
emission peaks, both labeled (QD) and unlabeled (QDA), are found for each mutant. The
FRET-distances were calculated based on the following equation:

⁄

r = R0 (

)

, where R0 for the tryptophan-IAEDANS pair is equal to 22 Å.

Figures 3-5, 3-6 and 3-7 show the spectra for the three single tryptophan MESD
mutants as well as their distance calculations.
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FIGURE 3-5: Emission scan of MESD_W98/130A with a λex = 295 nm and an emission
range of 305-600 nm. The tryptophan emission peaks are represented by QD for the
unlabeled protein and QDA for the IAEDANS labeled protein.

Figure 3-5 shows an example of emission scan for MESD_W98/130A. The blue
line represents the emission of the unlabeled protein, while the red line represents the
emission of the IAEDANS labeled protein. The expected distance based on the NMR
structure is 23.5 Å, which is quite close to the R0 value of 22 Å. Since the R0 value is
equal to the distance at which 50% of the donor’s emission is captured by the acceptor
molecule, we would expect to see the donor intensity decrease by half. In fact, we do
observe this halving of the intensity as shown above.
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Figure 3-6: Emission scan of MESD_W32/130A with a λex = 295 nm and an emission
range of 305-600 nm. The tryptophan emission peaks are represented by QD for the
unlabeled protein and QDA for the IAEDANS labeled protein.

Based on the observed NMR distance of 26.1 Å, we expect to see the least
change in intensity as the W98 residue is furthest from residue C142. Compared to
figures 3-5 and 3-6, we do in fact see the least change in intensity and thus, the largest
calculated distance.
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Figure 3-7: Emission scan of MESD_W32/98A with a λex = 295 nm and an emission range
of 305-600 nm. The tryptophan emission peaks are represented by QD for the unlabeled
protein and QDA for the IAEDANS labeled protein.

Since residue W130 is expected to be the closest to residue C142, with an
expected distance based on the NMR structure of 20.5 Å, the acceptor molecule should
accept most of the W130 emission. As shown above, we see a 4-fold decrease in
intensity and the shortest calculated distance.
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Table 3-2 lists the calculated distances for each mutant with a standard deviation
based on six separate experiments. The calculated distances are similar to the observed
distances from the NMR structure. The NMR structure did not have an IAEDANS label,
which could account for the ~ 2 Å differences seen. In addition, the addition of the
IAEDANS label could slightly alter the structure. A simple

15

N-HSQC NMR experiment

could indicate whether or not there are any structural changes after fluorescence
labeling.

TABLE 3-2: Calculated distances versus observed distances
Mutant

Calculated Distance

Observed Distance

Difference

Percent Error

(NMR)
W32/98A

18.5 ± 0.4 Å

20.5 Å

-2.0 Å

11%

W32/130A

28.4 ± 0.8 Å

26.1 Å

+2.3 Å

8%

W98/130A

22.3 ± 0.7 Å

23.5 Å

-1.2 Å

5%

3.3.4 Assignment

of

FRET-peaks

using

synchronous

scanning

fluorescence

spectroscopy
Synchronous scanning fluorescence spectrometry takes advantage of the ability
to vary both the excitation and emission wavelengths simultaneously during the data
collection. In this technique, the fluorescence signal is recorded when excitation and
emission wavelengths are simultaneously scanned keeping in between a fixed
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wavelength interval (called the offset value, Δλ) throughout the spectrum. As a result,
the selectivity for individual components is considerably improved; additionally, much
more information on mixtures of fluorescent compounds is gained [43, 44].
In the case of MESD, we have mutants that contain two donors in addition to the
wild-type MESD which contains three donors. The utilization of synchronous scanning
was explored to determine whether the FRET peaks can be separated for each donor to
acceptor using a multiple donor/one acceptor protein sample.

3.3.4.1 Tryptophan residues of MESD have unique environments
Typically, synchronous scanning is used to help identify various fluorescent
components within a mixture. The tryptophan residues of MESD are each in their own
unique environment and could possibly have unique spectral patterns. Indeed, based
on the NMR structure of MESD, we found that each tryptophan has a distinct surface
exposure value and forms possible hydrogen bonds with nearby residues (Table 3-3).
The immediate chemical environment of tryptophan residues can have effects on its
fluorescent properties resulting in slight red or blue shifts of its emission spectrum,
causing

different

wavelengths

of

the

FRET-peaks

for

different

tryptophan

donor/IAEDANS acceptor pairs [45]. These wavelength differences may possibly allow
us to assign the FRET-peaks to an individual FRET donor/acceptor pair, if these
synchronous scanning fluorescence spectra can separate the individual FRET-peaks.
Table 3-3 illustrates the uniqueness of each environment surrounding the
tryptophan residues. Residue W32 is highly exposed to the solution, but does not seem
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to participate in any hydrogen bonds. Residue W98 is deeply buried and has one
potential hydrogen bond with the carbonyl oxygen acting as the acceptor. Residue
W130 is in an intermediate state of surface exposure and potentially participates in two
hydrogen bonds in which both backbone and sidechain atoms are involved.

Table 3-3: Environment of MESD tryptophan residues
Residue

ASA*

Possible H-Bonds (Donor:Acceptor)

W32

0.78

--

W98

0.13

SER 101 (Oγ—Cβ) : TRP 98 (O—C)

W130

0.43

ASP 134 (Oδ2—Cγ) : TRP 130 (O—C)
TRP 130 (Nε1—Cγ): ASP 108 (Oδ2—Cγ)

*

ASA: Accessible surface area.

3.3.4.2 Optimization and organization of the synchronous scanning fluorescence
spectra
In order to determine the best offset value (Δλ) to use for the synchronous scans
of MESD, an extensive amount of emission ranges were tested. The most interesting
data and clearly defined peaks came from using an excitation range of 240 -370 nm with
a Δλ = 210 nm, therefore the collected emission range was 450 – 580 nm. Once the
emission and excitation ranges were determined, synchronous scans could be collected
for wild-type MESD and all its mutants.
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In order to perform FRET-peak assignment, the collected spectra are divided into
three subgroups. Each subgroup contains all the spectra for proteins containing a
particular tryptophan residue. As an example, one subgroup would contain all the
spectra for proteins containing the W32 residue: MESD_wt, MESD_W98A,
MESD_W130A, and MESD_W98/130A. The “no tryptophan” mutant spectrum was
included in each subgroup to be used as a baseline of sorts.

3.3.4.3 Separation of the FRET-peak for each TRP donor-IAEDANS acceptor in MESD
Figures 3-8, 3-9 and 3-10 show the spectra obtained from these synchronous
scanning experiments. In each figure, Panel A shows the full emission spectra collected
for each protein with three distinct regions of peaks. Panel B is a zoomed-in spectra
showing the emission region of 480 – 510 nm and Panel C shows the difference spectra
after the “NoW” mutant spectra has been subtracted from the MESD protein spectra,
treating it similar to a baseline.
Focusing on the emission range of 480 – 510 nm, we believe that this
corresponds to the “FRET peak”. The FRET peak is the IAEDANS emission observed
based on its excitation by tryptophan. The emission range of 480 – 510 nm coincides
with an excitation range of 270 – 300 nm which does in fact cover tryptophan’s
absorbance spectrum. When looking for FRET peaks, the first comparison is between
the “no tryptophan” mutant and the single tryptophan mutant. The new peak observed
in the single tryptophan mutant spectra, as compared to the “no tryptophan” mutant, is
assigned for this tryptophan residue. By identifying the FRET peak for each tryptophan
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residue, we can tentatively assign these single tryptophan residues. This tentative
assignment can be verified by comparisons with the double tryptophan mutants for
confirmation. By the time wild-type MESD is analyzed, the FRET spectra should contain
all three FRET peaks for the three tryptophan residues in the MESD protein.

3.3.4.4 Assignment of the FRET peak for each tryptophan residue of MESD
Starting with Figure 3-8, the spectra are shown for all MESD and mutants
containing residue W32 as well as the no tryptophan mutant. Panel A shows the full
spectra, while Panel B zooms in on the FRET peak region. To create Panel C, the spectra
of the no tryptophan mutant was subtracted from each mutant containing W32.
First, looking at the single tryptophan mutant (MESD_W98/130A) that contains
W32, there is one broad peak at 502 nm and has been assigned and labeled as W32.
Next, looking at the double tryptophan mutant containing W32 and W130, there are
two distinct peaks. The first peak is at 495 nm and the second is also around 502 nm. If
we assume that the peak at 502 nm is W32, then the peak at 495 nm must be from
W130. Labeling the 495 nm peak as W130 also makes sense since the intensity of the
W130 should be higher than both W32 and W98 as it is the closest to the IAEDANS
labeled C142 residue. Due to the close proximity, IAEDANS should capture more of
W130’s emission and have a more intense FRET-based emission. After examining all the
spectra, it is noted that whenever the W130 residue is present in a protein, there is a
more intense peak around 495 nm. Finally, after examining the wild-type spectra, there
are once again two distinct peaks. Residue W98 could have an overlapping FRET peak
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with either W130 or W32. After examining the other spectra in Figures 3-9 and 3-10, it
has been determined that W98 has an overlapping FRET peak to W32 and has been
labeled as such.
The same process was repeated for each subgroup of proteins. In Figure 3-9,
residue W98 has a FRET peak at 503 nm, which indeed is very similar to the W32 FRET
peak. The FRET peak strategy allows us to confidently assign the FRET peaks for all three
tryptophan residues (Table 3-4). Although the data is conclusive, further exploration
into this FRET assignment technique may be fruitful. However, another challenge to
overcome would be the ability to calculate distances based on changes in FRET peaks
and not changes in donor emission.

Table 3-4: FRET peak assignment
Tryptophan Residue

W32

W98

W130

FRET Peak (nm)

502

503

495
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Figure 3-8: Synchronous scans for all MESD proteins containing residue W32. Panel A is
full spectrum. Panel B is zoomed in on the FRET peak region. Panel C is the difference
spectra with peak assignments.
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Figure 3-9: Synchronous scans for all MESD proteins containing residue W98. Panel A is
full spectrum. Panel B is zoomed in on the FRET peak region. Panel C is the difference
spectra with peak assignments.
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Figure 3-10: Synchronous scans for all MESD proteins containing residue W130. Panel A
is full spectrum. Panel B is zoomed in on the FRET peak region. Panel C is the difference
spectra with peak assignments.
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3.3.5 MESD bacterial expression using auxotrophic bacterial stain: DL41 (DE3).
The double mutant plasmids were transformed into the DL41 (DE3) auxotrophic
bacterial strain. After transformation, the colonies were screened using double colony
selection for each mutant. Both transformation and double colony expression utilized
rich medium and regular tryptophan. Figure 3-11 shows an example of expression of
two of the three double mutants after double colony selection. The second and third
lanes compare a non-induced and induced expression of MESD_W32/130A. The fourth
and fifth lanes compare a non-induced and induced expression of MESD_W32/98A.

M

1-I

1+I

2-I

2+I

50 kD

37 kD

20 kD

Figure 3-11: 12% SDS-PAGE of samples taken after expression. M = Marker. 1 =
W32/130A, 2 = W32/98A, -I = uninduced and +I = induced with IPTG.
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3.3.6 Optimization of 5-HT-labeling of MESD
The initial attempts to selectively label MESD with 5-HT were performed using
the high-cell density method. The medium was supplemented with MET and 5-HT, but
the protein yield was quite low after performing SDS-PAGE analysis. After several failed
attempts using the high-cell density method, the traditional IPTG method was used for
expression, but the yield was even lower. We then focused back on the high-cell density
method with the following modifications.
First, instead of growing the starting culture in rich medium, the starting culture
was grown in a minimal medium containing glucose, ammonium chloride, MET and TRP
(both amino acids at 25 mg/L) for ~20 hours overnight. The following morning, the
OD600 was ~ 1.0 and the culture was spun down at 5,000 x g for 7 minutes. The pellets
were re-suspended in 1X PBS and vortexed briefly in order to remove as much regular
TRP as possible. After spinning down the cells again and removing the supernatant, the
pellets were re-suspended in the defined medium listed in Table 3-5, with the exception
of 5-HT. The flask was placed back in the 37 °C shaker for two hours in order to “starve”
the cells and to use all the remaining TRP in its reserves. After the two hour starvation
period, 5-HT was added and the flask was placed back in the shaker for 30 minutes. At
this point, 0.5 mM IPTG was added to induce protein production. The bacterial cells
were cultured for 5 hours at 37 °C before harvesting. Removing the rich medium source
and starving the cells seemed to be most beneficial for 5-HT incorporation.
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Table 3-5: Defined medium for 5-HT labeling
Component

Amount per L

5X M9 Minimal Salts (-NH4Cl)

200 mL

1M MgSO4

2 mL

1M CaCl2

0.1 mL

1000X Trace Metals

0.25 mL

Kanamycin (30 mg/mL)

1 mL

19 standard amino acids (-W)

50 mg

5-hydroxy-L-tryptophan

50 mg

To ensure that the 5-HT was being taken up by the bacteria, the uptake of 5-HT
was monitored by taking samples of the medium every hour. Furthermore, it also
tested whether or not adding additional boosts of 5-HT made a difference in expression
levels and incorporation of 5-HT into MESD. Figure 3-12 shows two spectra of the
uptake experiments. In Panel A, starting at 0 hours (the point at which IPTG was added
to induce culture), a significant decrease in intensity was observed after 1 hour. At the
2-hour point, only a slight intensity decrease was observed, suggesting that the uptake
of 5-HT into the bacterial cells had significantly slowed down (light blue dotted line). At
the 2 hour mark, additional 5-HT was added and a new medium sample was taken (dark
red line). Samples were again collected after 3 and 4 hours, and decreases in intensity
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where noted for both time points, with a similar pattern as we observed for the first few
hours.
Generally, significant 5-HT uptake was observed during the first hour, but
significantly slows during the second hour. After the fourth hour, additional 5-HT was
added and another medium sample was taken (dark green line). There was a decrease
in intensity seen at the 5 hour mark (light green line), but there was not a notable
decrease at the 6 hour mark (black dotted line) , again repeating the same pattern as
the first four hours. This data indicate that the bacterial cells seem to uptake the 5-HT
during the first hour significantly, however, this uptake is inhibited somehow during the
second hour. Based on this result, we believe that it is critical to add more 5-HT during
expression for efficient labeling of the MESD protein with 5-HT. Panel B was a control
experiment of the medium containing 5-HT without any bacterial cells to see if intensity
decreased for some other reason besides uptake. No changes in intensity were noted
for the 6 hour period. Based on the results shown in Figure 3-12, the bacteria do not
seem to have a problem with the uptake of 5-HT, however, additional amount of 5-HT
have to be added every 2 hours during bacterial expression to efficiently label MESD
with 5-HT.
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Figure 3-12: Absorption spectra of culture medium with (Panel A) and without (Panel B)
bacteria. Excitation range = 250 – 330 nm, λem = 336 nm.
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3.3.7 Characterizations of the 5-HT labeled MESD
In order to determine if 5-HT had been incorporated into MESD, fluorescence
absorption spectra were collected for the labeled proteins. If MESD has been labeled
with 5-HT, there should be a noticeable shoulder on the right half of the spectra. Figure
3-13 shows two absorbance spectra of a protein produced before (Panel A) and after
labeling optimization (Panel B). It is clear in Panel B that there is a shoulder and the
protein can be excited at 310 nm, indicating that 5-HT was efficiently incorporated into
MESD. Under this condition, we estimated that about 50% of MESD was labeled with 5HT.
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Figure 3-13: Absorbance spectra (λem = 332 nm). Panel A – before optimization of
expression conditions. Panel B – after optimization of expression conditions.
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Figure 3-14 shows the fluorescence emission spectra of the same protein with λex
= 295 nm and λex = 310 nm. The protein expressed with regular tryptophan can be
excited at λex = 295 nm, as shown by the black solid line. However, exciting that same
protein at λex = 310 nm results in a nearly flat line (black dotted line).

1.1

98W - Ex @ 295 nm
98W - Ex @ 310 nm

1
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0.9

98(5-HT) - Ex @ 310 nm

Fluorescence Intensity (a.u.)

0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
310

320

330

340

350

360

370

380

Wavelength (nm)

Figure 3-14: Emission spectra of MESD_W32/130A with λex = 295 nm and λex = 310 nm.

After examining the protein that has been labeled with 5-HT, Figure 3-14
demonstrates that it also can be excited at λex = 295 nm (red solid line). As opposed to
the protein expressed with regular tryptophan however, we see that this protein can be
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excited when λex = 310 nm (red dotted line), although the intensity is much lower. Once
the labeling efficiency of MESD with 5-HT is optimized, the excitation intensity should be
significantly enhanced.

3.4

Conclusions
In order to perform in-cell FRET experiments, a protein must be labeled in such a

way that will allow for specific excitation of the target protein inside the cells without
excitation of the intracellular background proteins. Our rationale is to use tryptophan
residues as the fluorescence donor and IAEDANS labeled on the cysteine residue as the
fluorescence acceptor to minimize any potential structural perturbation of the protein
of interest. We have chosen MESD as the model protein for our studies since this
protein contains three tryptophan residues (W32, W98 and W130) that can be used as
the FRET donors and a single cysteine at residue 142 which allows for labeling with a
small fluorophore, IAEDANS, as the fluorescence acceptor. MESD is also a good choice
since it is an ER-resident protein and should remain in the ER and Golgi during the FRET
experiments. After a few rounds of mutagenesis, three double W-to-A mutants were
made that contain one tryptophan residue each (single tryptophan mutants), since the
traditional FRET-based distance calculations require one donor and one acceptor within
MESD. We also prepared three double tryptophan mutants of MESD and these mutants
allows us to explore a methodology that possibly permits us to calculate two FRETdistances from a single FRET experiment. Furthermore, this methodology may also allow
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us to calculate three FRET-distances from a single FRET experiment using wild-type
MESD that contains three tryptophan donors.
To verify our in vitro FRET-technique, we performed in vitro FRET experiments of
the single tryptophan mutants after labeling each mutant with a thiol-reactive probe
(IAEDANS) at C142 of MESD. We compared the distances calculated from the FRET
experiments to the distances observed on the NMR structure. Our calculated FRETbased distances of the three single tryptophan mutants are nearly identical to the
distances of these tryptophan residues to C142 observed in the NMR structure of MESD,
demonstrating that the validity of our FRET-based distance calculations using the
strategy established. This allows us to verify the FRET technique first works in vitro
before moving to an in-cell experiment.
In addition to verifying the standard in vitro FRET-based distance calculations, we
also explored the ability to calculate distances based on multiple donors and one
acceptor. Synchronous scanning fluorescence spectroscopy has been used to identify
multiple fluorescent components contained in a mixture by varying both the excitation
and emission wavelengths simultaneously during the data collection. However, this
technique has not been used on proteins to detect multiple tryptophan residues.
Typically, tryptophan residues in a protein are in their own unique chemical
environments and their emissions may vary slightly depending upon the nature of the
differences of those chemical environments.

After optimizing the excitation and

emission ranges, as well as the offset value (Δλ), spectra were collected of the wild-type
MESD protein and all of the MESD tryptophan mutants. After careful analysis, FRET-
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peaks were assigned for all three tryptophan residues of MESD. We believe further
exploration of this technique could yield interesting results leading to the possibility of
calculating multiple distances based on a single FRET experiment. The success of this
strategy will significantly reduce the amount of work involved in sample preparation
during FRET-distance calculations, holding the potential to push the FRET technique into
an atomic resolution structural biology tool.
Once the in vitro data showed that the FRET measurements were similar to the
NMR structural data, we moved on to the next step of incorporating a tryptophan
analogue, 5-HT, that would allow for specific excitation of the target protein without
excitation of the background cellular proteins inside living cells. Several modifications of
the minimal medium used and the high cell density method resulted in MESD mutant
proteins that displayed fluorescent properties similar to free 5-hydroxy-L-tryptophan,
demonstrating that our current optimized method efficiently labels MESD with 5-HT.
This success allows us to pursue in-cell FRET experiments to study protein structure
inside the living cells, which is the main focus of Chapter 4.

3.5

Discussion
While the overall goal of this thesis is to develop an in-cell FRET technique for

protein structural determination in living cells, this chapter focused on verifying several
methods and ideas in vitro first. First, the accuracy of the FRET technique to calculate
distances between a donor and acceptor within a protein must be validated. By
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comparing the FRET-based distances to the NMR protein structure, this will confirm that
FRET is a valid structural tool at atomic resolution.
Since MESD contains three tryptophan residues, a series of mutagenesis was
performed that resulted in a total of seven mutants: 3 single tryptophan mutants, 3
double tryptophan mutants and a “no tryptophan” mutant. MESD contains a single
cysteine residue, so once the proteins were expressed and purified, they were labeled
with a thiol-reactive fluorophore, IAEDANS, to act as the acceptor. IAEDANS has a peak
excitation that overlaps tryptophan’s peak emission. Emission scans were collected for
each IAEDANS labeled double mutant (one donor: one acceptor) as well as the buffer
which was used for baseline correction. Finally, distances were calculated based on
changes in donor emission intensity. Comparing the calculated distances to the NMR
protein structure, they were found to be within 2 Å of each other. Therefore, the FRET
technique was validated as an atomic resolution structural technique.
Traditional in vitro FRET-based distance calculations within a protein require one
donor and one acceptor, resulting in a measured distance between that donor and
acceptor. Currently, it is impossible to use FRET to calculate multiple distances within a
protein containing multiple donors or acceptors. In order to make in-cell FRET a feasible
structural technique, we explored a FRET technique that obtains multiple distances from
a single measurement using protein samples that contain multiple donors and a single
acceptor.
When performing an emission scan on a protein sample labeled with multiple
donors and a single acceptor, the emission of each donor coalesces into a single uniform
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spectra. Synchronous scanning fluorescence spectroscopy has the ability to detect
multiple fluorescent components within a single mixture. The donors in the case of
MESD are native tryptophan residues and each residue resides in its own unique
chemical environment. It might be possible to detect slight changes in tryptophan
emission

and

IAEDANS

excitation

using

synchronous

scanning

fluorescence

spectroscopy.
Extensive optimizations were done to ensure that the best excitation and
emission ranges were chosen for these studies. The excitation range of 240 – 370 nm
with an offset value of 210 nm which leads to an emission range of 450 – 580 nm
displayed the most interesting results. Upon examination, three regions of peaks are
clearly defined. Region 1 includes emissions 465 – 485 nm, region 2 includes emissions
485 – 510 nm and region 3 includes emissions 510 – 580 nm. Region 1 has been
explained as the result of exciting the 11 tyrosine and phenylalanine residues of MESD
and their combined effect to excite IAEDANS. Region 3 is the IAEDANS emission as a
result of direct excitation of the fluorophore.
We are most interested in region 2 as this is the FRET peak region and we can
clearly see the most differences between the different spectra in this region. Each
MESD protein is of equal concentration, so the only difference between each protein is
the amount of tryptophan residues present. By careful comparisons of the fluorescence
emission spectra of these samples, we identified the FRET regions of the multiple
tryptophan donors to a single IAEDANS acceptor, allowing us to observe different FRET
peaks. By comparing the FRET regions of the wild-type MESD with the single and double
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tryptophan mutants of MESD, we assigned the FRET peak for each tryptophan residue.
The FRET peak resulting from residue W130 was found to be around 495 nm, while
residues W32 and W98 were found to be around the 502 – 503 nm range. Although this
technique needs further optimization, it represents the first step for measurement of
multiple distances from a single FRET experiment. In our opinion, this is the key step
towards development of a FRET technique into a high-resolution structural biology tool
to study protein structure inside the cells.
For future experiments, the collection of region 1 and region 3 is unnecessary.
The information that is necessary for structural purposes is found within region 2 – the
FRET region. When designing experiments, the excitation range of the synchronous
scan should cover the full absorption range of the donor. In turn, the emission range of
the synchronous scan should be centered around the peak emission of the acceptor.
Finally, since tryptophan is being used as a donor, intracellular background
proteins containing tryptophan could result in interference when performing in-cell
FRET experiments. Since both in vitro FRET experiments were validated and explored,
the next task was to selectively label MESD with 5-HT that would ensure specific
excitation of the 5-HT labeled protein without excitation of background cellular proteins
that contain regular tryptophan residues. An auxotrophic bacterial strain, DL41(DE3),
was used that is auxotrophic for methionine and tryptophan. After various attempts to
express the proteins within this strain, it was found that an altered high-cell density
method lead to the best expression and incorporation of 5-HT into MESD. Incorporation
of 5-HT into the protein was confirmed by performing excitation and emission scans
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demonstrating that the protein could be excited at λex = 310 nm. Although,
incorporation has not reached 100%, further optimizations of the expression conditions
should yield an MESD protein with full incorporation of 5-HT. Once full incorporation of
5-HT has been achieved, a
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N-HSQC NMR experiment should be collected and

compared to wild-type MESD to ensure that there are no major structural changes after
addition of the amino acid analogue.
This chapter has laid the foundation for future development of an in-cell FRET
methodology. MESD serves as a good model for in vitro work and will continue to be a
good model for future in-cell work. Since MESD is an ER-resident protein due to its
“RDEL” ER retention signal, once delivered inside living cells using QQ-protein delivery, it
will remain in the ER and Golgi, making any information gained physiologically relevant.
Also, since the in vitro FRET-based distance calculations are comparable to the NMR
protein structure, the FRET-technique is a feasible option for measuring distances within
a live cell.
In regards to the synchronous scanning fluorescence data and analysis, this
illustrates the potential that FRET can be potentially used as an in-cell structural biology
technique at atomic resolution. This synchronous scanning fluorescence technique has
never been used for proteins, but in principle it should be able to detect the subtle
differences of tryptophan’s emissions based on each residue’s unique chemical
environment. In our analysis, we were able to visualize differences between different
protein spectra in the FRET-peak region of the emission spectra. The other two regions
did not display any differences in the shape of the spectra, but since the FRET-peak
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region is dependent upon the number of tryptophan residues present in each protein, it
is here that we see differences.
Further optimization and analysis of synchronous scanning fluorescence
spectroscopy using protein samples that contain multiple fluorescence donors and one
single acceptor could yield interesting results. Indeed, our results shown in this chapter
suggest that the methodology developed in this chapter a potential to calculate multiple
distances based on a single FRET experiment. In addition, expression and selective
labeling of MESD with 5-HT needs to be further optimized until greater than 80%
incorporation is achieved. This will be beneficial for future in-cell work to guarantee the
intensity is strong enough to allow for usable FRET data. However, while there is still
room for improvement, we feel that a strong enough foundation has been laid so that
we can move on to developing an in-cell FRET methodology.
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CHAPTER 4
DEVELOPMENT OF AN IN-CELL FRET TECHNIQUE:
OPTIMIZATIONS OF IN-CELL EXPERIMENTAL CONDITIONS

4.1

Introduction
The ultimate goal of this thesis project is to develop an in-cell fluorescence

technique that allows for measurement of the distances between fluorescence donors
and acceptors within a protein or between two proteins inside the correct intracellular
compartment of living cells. The successful achievement of this goal will allow us to
obtain high-resolution structural information within a protein or between two proteins
inside living cells, a key step towards high-resolution structural biology of proteins inside
the living cell.
Development of this methodology is extremely challenging.

Proteins only

perform their biological functions inside the correct intracellular compartments and
different intracellular compartments may display different chemical environments. In
addition, the intracellular environment is highly crowded and harbors an intricate
network of biological activities simultaneously due to protein interactions with their
partners. Different intracellular events, such as folding, post-translational modification,
protein interactions, intracellular trafficking and secretion, may cause different protein
concentrations and structures in different compartments [112]. This complex cellular
environment suggests that protein concentration and structure inside living cells are
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spatiotemporal dependent, making high-resolution structural studies of proteins inside
living cells extremely challenging.
Fluorescence spectroscopy has been used on cell cultures before, but has not
been used in an attempt to collect high-resolution structural information of a target
protein inside living cells [17, 29, 37, 38, 41, 42]. This project is challenging for a number
of reasons. First, the intracellular protein concentration of a target protein may vary in
different intracellular compartments. However, these concentrations must be known in
order to accurately calculate distances based on the current in vitro FRET approach [41].
Currently, it is impossible to determine the intracellular concentration of a protein
inside a specific intracellular compartment of living cells. Second, a protein may display
different conformations in different compartments due to changes in the chemical
environment of these intracellular compartments. This causes different structural
populations of a protein in different intracellular compartments, further complicating
structural studies of a protein in living cells. Currently, there is no structural biology
technique that allows us to study a protein structure within a specific intracellular
compartment. An alternative is to deliver the labeled protein into its destiny
compartment for structural studies. The next challenge is to deliver the target protein
into a specific intracellular compartment.

In order for the structural information

obtained to be physiologically relevant, the target protein should be located where it
functions.
Finally, the biggest challenge involves the complexity of the intracellular
environment. Since there can be up to 300 – 400 mg/mL of protein inside a living cell,
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macromolecular crowding will have an effect on a protein’s structure and function
[113]. The protein interaction network must also be considered as protein-protein
interactions may also have an effect on a protein’s structure. Finally, there is the
potential for different sub-populations of a protein in different cellular compartments
within a cell. In the case of MESD, it traffics from the ER to the Golgi as it acts as a
chaperone and escort protein for LRP5/6 [62]. The structure of MESD within the ER may
differ from the structure within the Golgi.
The concept behind an in-cell structural technique also poses several technical
challenges that we have sought to overcome. First, the minimum concentration needed
for a protein to collect FRET spectra is in the low micromolar range. While this is much
closer to being physiologically relevant as compared to the required millimolar
concentrations needed for NMR studies, it is still probably higher than what would
normally be found in a cell, depending on the protein. Another technical challenge is
the ability to deliver an exogenous labeled protein to the correct intracellular
compartment of a living cell. Cell-penetrating peptides and their counterparts do not
have this targeting capability. The QQ-protein delivery technique developed by our lab
can deliver exogenous proteins to the correct intracellular compartment and solves this
technical challenge.
The final technical challenges involve overcoming the complexity of the
intracellular environment. With regards to macromolecular crowding, it should not
have an effect on the fluorophores’ ability to act as a donor or acceptor within the
target protein. If the macromolecular crowding has an effect on the protein’s structure,
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this will be detected by the FRET measurements and provide insight into the in situ
structure of MESD within living cells. As to the possibility of protein-protein interactions
affecting the FRET measurements due to intermolecular FRET, we propose to utilize 5HT-labeling to solve this problem, since the 5-HT-labeled protein can be specifically
excited at 310 nm whereas the background intracellular proteins with regular
tryptophan remain un-excited [105]. This allows us to separate 5-HT-labeled proteins
from the intracellular background proteins, eliminating any possible intermolecular FRET
and providing a major advantage of our FRET-measurement under native intracellular
conditions. Thus, this FRET-measurement is only from the intramolecular FRET while the
protein of interest is actually interacting with its binding partners under native
intracellular conditions. In regards to the potential of different sub-populations of the
protein within a living cell, this can be overcome by utilizing several cell biology
techniques such as knockout and knockdown techniques. For example, the siRNA
technique can be used to knockdown interaction partners like LRP5/6 for MESD protein.
In addition, adding an inhibitor to prevent traffic from the ER to the Golgi would ensure
all the MESD would be located in the ER only.
Our proposed methodology is to use an auxotrophic bacteria strain to produce a
5-HT labeled protein, ensuring that only the target 5-HT-labeled protein will be excited
within a mixture of background unlabeled intracellular proteins [105]. We will use MESD
as a model protein for this methodology development. A thiol-reactive small molecule
fluorophore was chosen since it will bond to the single cysteine residue of MESD and
serve as the fluorescence acceptor. The next two steps in this methodology
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development is to deliver this specifically labeled protein to the correct intracellular
compartment of a living cell and determine the intracellular protein concentration. In
the case of MESD, it needs to be delivered to the ER of the living cell. The QQ-protein
delivery technique serves as the protein transduction method to achieve this goal [102,
103].

4.1.1 Cell-penetrating peptides
Protein transduction is a technique that delivers proteins into living cells. It
emerged after the discovery of the cell penetrating peptides (CPP) [46, 47]. These CPPs
are small peptides with the ability to enter cells via an unconventional way, although
their transduction mechanism is still debatable [48, 49]. Fusion of a CPP with
proteins/DNAs/RNAs allows their intracellular delivery [48-50]. Efforts have been made
to pursue non-peptide protein delivery reagents. Polyethyleneimine (PEI) is found to
have the ability to deliver protein and DNA intracellularly [8, 52]. A small-molecule
mimic (SMoCs) of CPP has been reported to have a similar protein delivery property
[53].
Despite these notable successes, protein delivery technology has yet to become
commonplace for biomedical applications [46, 47]. The CPP-fused proteins share
common problems. The CPP-fusion changes protein sequence and intracellular
proteases likely degrade the delivered proteins, if they are not folded properly, before
they reach their target intracellular compartment. The CPP-fusion also lacks targeting
capability to specific intracellular compartments, significantly restricting their
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applications. It remains unknown if the intracellular folding machinery can refold the
CPP-delivered bacterial expressed proteins. Blobel’s “signal theory” guides the fate of
endogenous proteins, dictating their intracellular locations and trafficking [54, 55].
Questions remain regarding whether the CPP-delivered proteins follow the same
intracellular trafficking/secretion pathway inside cells. These are critical questions
regarding the physiological relevance of protein delivery technology.

4.1.2 QQ-protein delivery technique
Recently, our lab has developed a QQ-reagent based protein delivery technology
that has solved the problems related to the CPP-based technology [102, 103]. The QQprotein delivery has several novel features that make this technique advantageous to
development of in-cell FRET methodology. First, the QQ-modification reagents noncovalently associate with proteins so there are no structural changes to the protein. The
modification reagents also provide protection from intracellular protease degradation.
The delivery system has targeting capability to specifically deliver proteins to the correct
intracellular compartments. Indeed, QQ-protein delivery provides new tools in cell
biology studies, allowing one to introduce specific labeled proteins inside the cells for
high-resolution biophysical studies of these proteins at the molecular level.
Another advantage of the QQ-protein delivery is that it only requires an
incubation step of the QQ-modified proteins with cells. Uptake of QQ-modified proteins
is highly efficient and can be visualized by SDS-PAGE analysis, Western blots and live cell
fluorescent imaging. Although the mechanism of the QQ-protein delivery is unknown,
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this is a significant result since high delivery efficiency is critical for applications of a
protein delivery technology.
The development of this critical technology is the necessary step needed to
introduce a model protein labeled with a FRET donor and acceptor pair to obtain in-cell
FRET measurements.

4.1.3 General description of this proposed in-cell FRET technique
Figure 4-1 displays the general design of this in-cell FRET technique. To solve the
technical challenges associated with in-cell FRET technique, our rationale is to first label
the proteins with 5-HT and small molecule fluorophores (SMFs) in vitro. We will then
specifically deliver the labeled proteins into their target intracellular compartment for
in-cell fluorescence FRET studies using the QQ-protein delivery technology.
We will pioneer this novel in-cell FRET technique to determine the FRETdistances within the labeled protein in the correct intracellular compartment of living
cells. These measured FRET-distances provide atomic resolution structural information
of the labeled protein inside the cells. Our approach is to use labeled 5-HT as the
fluorescence donor and a small molecule fluorophore at a specific residue as the
fluorescence acceptor for the FRET-experiments. This allows us to specifically excite the
labeled protein (5-HT) at 310 nm, while the background cellular proteins (natural
tryptophans) remain unexcited. This ensures the in-cell FRET measurement to be
performed only between 5-HT (donor) and a site-specific SMF (acceptor) within the
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labeled protein and eliminates the complications of protein interactions with the
background cellular proteins.
We will first work out experimental conditions for in-cell FRET measurements
using a protein sample that contains a single fluorescence donor/acceptor pair. We will
explore a methodology to calculate the FRET distance based on these in-cell FRET
measurements. Using cell biology techniques, such as knockout, knockdown and
transgenic cells, we can manipulate gene expression of a specific protein that interacts
with the labeled protein, enabling us to study the bound structure of the labeled protein
to other proteins using this novel in-cell FRET-technique.
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Figure 4-1: A schematic diagram of the experimental design of this in-cell FRET strategy.
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We will then prepare specifically labeled protein samples that contain multiple 5HT donors and a single acceptor for synchronized fluorescence experiments. Our results
shown in Chapter 3 demonstrated that the overlapped FRET peaks of these multiple
donor/single acceptor samples could be separated using this synchronized scanning
fluorescence spectroscopy. Our data further indicated that the individual FRET peak
could be unambiguously assigned to different donor/acceptor pair. This advance
suggests a possibility for generating multiple FRET-distances from a single FRETmeasurement. We will explore new FRET-methodology to achieve this goal. The success
of this FRET-methodology will demonstrate a feasibility of developing FRET technique
into an atomic resolution structural biology tool. In this case, we can simply make single
cysteine mutants of the target protein and label them with a small molecule
fluorophore as the acceptor and with multiple 5-HT as the donor. We will perform
synchronized fluorescence experiments using these samples to calculate multiple FRETdistances with minimized efforts in sample preparation and FRET measurement. The
generated FRET-distances will possibly allow us to generate protein structure at atomic
resolution. Therefore, this approach may hold a great potential for real time atomic
resolution structural determination of labeled protein at a near physiological
concentration inside living cells.

4.1.4 Specific research goals of this chapter
While the overall long-term goal of this challenging project is the development of
in-cell FRET methodology to calculate intramolecular distances of a protein located
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within a living cell, the scope of this dissertation will focus on laying the foundation for
this extremely challenging endeavor by optimizing several aspects concerning future incell FRET experiments. First, it must be proven that MESD can be specifically delivered
into the ER of living cells with a high intracellular concentration enough for efficient
FRET-measurements. Then various aspects of data collection must be optimized which
includes cuvette size, determination of light scattering effects of cells, the
buffer/medium used for cell suspensions, and which cell lines allow for the best
detection of fluorescently labeled protein within a cell. Finally, intracellular protein
concentration will be required for future in-cell FRET-based distance calculations. A
method needs to be established for the determination of intracellular protein
concentrations within a living cell.
The main focus of this chapter will be these optimizations of in-cell FRET
experiments. We believe that these optimizations are essential for successful in-cell
FRET experiments aiming at FRET-distance calculation. As the first pioneer of this
challenging project, my central focus is to derive an optimized experimental condition
for efficient FRET-experiments. We anticipate that the results obtained from these
optimizations will lay the foundation for successful measurements using in-cell FRET in
future continued studies.
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4.2.

Materials and Methods

4.2.1 Strain, plasmid and mutants
The MESD gene was subcloned into a pET30a vector from EMD Biosciences. We
engineered the pET30a vector to introduce a Factor Xa site between the long his-tag and
the MESD gene. The pET30a-sHT is also an engineered pET30a vector in which the long
his-tag was replaced by a short his-tag containing a six histidine tag plus a two serine
linker. The pET30a and pET30a-sHT are kanamycin resistant vectors. The expression
vectors were transformed DL-41(DE3) auxotrophic bacterial strains.
MESD contains three tryptophans at residues 32, 98 and 130. Seven MESD
mutants have been prepared as shown in Table 3-1, including three single tryptophan,
three double tryptophan and one no tryptophan MESD mutants.

4.2.2 5-HT labeled MESD: Protein expression and purification
In order to produce MESD selectively labeled with 5-hydroxy-L-tryptophan (5HT), glycerol stock (DNA transformed into DL41 (DE3) competent cells) was added to
500 mL M9 minimal medium supplemented with 25 mg/L of MET and TRP and allowed
to grow overnight for at least 20 hours. After overnight growth, the OD 600 reached ~ 1.0
before spinning down the culture at 5,000 x g for 7 minutes. The supernatant was
removed and the container was inverted for 1 minute on a paper towel. The pellet was
re-suspended with 25 mL 1X PBS and vortexed briefly in order to remove any remaining
TRP. After spinning down and removing the supernatant, the pellet was re-suspended
with 500 mL defined M9 minimal medium (not containing any glucose, ammonium
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chloride or tryptophan, but supplemented with 50 mg/L of the other 19 amino acids).
The re-suspended culture was poured into a 2 L flask and placed back in the 37 °C
incubator shaker for 2 hours. After 2 hours, 25 mg 5-HT was added to the culture and
placed back into the incubator shaker for an additional hour. At this point, 0.5 mM IPTG
was added to the culture and grew for 5 hours at 37 oC. Cells were harvested by
spinning the culture down at 10,000 x g for 10 minutes.

After removing the

supernatant, the pellet was either stored in the -80 °C freezer or used immediately for
purification.
In order to purify the 5-HT labeled MESD proteins, the cell pellets collected after
harvesting were resuspended in 20 mL 1X binding buffer (recipe modified slightly from
His-Bind Resin manual and all buffers containing 6 M urea). The solution was sonicated
3X for 1 minute each time at 10 V. The lysate was spun down at 10,000 x g for 10
minutes. The supernatant was poured into a second container and stored on ice. The
pellet went through two more rounds of sonication adding 10 mL of 1X binding buffer
each time to resuspend the pellet.

The clear lysate was loaded twice onto the

previously charged and equilibrated His-Bind resin. The resin was then rinsed with 100
mL 1X binding buffer and 100 mL 1X wash buffer (25 mM imidazole). Finally, the protein
was eluted with 60 mL 1X elution buffer (200 mM imidazole).
The elution was poured into a dialysis bag (MWCO 10,000 kD) and placed in 4 L
of distilled water containing ~20 mM NaHCO3. The solution stayed on dialysis for at
least three days with three water changes per day. Once dialysis was complete, the
solution was poured into a thick glassed beaker and place in a small container of liquid
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nitrogen to freeze. Once frozen, the beaker was placed on a lyophilizer to obtain
protein powder. The protein was weighed and a small sample was taken to check the
purity of the protein powder.

4.2.3 Labeling MESD with IAEDANS
The protocol provided by Invitrogen was used to label MESD with IAEDANS, with
minor modifications. First, MESD protein powder was dissolved in buffer (25 mM NaCl,
25 mM sodium-phosphate buffer, 10 mM EDTA, pH 7.6) at a concentration of ~ 80 μM
(2 mg/mL). To disrupt the intermolecular disulfide bonds that have possibly formed,
20X molar excess of TCEP (1.6 mM) was added to the solution and was placed on a
rocker at room temperature for 1 hour. Next, the solution was divided evenly into two
microcentrifuge tubes and were labeled “unlabeled” and “IAEDANS”. To the IAEDANS
tube, 40X molar excess of IAEDANS (3.2 mM) was added. Both tubes were wrapped
completely in foil and placed on the rocker at room temperature for at least 2 hours.
Finally, to both tubes, 20X molar excess of DTT (1.6 mM) was added to stop the
reaction. The tubes were once again wrapped in foil and placed on the rocker at room
temperature for 1 hour. In order to remove the free IAEDANS, the solution underwent
size exclusion gel chromatography with a molecular weight cut off of 10 kD.
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4.2.4 QQ-protein delivery
4.2.4.1 QQ-protein modification of MESD
First, three stock solutions were prepared that would be necessary for QQmodification of MESD: Buffer A (8% DMSO, 1% glucose, 5 mM EDTA in 0.15 M sodium
phosphate buffer, pH 8.0), Buffer B (8% DMSO, 1% glucose, 1 mg/mL 2k PEI in 0.15 M
sodium phosphate buffer, pH 8.0) and Buffer C (0.5 M EDTA in 0.15 M sodium
phosphate buffer, pH 8.0).
Next, 1 mg of MESD protein powder was dissolved in 500 μL Buffer A in a
microcentrifuge tube and put on a rocker at room temperature for at least two hours.
After 2 hours, 500 μL of Buffer B was added to the solution in the tube. The tube was
then covered in foil and placed on a rocker in the cold room to modify overnight. The
following morning, 1 mL of FreeStyle 293 Expression Medium (Invitrogen) was added to
the modified protein solution and vortexed to mix completely.

4.2.4.2 QQ-protein delivery of MESD to mammalian cell lines
A variety of mammalian cell lines were used throughout the development of the
QQ-protein delivery technology using MESD, including: GM01300 cells, HeLa cells,
fibroblasts and ID8 cells. The protein delivery procedure was the same for each cell line
with minor variances in cell line maintenance, such as serum percentage added to
DMEM. Mammalian cells were used for QQ-protein delivery once they had reached ~
80-90% confluency on a 75 cm2 angled flask. The cells were prepared by removing the
growth medium (DMEM + 8% FBS) and washing 3X with warmed 1X PBS. The modified
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protein + FreeStyle medium solution was added to the cells and placed back in the 37 °C
incubator for 2 hours. After the 2 hour loading period, the medium was removed from
the flask and the cells were gently washed 3X with warmed 1X PBS solution.
To lift the cells from the flask, 500 μL of 0.25 % trypsin was added to the flask
and tilted to ensure the trypsin coated the entire plate. Excess trypsin was removed
before placing the flask back in the 37 °C for 2 minutes. After 2 minutes, the plate was
removed from the incubator and the flask was lightly tapped on the surface the cells
were attached to in order to assist lifting from the plate. To collect the cells from the
flask, 3 mL of warmed 1X PBS was added to the flask to “wash” the plate and collect all
the lifted cells. The lifted cells were removed via pipet and placed in a 15 mL conical
tube. An additional 1 mL warmed 1X PBS was added to rinse the flask and remove any
remaining cells.

This rinse was also added to the 15 mL tube.

The cells were

immediately spun down at 2,000 x g for 3 minutes. The PBS solution was removed and
the cells could now be utilized for fluorescence spectroscopy experiments.

4.2.4.3 Western blot of mammalian cell lysates
In order to perform a time course of MESD delivery into GM01300 cells, a small
sample of cells were removed at one hour increments during the loading process for a
total of four hours. Once the cells were removed from the flask, they were washed 3X
with warmed 1X PBS with a gentle spin down of the cells following each wash (2,000 x g
for 3 minutes). After removing the supernatant of the last wash, 100 μL of 2X SDS
loading buffer was added to re-suspend the cells before putting the samples on a 90°C
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heat block for 10 minutes. After heat shocking the samples, they were spun down at
10,000 x g for 10 minutes. The samples were loaded onto a 12% SDS poly-acrylamide
gel by adding 10 μL into each lane. As a control, 0.1 mg MESD powder was dissolved in
100 μL SDS loading buffer and a 2 μL sample was added to the last lane.
After running the SDS-PAGE at 88V for 2 hours, the gel was soaked in Western
transfer buffer for 20 minutes along with two filter papers and one nitrocellulose
membrane cut to the same size as the gel. A semi-dry transfer was performed using 200
mA for 1.5 hours. After transfer, the membrane was soaked in 3% milk for twenty
minutes on a rocker at room temperature. The primary antibody (anti-MESD, 1:3000
dilution) was added and incubated overnight in the cold room on a rocker. The
following morning, the primary antibody was removed and the membrane was washed
3X with 1X PBS. After the final rinse, the secondary antibody (anti-mouse, 1:3000
dilution) was added and incubated for 1 hour on a rocker at room temperature. The
secondary antibody was removed and the membrane was washed 3X with 1X PBS.
Pierce ECL Western binding substrate was used to detect antibodies and expose to film.

4.2.4.4 De-glycosylation of MESD
After using the QQ-protein delivery into HeLa cells, the cells were washed 3X
with warmed PBS buffer. The cell pellet was re-suspended in 1 mL PBS buffer and
aliquoted equally in 4 separate microcentrifuge tubes. The cells were gently lysed by
sonication. To the first tube, no enzyme was added as the control. To the second tube,
10 mU of NAase was added and gently mixed. To the third tube, 20 mU of NAase was
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added and gently mixed. To the fourth tube, 40 mU of NAase was added and gently
mixed. The tubes were allowed to incubate for 4 hours. After 4 hours, 10 μL of 4X SDS
loading buffer was added to 30 μL of cell lysate from each tube. A Western blot was
performed using these samples with an anti-MESD antibody.

4.2.4.5 Live cell fluorescence imaging
BSC-1 cells were grown to about 75% confluency and transfected with a GFP-ER
marker according to the protocol provided by COMPANY. The next day, MESD was
labeled with the amine-reactive fluorophore ArrayIt 640 (Arrayit Corporation,
Sunnyvale, CA) according to the protocol provided by the company. After removing the
free fluorophore, the fluorescently labeled MESD was QQ-modified as described in
4.2.4.1.

Next, the labeled and modified protein was delivered to the BSC-1 cells

expressing GFP-ER marker as described in 4.2.4.2 with a few modifications. First, the
cells were only incubated with the protein for 20 minutes after which there was a 3 hour
incubation period in the 37°C incubator.
After the 3 hour incubation period, the cells were imaged using a Zeiss Apo Tome
microscope. Images were collected of cells using the light imaging channel, the FITC
channel (detects green fluorescence) and the rhodamine channel (detects red
fluorescence). The images were superimposed on one another to show the outline of
the cell and the location of MESD within the cell and the ER. If the overlain images
produce a yellow color, that proves MESD localizes in the ER of the cell.
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4.2.5 In-cell fluorescence optimizations
4.2.5.1 Alternative fluorophores
The use of alternative fluorophores for detection of fluorescently labeled
proteins within the living cells was explored.

ArrayIt 640 (Arrayit Corporation,

Sunnyvale, CA) as well as DyLight 488 and DyLight 649 (Pierce Biotechnology, Rockford,
IL) are amine reactive and will bind to the amine group of lysine sidechains of MESD.
Since MESD contains 24 lysine residues, the intensity will be much stronger and more
easily detectable than an MESD protein labeled with a single IAEDANS fluorophore.
MESD_wt was labeled with ArrayIt 640 and used for live cell fluorescence imaging.
MESD_NoW was labeled with DyLight 488 and DyLight 649 (according to manufacturer’s
protocol) and absorbance and emission spectra were collected to determine the best
excitation wavelength and emission range to be used for in-cell fluorescence
spectroscopy optimizations.
For MESD_NoW labeled with DyLight 488 the following fluorescence spectra
were collected: Using the Felix32 software package, a new data acquisition file is
opened, the “Excitation Scan Method” is selected: excitation wavelength range is set at
450 – 525 nm, emission wavelength point is set at 530 nm, step size is set at 0.5 nm,
integration time is set at 0.5 sec and average is set at 5. The buffer spectrum is
collected for baseline correction. Next, a new data acquisition file is opened, the
“Emission Scan Method” is selected: excitation wavelength is set at 507 nm, emission
range is set at 510 – 640 nm, step size is set at 0.5 nm, integration time is set at 0.5 sec
and average is set at 5. The buffer spectrum is collected for baseline correction.
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For MESD_NoW labeled with DyLight 649 the following fluorescence spectra
were collected: Using the Felix32 software package, a new data acquisition file is
opened, the “Excitation Scan Method” is selected and the following information is
inputted: excitation wavelength range is set at 500 – 700 nm, emission wavelength point
is set at 673 nm, step size is set at 0.5 nm, integration time is set at 0.5 sec and average
is set at 5. The buffer spectrum is collected for baseline correction. Next, a new data
acquisition file is opened, the “Emission Scan Method” is selected and the following
information is inputted: excitation wavelength is set at 654 nm, emission range is set at
600 – 750 nm, step size is set at 0.5 nm, integration time is set at 0.5 sec and average is
set at 5. The buffer spectrum is collected for baseline correction.

4.2.5.2 Cuvette size
When performing in vitro FRET experiments, small sample volumes are placed in
a 4-walled quartz cuvette with an inner chamber light path of 10 x 2 mm and a
maximum volume of 500 μL (minimum volume = 250 μL). Since the light path is narrow,
not as much of the sample will be excited in comparison to a larger volume cuvette with
a light path that measures 10 x 10 mm. It is cost-effective to use the smaller volume
cuvette, however for the purposes of methodology development of in-cell fluorescence
experiments, the larger volume cuvette may provide us with a higher level of sensitivity.
First, MESD_NoW was labeled with DyLight 488 according to the manufacturer’s
protocol. The final sample volume was 3 mL with a protein concentration of ~ 80 μM.
To collect fluorescence spectra, 300 μL of the sample was placed in the small cuvette
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and placed into the QuantaMaster-6 Spectrometer (Photon Technology International,
South Brunswick, NJ). The emission scan method data is collected using the Felix32
software provided by PTI with the following conditions: excitation wavelength is set at
507 nm, emission range is set at 517 – 600 nm, step size is set at 0.5 nm, integration
time is set at 0.5 sec and average is set at 5. The buffer spectrum is collected for
baseline correction.
The same sample is also placed into the large cuvette, with an initial volume of
3.0 mL. The same emission spectra were collected as the small cuvette. In addition,
several other variable were also tested. First, the cuvette was rotated at 90° increments
to confirm that position of the cuvette within the spectrophotometer yielded the same
results. Next, a stir bar was added and the stirrer turned on to ensure this did not have
any effect on spectra collection. Finally, a rubber stand was added to lift the position of
the cuvette and allow for a minimum volume of protein sample. The absolute minimum
volume necessary for data collection was determined by removing the sample in
increments of 100 μL.

4.2.5.3 Time course of QQ-delivery of MESD into mammalian cells
During the QQ-delivery of DyLight 488-labeled MESD into HeLa cells, loading
medium samples and cell samples were taken. The easiest way to perform a time
course is to prepare multiple small dishes of the cells. HeLa cells are first grown in a 150
cm2 angled flask to over 90% confluency. The cells are then lifted and transferred to 4
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small petri dishes (35 x 10 mm) in equal aliquots. The dishes are placed back in the 37°C
incubator for 24 hours to re-establish adherence to the dish.
The next day, the cells are washed 3 times with warmed 1X PBS. After preparing
the cell loading medium containing the QQ-modified MESD (4.2.4.1), 1.5 mL is added to
each dish. After 1 hour, one dish is removed from the incubator. A 300 μL sample of
the medium is taken and the rest of the medium is removed. The cells are washed again
3 times with warmed 1X PBS. The cells are lifted and re-suspended in warmed PBS
followed by immediate collection of emission spectra using FeliX32 software. The
excitation wavelength is set at 507 nm, emission range is set at 510 – 600 nm, step size
is set at 0.5 nm, integration time is set at 0.5 sec and average is set at 5. The PBS buffer
spectrum is also collected for the baseline. The medium samples are collected in the
same manner. This procedure is repeated at the 2, 3 and 4 hour time points. If
necessary, longer time courses can be determined.

4.2.5.4 Buffer or medium for cell suspensions
MESD_NoW is labeled with IAEDANS first. Then, 50 μL of labeled MESD is added
to 250 μL of the following solutions: 1X PBS, DMEM, DMEM + 2% FBS, DMEM + 5% FBS.
A total of 8 emission spectra are collected: 4 spectra of the solutions without labeled
protein and 4 spectra of the solutions with labeled protein. The excitation wavelength is
set at 336 nm, emission range is set at 350 – 600 nm, step size is set at 0.5 nm,
integration time is set at 0.5 sec and average is set at 5. The buffer used for IAEDANSlabeling is also used to collect a emission spectrum for baseline correction.
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4.2.5.5 Determination of light scattering by mammalian cells
HeLa cells are grown to ~80% confluency in a 75 cm2 angled flask. The medium is
removed and the cells are washed 3 times with warmed 1X PBS. To lift the cells from
the flask, 500 μL of 0.25 % trypsin was added to the flask and tilted to ensure the trypsin
coated the entire plate. Excess trypsin was removed before placing the flask back in the
37 °C for 2 minutes. After 2 minutes, the plate was removed from the incubator and the
flask was lightly tapped on the cell-attached surface in order to assist lifting from the
plate. To collect the cells from the flask, 3 mL of warmed 1X PBS was added to the flask
to “wash” the plate and collect all the lifted cells. The lifted cells were removed via
pipet and placed in a 15 mL conical tube. An additional 1 mL warmed 1X PBS was added
to rinse the flask to remove any remaining cells. This rinse was also added to the 15 mL
tube. The cells were immediately spun down at 500 x g for 3 minutes at room
temperature. The PBS solution was removed and then gently re-suspended with 3 mL
warmed 1X PBS.
In a large cuvette, 990 μL of the cell suspension (which does not contain labeled
MESD) was added followed by 10 μL of MESD_NoW labeled with DyLight 488 (80 μM).
Using the FeliX32 software, “Emission Scan Method” is selected. The excitation
wavelength is set at 507 nm, emission range is set at 510 – 600 nm, step size is set at 0.5
nm, integration time is set at 0.5 sec and average is set at 5. The PBS buffer spectrum is
collected for baseline correction. After data collection, an additional 500 μL of the cell
suspension is added to the sample and gently mixed. The same emission scan is
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collected. This process is repeated 4 more times until the final volume of the cell
suspension is 3.0 mL.

4.2.5.6 Cell line for detection of fluorescently labeled MESD within the cell
Several cell lines were tested to determine which allowed for the best detection
of fluorescently labeled MESD within the cells. Three cell lines were used for collecting
in-cell fluorescence spectra: fibroblasts, HeLa cells and ID8 cells. MESD_NoW was either
labeled with IAEDANS or DyLight 488. After fluorescently labeling the protein it was QQmodified and QQ-protein delivered into the cells. The samples were prepared for
fluorescence spectroscopy by re-suspending the cell pellets in 1 mL of 1X PBS buffer.
Using the FeliX32 software, the “Emission Scan Method” is selected and excitation
wavelength is set at 336 nm for IAEDANS labeled MESD and 507 nm for DyLight 488
labeled MESD, emission range is set at 350 – 600 nm for IAEDANS labeled MESD and 510
– 600 nm for DyLight 488 labeled MESD, step size is set at 0.5 nm, integration time is set
at 0.5 sec and average is set at 5. The PBS buffer spectrum is collected for baseline
correction. Control cell samples of all cell lines are also created and undergo the same
emission scan data collection.

4.2.6 Determination of intracellular protein concentration
The “no tryptophan” mutant was utilized to perform these experiments. The
protein was labeled with IAEDANS. A BCA assay was performed to ensure that the
protein concentration was around 80 μM (2 mg/mL). A series of emission scans were
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collected by first placing 400 μL into a 4-walled quartz cuvette and setting the λex = 336
nm and collecting an emission range of 350 – 600 nm. Five scans were collected and
averaged. Next, 200 μL of the sample was removed and 200 μl of buffer was added to
dilute the sample concentration by half. Again, five emission scans were collected and
averaged. This series of dilutions continued until the concentration of MESD was 40 nM
(1 μg/mL). After exporting the data to excel and removing the baseline, the peak of
each emission was plotted against the concentration and a best-fit line was generated.
To validate that the generated line was accurate, samples from previous experiments
were taken and collected the same emission scan. Using the peak intensity from each
sample, the concentration was calculated based on the generated equation from the
best-fit line. Afterwards, a BCA assay was performed on each sample to compare the
calculated concentration to the observed concentration.

4.3

Results

4.3.1 QQ-delivery of MESD inside living cells
To ensure high QQ-protein delivery efficiency for in-cell FRET experiments,
verification of protein delivery had to be determined. First, cells were collected at 1
hour increments during the loading stage. A Western blot was performed on the cell
lysates using an anti-MESD antibody. Figure 4-2 Panel A shows an example of a Western
blot on GM01300 cell lysates during MESD cell loading, the fifth lane contains bacterial
MESD as a control. In lanes 1-4 we see a strong lower band at the same level as the
bacterial MESD control band, but we also see several upper bands as well. Cell lysates
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from several mammalian cell lines that express endogenous MESD also show the same
pattern of bands [102]. The varying intensities seen at different time points can be
explained by the dynamic nature of MESD trafficking between the ER and Golgi. To
prove that these upper bands are in fact glycosylated MESD bands, the cell lysates were
treated with varying dosages of a deglycosylating enzyme, NAase. In Panel B, the results
of this treatment are shown. In Lane 1, no enzyme was added and the three main bands
remains visible after 4 hours. In Lane 2, 10 mU of NAase was added to the cell lysate
and incubated for 4 hours. A noticeable decrease in the strength of the upper bands is
observed in Lane 2 and is also true of Lane 3 in which 20 mU of NAase was added. In
Lane 4, 40 mU of NAase was added and after the 4 hour incubation, no upper bands
were observed indicating that MESD was fully deglycosylated.
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Figure 4-2: Panel A shows a Western blot of samples taken from GM01300 cell lysates
during loading with QQ-modified MESD at different time points using an anti-MESD
antibody. The fifth lane contains a sample of bacterial MESD as a control. Panel B
shows a Western blot of HeLa cell lysate with and without different dosages of a
deglycosylation enzyme, NAase. Lane 1 = no enzyme added to cell lysate. Lane 2 = 10
mU added. Lane 3 = 20 mU added. Lane 4 = 40 mU added. Lane 5 = bacterial MESD
sample as a control.

In addition to performing Western blots and enzyme assays, live cell
fluorescence imaging was performed to prove MESD localized in the ER. After labeling
MESD with Array-It 640 and performing QQ-modification, the modified protein was
incubated with BSC-1 cells for 2 hours. After removing the medium and washing the
cells with warmed 1X PBS, the cells were subjected to fluorescent imaging using a Zeiss
Apo Tome microscope.
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Figure 4-3: Live fluorescence images of BSC-1 cells after loading with MESD. Panel A
shows the location of MESD labeled with Array-It 640. Panel B shows the location of the
ER which has been labeled with GFP-ER marker. Panel C shows the merged images of
the red channel, green channel and light image.

The live cell imaging results of the BSC-1 cells are shown in Figure 4-3. In Panel
A, the rhodamine (red) channel was collected in order to visualize the location of
labeled MESD within the cells. In Panel B, the FITC (green) channel was collected to
visualize the location of the ER. Finally, in Panel C, the light image that was collected
was merged with the red and green channel images. The yellow color now seen
indicates that MESD is in fact located in the ER of the cells.

4.3.2 Optimizations of in-cell fluorescence spectroscopy
Since the focus of this thesis is methodology development, many factors had to
be optimized.

When developing a new in-cell fluorescence technique all aspects

regarding the experiment must be considered which include the type of fluorophore
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used for data collection, the type of cuvette a sample is placed in, the buffer/medium
that the cells will be suspended in, in addition to optimizing the conditions that lead to
successful delivery and detection of MESD within living cells.

4.3.2.1 Alternative fluorophores
Since MESD has 24 lysine residues as compared to a single cysteine residue, we
decided to use amine-reactive small molecule fluorophores for the optimization of the
experimental conditions for in-cell fluorescence spectroscopy. The ability to attach 20+
fluorophores to MESD will provide us with a brighter sample for easier detection of
MESD within living cells. As we are still in the optimizing stage, using a more sensitive
approach will guide us in developing a technique that will eventually be able to detect a
protein labeled with a single fluorophore.
Figure 4-4 shows the absorbance and emission spectra of both DyLight 488 and
DyLight 649. From this data, the best excitation wavelengths were found to be 507 nm
for DyLight 488 and 654 nm for DyLight 649.
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Figure 4-4: The absorption and emission spectra are displayed for both DyLight 488
(green) and DyLight 649 (red) by solid and dotted lines, respectively.

4.3.2.2 Cuvette Size
When performing in vitro FRET experiments, using small sample volumes is
efficient and cost-effective. However, during the methodology development of an incell FRET experiment, the most sensitive approach must be taken. When exciting
samples contained within a cuvette, the larger the light path, the more of the sample
will be excited resulting in a more intense emission. To determine whether this increase
in intensity was worth a more costly and labor intensive sample, a comparison between
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samples placed in a small cuvette versus a large cuvette were performed. The small
cuvette has a light path of 10 x 2 mm and a maximum volume of 500 μL. The large
cuvette has a light path of 10 x 10 mm and a maximum volume of 4 mL. Emission
spectra were collected of MESD_NoW labeled with DyLight 488 in both a large and small
cuvette. As shown in Figure 4-5, Panel A, the emission spectra more than doubles when
placed in the larger cuvette, indicating that the gain in intensity is worth the more costly
and labor intensive sample preparation.
Once it was determined that the large cuvette would be used in future in-cell
FRET experiments, other aspects of cuvette where analyzed. In Figure 4-5, Panel B, it is
shown that no matter what position the cuvette is placed in the cuvette holder within
the spectrophotometer, similar spectra will be collected. Next, it is also shown that by
adding a stir bar and turning on the stirrer, spectra are unaffected. Finally, a rubber
stand was added to the cuvette holder within in the spectrophotometer to raise the
position of the cuvette allowing for a small minimum volume to be added. All of these
variances did not alter the emission spectra collected. From these experiments it was
determined that by adding a rubber stand to the cuvette holder, a 1 mL sample needed
to be prepared and a stir bar could be used to keep the cells suspended in the buffer.
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Figure 4-5: Panel A shows emission spectra of MESD_NoW labeled with DyLight 488 in a
large cuvette at various volumes versus a small cuvette. Panel B shows emission spectra
of MESD_NoW labeled with DyLight 488 in a large cuvette in various positions within the
machine.

4.3.2.3 Time course for loading MESD
During the development of the QQ-protein delivery technique, it was clear that
each protein delivery needed optimization of several variables. The concentration of
protein used and ratio of modified protein solution to cell culture medium both needed
to be optimized, as well as loading times. When optimizing these variables, both uptake
of protein and cell viability are examined.
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The MESD protein concentration ranged from 0.1 mg to 0.5 mg per mL of loading
medium with no adverse effects on cell viability. However, the higher the concentration
of MESD used, the more taken in by the cells resulting in brighter intensity. Figure 4-6
demonstrates the uptake of MESD by fibroblast cells. In Lane 1, QQ-modified MESD is
shown. Lanes 2 – 4 represent various time points during cell loading. Lane 2 was a
sample taken after adding the cell culture medium containing 5% FBS, right before
adding it to the cell culture (time point zero). Lane 3 was a sample of the medium taken
after 2 hours of loading. Lane 4 shows a sample taken after 4 hours of loading showing
almost complete uptake of the protein by the cells. The strong upper band has been
attributed to FBS that has been added to the cell culture medium. There are additional
upper bands and lower bands seen as well. The lower bands do not appear to be
degraded MESD as, as the sample shown in Lane 2 was taken immediately after mixing
the QQ-modified protein with the cell culture medium.
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Figure 4-6: SDS-PAGE of MESD loading into fibroblast cells. Lane 1 = QQ-modified MESD
before loading. Lane 2 = Sample taken from loading medium at the 0 hour point. Lane 3
= Sample taken from loading medium at the 2 hour point. Lane 4 = Sample taken from
loading medium at the 4 hour point.

Since the SDS-PAGE analysis is not entirely conclusive, we also measured the
fluorescence emissions of the medium and within the cell to determine the best amount
of time needed for uptake of the protein. As shown in Figure 4-7, Panel A, the emission
of labeled MESD continuously decreases with each hour of cell loading. Panel B displays
the emission spectra collected of the washed cells suspended in PBS buffer before. Both
panels indicate that the HeLa cells have taken up the maximum amount of MESD by the
6th hour of loading.
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Figure 4-7: Panel A – Emission spectra collected of loading medium at various time
points (0 to 6 hours) with λex = 507 nm. Panel B – Emission spectra of HeLa cells before
and after loading with MESD with λex = 507 nm.

4.3.2.4 Medium used for in-cell fluorescence spectroscopy
Ideally, when performing in-cell FRET experiments, cell culture medium would be
the best choice for the cell suspension solution in regards to maintaining healthy cells.
However, the fluorescence properties of DMEM and fetal bovine serum (FBS) had to be
determined. Since the final in-cell FRET experiments will be performed at λex = 336 nm,
various samples were prepared that contained MESD_NoW labeled with IAEDANS in
various buffers and mediums. As shown in Figure 4-8, any sample containing DMEM
displays a very intense peak that overlaps the IAEDANS emission peak.
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Figure 4-8: Emission spectra of 5μM MESD_NoW in various solutions: PBS, DMEM,
DMEM + serum with λex = 336 nm.

In Figure 4-9, the absorption and emission spectra of DMEM were collected.
Although DMEM does not have identical excitation and emission peaks as those of
IAEDANS, its intense emission peak masks the emission peak of IAEDANS due to the fact
that the fluorescent components of DMEM are at a much higher concentration than
that of MESD, as shown in Figure 4-8.

Therefore, when performing in-cell FRET

experiments, DMEM cannot be used and the cells must be suspended in a PBS solution.
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Cell viability in PBS should not pose a problem since data can be collected in a manner
of minutes.
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Figure 4-9: Absorbance and emission spectra of DMEM with a peak excitation
wavelength of 370 nm and a peak emission wavelength of 450 nm.

4.3.2.5 Light scattering effects (Beer-Lambert Law)
Another factor to consider for in-cell FRET experiments are the effects of the cell
turbidity of the solution on photon transmission through the sample. The Beer-Lambert
law states that there is a logarithmic dependence between the transmission of light
through a substance and the product of the absorption coefficient of the substance and
the distance the light travels through the material (i.e. the path length of the cuvette).
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In regards to FRET experiments, the photons that enter the cuvette will be more
intense than the photons that exit the cuvette which are collected as the emission of
the sample. The question now becomes, will the addition of mammalian cells to the
sample effect the spectra by absorbing and scattering the photons? To answer this
question, live HeLa cells were suspended in 3 mL of PBS buffer. In a large cuvette, 990 μL
of the cell suspension was added followed by 10 μL of MESD_NoW labeled with DyLight
488. The emission spectrum was collected of this sample and is shown in Figure 4-10.
Next, to dilute the sample, an additional 500 μL of the HeLa cell solution was added and
gently mixed in the sample. Now, only the MESD concentration has been reduced while
the turbidity of the sample remains the same. If the HeLa cells are absorbing light, there
will be a non-linear reduction of the labeled MESD emission peaks. The sample was
diluted in the same manner 4 more times and all the spectra can be seen in Figure 4-10.
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Figure 4-10: Emission spectra of a 1 mL HeLa cell suspension containing MESD_NoW
labeled with DyLight 488 with an λex = 507 nm. After the initial spectra were collected,
an additional 0.5 mL of HeLa cell suspension was added to the solution until the final
volume reached 3.5 mL.

After collecting all the emission spectra for each sample, the emission peak for
each sample was plotted against its dilution factor. In Figure 4-11, each blue point
represents an emission peak.

A best fit line was added and line equation was
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determined by Excel with a high R2 value indicating a strong linear relationship amongst
the peaks.
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Figure 4-11: The peak intensity for each spectrum in Figure 4-9 was plotted against the
dilution factor of that spectrum.

The dilution factor and peak fluorescence intensity are linearly correlated in a
1:1 ratio, which is what is expected [41]. Since a non-linear relationship is not seen, the
cell suspension must not be absorbing or scattering the photons and therefore does not
appear to effect fluorescence data collection.
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4.3.2.6 Suitable cell line for in-cell fluorescence spectroscopy
Several cell lines were used to determine which allowed for best detection of
MESD_NoW labeled either with DyLight 488 or IAEDANS. First, fibroblast cells were
loaded with MESD_NoW labeled with IAEDANS. Figure 4 -12 shows the results of the
emission spectra collected of control fibroblast cells and fibroblast cells containing
MESD labeled with IAEDANS in Panel A. Panel B contains the difference spectrum which
is obtained after subtracting the control spectrum from the MESD containing spectrum.
Ideally, only the IAEDANS peak should be observed after removing the control spectrum.
Unfortunately, the quality of the spectrum is poor as the intensity of the sample is quite
low.
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Figure 4-12: Panel A – emission spectra of control fibroblasts and fibroblasts containing
MESD labeled with IAEDANS with λex = 336 nm. Panel B – The difference spectrum
which is obtained after subtracting the control spectrum from the MESD containing
spectrum.

In Figures 4-13 and 4-14, HeLa cells are used when loading MESD_NoW labeled
with IAEDANS (Figure 4-13) and then labeled with DyLight 488 (Figure 4-14). In Figure 413, Panel A, the distinction between the control spectrum and the MESD containing
spectrum is much clearer as compared to fibroblast cells. In Panel B, the difference
spectrum is shown after subtracting the control spectrum from the MESD containing
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spectrum. A clearer peak is observed around 495 nm, which coincides with the emission
peak of IAEDANS.
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Figure 4-13: Panel A – emission spectra of control HeLa cells and HeLa cells containing
MESD labeled with IAEDANS with λex = 336 nm. Panel B – The difference spectrum
which is obtained after subtracting the control spectrum from the MESD containing
spectrum.
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In Figure 4-14, HeLa cells were loaded with MESD labeled with DyLight 488 and
the emission spectra are shown in Panel A. The distinction between the control
spectrum and MESD containing spectrum are much clearer largely in part to the use of
the DyLight 488 fluorophore instead of IAEDANS.
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Figure 4-14: Panel A – emission spectra of control HeLa cells and HeLa cells containing

MESD labeled with DyLight 488 with λex = 507 nm. Panel B – The difference spectrum
which is obtained after subtracting the control spectrum from the MESD containing
spectrum.
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The third cell line tested is ID8. These cells were loaded with MESD_NoW
labeled with DyLight 488 and the emission spectra collected can be seen in Figure 4-15,
Panel A. As with the fibroblast cells, there is not as clear distinction between the control
cells and MESD containing cells as compared to the HeLa cells.
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Figure 4-15: Panel A – emission spectra of control ID8 cells and ID8 cells containing MESD

labeled with DyLight 488 with λex = 507 nm. Panel B – The difference spectrum which is
obtained after subtracting the control spectrum from the MESD containing spectrum.
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In summary, HeLa cells seem to be the most suitable cell line for our in-cell
fluorescence spectroscopic studies.

4.3.3 Intracellular protein concentration
It is crucial to know the protein concentration for each sample when for FRETbased distance calculations.

When performing in vitro FRET experiments, protein

concentration is simply determined by a quick experiment, e.g., Lowry assay, Bradford
Assay or UV analysis.

Currently, however, it is impossible to determine protein

concentrations within living cells. Since fluorescence intensity is based on protein
concentration, a standard curve should be able to be determined. MESD_NoW was
labeled with IAEDANS and a set of standards were created (2000, 1000, 500… 1 μg/mL)
using the BCA assay to confirm protein concentration. Emission spectra were collected
for each sample and can be seen in Figure 4-16, Panel A. To calculate the standard
curve line, the peak of each spectrum was plotted against the corresponding protein
concentration (now in μM), shown in Figure 4-16, Panel B. A best fit line and equation
were created by Excel with a strong R2 value indicating a clear linear relationship
between protein concentration and fluorescence intensity.
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Figure 4-16: Panel A shows emission spectra of MESD_NoW labeled with IAEDANS at
various concentrations with a λex = 336 nm. In Panel B, each point represents the peak
intensity of each sample and the corresponding protein concentration (μM). A best fit
line (black line) and equation were determined by excel.
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MESD_W32/130A, was labeled with IAEDANS and emission spectra were collected at λex
= 336 nm. The peak intensity was entered into the standard curve equation and
resulted in a concentration value. This value was confirmed by performing a Lowry
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assay to determine the protein concentration of the sample. Table 4-1 summarizes the
results of the two different methods. As can be seen below, using the standard curve to
determine the protein concentration is a valid method.

Table 4-1: Protein concentration determination
Sample

Intensity @ 484 nm

Calculated
(μg/mL)

Lowry
(μg/mL)

% Difference

1

108100.5

481.86

474.5

1.6

2

52004.06

232.69

237.3

-1.9

3

128135.5

570.85

602

-5.2

4

67129.26

299.88

301

-0.4

These results suggest that the concentration of a protein can be estimated at a
reasonable accuracy using this fluorescence method. This will provide the confidence for
us to estimate intracellular protein concentration once we have optimized our in-cell
fluorescence experiments.
In order to determine in-cell protein concentration a standard curve must be
generated before collecting the in-cell FRET experiments.

All variables must be

identical, including: buffer, cuvette size, and emission scan input variables. This will
ensure the most accurate data measurements.
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4.4

Conclusions
In order to establish an in-cell methodology, many aspects of the experimental

method must be first optimized. The rationale behind this methodology is to deliver a
specifically labeled protein into the correct intracellular compartment of living
mammalian cells. This protein must be shown to be taken up by the cells and delivered
to the correct intracellular compartment.

Using SDS-PAGE analysis and live cell

fluorescence imaging, both of these aspects were confirmed. In the SDS-PAGE analysis,
MESD was shown to diminish from the loading medium over a 4 hour incubation period.
In the live cell fluorescence imaging, the ER was first labeled by transfection of a GFP-ER
DNA marker (green fluorescence). The ArrayIt 640-labeled MESD (red fluorescence) was
then QQ-delivered into the same cells; after superimposition of both the red and green
images, yellow fluorescence was observed, indicating MESD is indeed located inside the
ER of the living cells.
The next step was to optimize the various conditions that would lead to the
optimization of in-cell FRET measurements.

We examined cuvette size, the light

scattering effects of cells, buffer/medium to be used for cell suspension, different cell
lines used for delivery, as well optimal cell loading conditions of MESD into the
mammalian cells. During the optimization process, it was decided to label MESD with an
alternative fluorophore that would provide more sensitivity for these optimizations.
Since MESD contains 24 lysine residues, amine-reactive fluorophores were chosen,
including: ArrayIt 640, as well as DyLight 488 and DyLight 640.
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The first optimization was performed using different sizes of cuvettes. Previous
in vitro FRET experiments were performed in a small 4-walled quartz cuvette with a light
path of 10 x 2 mm and a maximum volume of 500 μL. For each experiment, a minimum
of 300 μL was required. With the smaller light path, a decrease in fluorescence intensity
is expected as a smaller volume of the sample is being excited. Since in-cell FRET
experiments will have a low concentration of protein within the cells, it might be
necessary to use a larger cuvette to ensure maximum fluorescence intensity. Identical
samples were placed in small and large cuvettes and emission spectra were collected.
The emission collected from the larger cuvette was more than doubled in intensity
which justified the use of larger cuvette for stronger fluorescence spectra. It was also
found that by adding a rubber stand to the cuvette holder within the
spectrophotometer, a minimum volume of 1 mL could be used for future in-cell FRET
experiments. This amount of sample is only 3-fold more than what is needed for the
small size cuvette, however, the fluorescence intensity remained the same as the 3 mL
protein samples using the large cuvette.
The second aspect to consider is the light scattering effects of a cell suspension
on FRET data collection. To determine if cells within a suspension absorb or scatter the
photons used to excite the protein, a 3 mL cell suspension was used. In the first sample,
10 μL of fluorescently labeled MESD (80μM) was added to 1 mL of the cell suspension.
An emission scan was collected of this initial suspension. Afterwards, increments of an
additional 500 μL of cell suspension were repeatedly added which would keep the cell
concentration constant, but lower the concentration of MESD. If the cells do not absorb
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or scatter the photons, a linear relationship will be observed between protein
concentration and fluorescence intensity. If the cells do absorb or scatter the photons,
a non-linear relationship will be observed. Our results showed that the relationship was
in fact linear and therefore the cells do not have a light scattering effect on the protein
sample.
The next optimization was the buffer conditions used for the cell suspension for
collection of in-cell FRET measurements. Ideally, to maintain the health of the cell, it
would be best to suspend the cells in cell culture medium containing DMEM plus fetal
bovine serum. However, our data indicated DMEM has spectral properties that overlap
those of IAEDANS and therefore could not be used for future in-cell FRET experiments.
The best choice is to re-suspend the cells in warmed PBS buffer and quickly perform the
experiments, which is feasible since data collection only takes a few minutes.
The final optimizations regarded QQ-protein delivery of MESD and detection of
fluorescently labeled MESD within various cell lines. The concentration of MESD in the
loading medium varied from 0.1 mg/mL to 0.5 mg/mL. The higher concentration of 0.5
mg/mL did not have an adverse effect on cell viability and were shown to be more easily
detected within the cell after collecting emission spectra of the cells. Three different
cell lines were explored: HeLa, fibroblasts and ID8. HeLa cells that had MESD delivered
within them displayed the most different spectra from the control cells and will allow
for future in-cell FRET measurements. In the cases of fibroblasts and ID8, the control
cell baseline has too much spectral overlap with the cells containing labeled MESD.

203

Another challenge presented for in-cell FRET measurements is the determination
of intracellular protein concentrations within living cells. In order to calculated FRETbased distances, protein concentrations must be known. Currently, it is impossible to
determine protein concentrations within a living cell. Since fluorescent intensity is
linearly dependent upon protein concentration, a best-fit line could be determined by
plotting peak intensity versus protein concentration. Using this best-fit line equation,
several samples with unknown protein concentrations were used for emission scan
spectra collection.

The peak emission values were entered into the best-fit line

equation and concentration values were determined. A Lowry assay was performed on
all the samples and the concentration values obtained from the protein concentration
assay were compared to those calculated from the emission spectra. The calculated
values were confirmed by the observed assay values, validating this technique. This
suggests that this method may be used to estimate the intracellular protein
concentration of living cells.
In summary, we have optimized a number of conditions that are needed before
collecting in-cell FRET measurements. First, a rubber stand must be added to the
cuvette holder in the spectrophotometer which will allow for a minimum sample
volume of 1 mL. A large cuvette with a light path of 10 x 10 mm should be used with a
stir-bar to keep the cells suspended in the cuvette. Next, we determined that the cells
do not have a light-scattering effect so FRET measurements will not be affected by the
cell suspension. We also determined DMEM cannot be used for the cell suspension due
to its fluorescent components, PBS must be used instead. HeLa cells were shown be the
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most suitable choice for future in-cell FRET experiments as labeled protein within the
cell is most clearly detected.

Finally, we have proposed a method to determine

intracellular protein concentration that will be critical for in-cell FRET-based distance
measurements.

4.5

Discussion
The overall long-term goal of this thesis project is to develop an in-cell FRET

technique as a structural biology tool to study protein structure inside living cells at
high-resolution. This is a very challenging project that deserves a major research effort
to overcome many technical challenges that will be encountered during development of
this novel in-cell FRET technique. As the first person in the lab pioneering this project,
the first step is to optimize several experimental conditions to make this in-cell FRET
measurement possible. This is the main focus of this chapter. The optimizations of
these experimental conditions will lay the foundation for future continued exploration.
First, it has to be shown that QQ-protein delivery can specifically deliver MESD
into the ER of living mammalian cells. In addition, optimization of QQ-protein delivery
has to be performed for best efficiency of protein delivery for MESD into the ER. Second,
many variables may affect data collection and optimization of these variable have to be
performed in order to obtain reasonable in-cell fluorescence spectra. These variables
include cuvette size, the possibility of light scattering, the buffer or medium used in cell
suspension and the cell line used for fluorescence spectroscopic data collection. Finally,
the intracellular protein concentration of MESD within living cells must be determined
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since it is important for FRET-distance calculation based on FRET-data. Currently, there
is no technique available to achieve this, so a technique must be developed to enable
intracellular protein concentration determination.
In order to prove that MESD was delivered inside the ER of living mammalian
cells, several experiments were performed. First, MESD uptake was visualized using
SDS-PAGE analysis using the samples of the loading medium before, during and after
loading.

it is clear that the MESD band intensity slowly decreases until it finally

disappeared after 4 hours in the loading medium.
examined during the loading process.

Cell lysate samples were also

Western blot analysis, using an anti-MESD

antibody, showed distinct MESD bands at every point during the time course. Two
higher molecular weight bands were also detected. By a comparison with the western
blot of cell lysates of the cell lines that express endogenous MESD, it was suggested that
these two higher molecular weight bands were glycosylated MESD. To verify this
suggestion, the cell lysates were treated with various dosages of NAase, which is a deglycosylating enzyme, for 4-hours at room temperature. As the dosage increased, the
upper bands became weaker and eventually disappeared at 40 mU of NAase.
Glycosylation of MESD confirms that the protein has been delivered into the ER
and Golgi since they are the intracellular compartments for glycosylation, suggesting
that the QQ-delivered MESD follows an identical intracellular trafficking and posttranslational modification as its endogenous counterpart. This provides confidence for
us for the QQ-protein delivery technique used in this in-cell FRET approach. In order to
visualize MESD location in the ER, the BSC-1 cells were first transfected with a GFP-ER
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DNA marker for 24 hours and then incubated with QQ-modified MESD_wt labeled with
ArrayIt 640 for 30-minutes. The BSC-1 cells were then subjected to live-cell fluorescence
imaging. The red and green images were collected and merged, showing that MESD
does in fact localize within the ER of the living cells.
Next, the various aspects that could affect in-cell fluorescence spectroscopy
were examined. First, we looked at cuvette size for protein samples. In vitro FRET
experiments can be collected in small cuvettes with short light paths and small
minimum sample volumes. While it is more cost-effective to produce small sample
volumes, the price is a decrease in fluorescence intensity. When performing in-cell
fluorescence spectroscopy, it is more beneficial to use a large sample volume if there is
a large enough increase in fluorescence intensity. We compared identical samples in
small and large cuvettes and found more than doubled spectral intensity was observed
using the large cuvette. By adding a rubber stand to the cuvette holder within the
spectrophotometer, we were able to decrease the sample volume required for data
collection to 1 mL using the large cuvette.
Next, we examined if light scattering of a cell suspension was a concern for incell fluorescence spectroscopy. We performed these experiments by continuously
adding 500 μL increments of the same cell suspension to a sample containing a fixed
amount of fluorescently labeled MESD. Since the peak intensity of the emission spectra
and concentration of MESD remained in a linear relationship, this indicated the cells
within the sample did not absorb and scatter the light.
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Another aspect to consider for in-cell FRET measurements is the buffer or
medium in the cell suspension used for in-cell FRET experiments. Ideally, cell culture
medium should not display fluorescence signals, thus the collected fluorescence spectra
are only from the labeled protein inside cells. In addition, cell viability is also critical for
data collection. Emission spectra were collected using several cell culture medium and
serum combinations. We found that DMEM displays significant fluorescence signals that
overlap with those of IAEDANS.

Therefore, PBS has to be used for in-cell FRET

experiments to eliminate any spectral contribution from the cell culture medium. Since
data can be collected in 10 minutes, cell viability in PBS should not be a concern.
Another possible solution to ensure cell viability when using PBS during in-cell FRET
experiments is to add glucose to the PBS solution. As long as glucose does not display
any interfering fluorescent properties, this should benefit cell health.
The type of cell line used for in-cell fluorescence spectroscopy also affects data
collection. Three different cell lines were tested: fibroblasts, HeLa cells and ID8. All the
cell lines were incubated with fluorescently labeled MESD_NoW followed by collection
of fluorescence emission spectra. Fibroblasts and ID8 control cell lines were not as
distinctly different from their MESD containing counterparts as HeLa cells were. HeLa
cells provided the least amount of spectral overlap and the clearest visualization of the
IAEDANS and DyLight 488 emission peaks. This cell line is the better choice for in-cell
FRET experiments.
Finally, to determine the intracellular concentration of a labeled protein in living
cells, we proposed a solution. Since fluorescence intensity is linearly dependent upon
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protein concentration, we collected emission spectra of many samples of known
concentrations. The emission peaks of these spectra were plotted against the protein
concentration and a best-fit line and equation were determined. This equation was
validated by collecting emission spectra on fluorescently labeled protein samples of
unknown protein concentrations.

The calculated protein concentrations were

confirmed by Lowry assays. This data indicates that the intracellular protein
concentration could be possibly obtained using this method once the experimental
conditions of in-cell fluorescence spectroscopy are optimized.
Based on these results, we propose that when performing in-cell FRET experiments,
emission spectra from the protein standards of known concentration should be
collected first that will be used to formulate a best-fit line equation. When collecting
the in-cell fluorescence data, include one emission spectrum that is the result of direct
excitation of the IAEDANS fluorophore. This emission peak can be used to determine
the overall protein concentration of the sample. To determine a rough estimate of
intracellular protein concentration, the cells can be counted using a cell counter and
then dividing the concentration (μg/mL) of the sample by the number of cells (cells/mL)
to estimate the intracellular concentration (μg/cell).
We were unable to calculate any in-cell FRET-based distance measurements
during this thesis period.

However, successful FRET-experiments require a full

optimization of different parameters, which is the main focus of this chapter of my
thesis. A wide range of parameters, including those in fluorescence instrumentation,
protein delivery, cell lines, cell culture medium used in FRET-experiments and
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intracellular protein concentration, have been optimized, providing a solid foundation
for successful FRET-experiments. With the successful optimizations of all these various
aspects outlined in this chapter, we believe that with a few more years of dedicated
exploration into this methodology development, this technique could become a feasible
atomic-resolution in-cell structural biology tool.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS

5.1

Conclusions
The primary objective of this thesis is to develop an in-cell structural biology

technique that can be used to study protein structures inside living cells. In order to
achieve this goal, many factors must be considered. First, after examining all the
available atomic resolution structural biology tools (NMR, X-ray crystallography and
cryo-EM), we concluded that the X-ray crystallography and Cryo-EM techniques were
not suitable to study protein structure within living cells. The NMR technique, although
possible for in-cell experiments, requires high intracellular concentration of labeled
proteins which are much higher than physiological concentration of a protein inside the
cells. Förster resonance energy transfer (FRET), on the other hand, has great potential to
become a structural biology tool for studying protein structure inside living cells. FRET
does not suffer from the same limitations as the other structural biology tools, such as
crystallization/freezing of the sample, broadening spectral linewidths, and excessive
intracellular concentration issues.
After deciding upon FRET as the chosen technique, a model protein with a
known structure had to be chosen and possible donor and acceptor molecules were
considered. MESD was chosen as the model protein due to our lab’s expertise in
working with this protein and recently determined NMR structure of MESD. MESD had
attractive features when determining possible donors and acceptors. In order to keep
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the protein as least perturbed as possible, tryptophan was chosen as the donor taking
advantage of its intrinsic fluorescent properties. MESD contains three tryptophan
residues and after two rounds of mutagenesis, single tryptophan mutants were
generated. MESD also contains one cysteine residue which can be used to label with
the acceptor.

IAEDANS is a thiol-reactive probe that has an absorption spectra

overlapping tryptophan’s emission and will allow for the labeling of the protein with a
single acceptor.
The final challenge to overcome when choosing the donor and acceptor was the
ability to specifically excite the target protein within the living cells. The excitation of
tryptophan in the target protein is not problematic in vitro, but once the target protein
is inside living cells, all proteins containing tryptophan residues will be excited. To solve
this problem, the target protein can be labeled with a tryptophan analogue (5-hydroxyL-tryptophan) which has a broadened absorption spectrum and can be specifically
excited at 310 nm. At this wavelength, regular tryptophan is not excited. Using this
strategy, we could only excite the protein of interest inside the cell, while the
background intracellular proteins remain un-excited for our in-cell FRET experiments.
The possibility of using FRET to measure multiple distances with a single
measurement needed to be explored in order for this new technology to be valuable
structural biology tool in the future. Proteins samples were generated that contained
multiple donors and a single acceptor. Synchronous scanning fluorescence spectroscopy
has the ability to identify multiple fluorescent components contained in a mixture by
varying both the excitation and emission wavelengths simultaneously during data
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collection. The tryptophan residues of MESD were shown to be in unique chemical
environments which results in varying emissions spectra from each residue. After
optimizing data collection procedures and careful analysis of the resulting spectra, FRET
peak separation was shown to be a possibility. Assignment of peaks resulting from
individual residues was elucidated. Further exploration of this technique may yield
interesting results leading to the calculation of multiple distances based on a single FRET
experiment.
It is possible to produce large quantities of MESD with bacteria and fluorescently
label the protein in vitro. Once labeled, it can be modified with the QQ-reagents and
delivered to the ER of living cells. The next step is to optimize the conditions necessary
for successful in-cell FRET measurements.

A number of factors were examined,

including sample preparation, cuvette size, buffer conditions and cell line used for
delivery. After careful optimization of these conditions, we could collect descend in-cell
FRET spectra of MESD using HeLa cells. We believe that with the continued optimization
of these conditions, a viable in-cell FRET technique can be developed into a robust
structural biology tool in the near future.

5.2

Future directions

5.2.1 Proposed optimized experimental conditions for in-cell FRET experiments
Based on the results of this thesis, we can propose a methodology for in-cell
FRET experiments.

First, in regards to instrumentation, the QuantaMaster 6

Spectrophotometer (Photon Technology International, New Brunswick, NJ) can be used
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with the addition of a rubber stand to the cuvette holder. This stand will allow the
sample to be excited near the bottom of the quartz cuvette instead of the middle. A stir
bar, set at a gentle speed, can be used to keep the cells suspended during data
collection. The FeliX32 software provided by PTI contains necessary experiments for
data collection including the “Emission Scan Method” and “Synchronous Scanning
Method”.
To produce a selectively labeled protein with a single donor/acceptor pair, a
protein must be produced in an auxotrophic bacteria strain and the culture medium will
be supplemented with 5-hydroxy-L-tryptophan (donor). After obtaining the protein
powder, it is then labeled with the small molecule fluorophore IAEDANS (acceptor).
Finally, the labeled protein is QQ-modified and mixed with cell culture medium for QQdelivery of the protein into mammalian cells.
We determined that HeLa cells loaded with fluorescently labeled protein
resulted in the best spectral quality, as compared to fibroblasts and ID8 cells. Another
advantage of the HeLa cell line is that it can be grown in suspension or adherent
cultures. Since the in-cell FRET experiments will be performed in suspension, the results
might be more physiologically relevant using a cell line that normally grows in
suspension as well. After the HeLa cells have been loaded with labeled protein and
properly washed, they should be suspended in 1 mL PBS buffer and have the
fluorescence spectra collected immediately. If the protein used in the experiment has a
single donor/acceptor pair, an emission scan can be collected in 10 minutes. A final
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spectrum should be collected that directly excited IAEDANS which will be used for
protein concentration determination.
After performing the in-cell FRET data collection, a set of protein standards with
known protein concentration should have emission spectra collected as well. The
emission peaks will be plotted against the corresponding protein concentration and a
best-fit line equation will be generated. This equation can be used to determine the
intracellular protein concentration of the samples used in the in-cell FRET experiments.
The cells must be counted after the in-cell FRET experiment and this number can be
used to calculate an intracellular concentration with units μg/mL or ng/mL.

5.2.2 Calculation of multiple FRET distances
In vitro fluorescence spectroscopy of protein samples containing multiple donors
and one acceptor will be used first to establish a methodology that allows for multiple
distance calculations. After preparing protein samples that contain multiple donors and
a single acceptor, the synchronous scanning fluorescence spectra will be optimized to
ensure best separation of FRET peaks. The strategy that was outlined in chapter 3 can
be used to assign an individual FRET peak to a specific donor/acceptor pair. This
strategy involves comparisons of synchronous scanning spectra of a protein that has 0,
1, 2 and 3 donors, each with 1 acceptor. The next challenge to overcome is the
calculation of the distance between a donor and acceptor based on changes in the FRET
peak and not the donor emission peak. Theoretically, this should be possible since the
distance between the donor and acceptor determines the intensity of the FRET peak.
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Once this methodology has been established in vitro, the next step is to
determine multiple distances of multiple donors to a single acceptor in a target protein
within living cells. This step will lead us in the direction of making the in-cell FRET
technique a high-resolution structural biology tool.

If multiple distances can be

calculated, then by changing the acceptor position via mutagenesis and creating a set of
mutants that contain multiple donors and a single acceptor in varied position, this will
allow us to obtain many distances between two residues with a minimum effort in
sample preparation, possibly generating a protein structure at atomic resolution using
computer simulation with these distance restraints.

5.2.3 Solving biological questions
The goal of any scientific endeavor in this field is to ultimately answer biological
questions. By creating an in-cell structural biology tool, we will be able to answer a
number of previously unanswerable questions. For instance, does the in vivo structure
of a protein match the structure determine in vitro?

Do different chemical

environments of different intracellular compartments have an effect on protein
structure?
To answer these questions, the in-cell FRET technique first needs to be
established. Then, several cell biology techniques can be utilized to specifically address
certain

questions

concerning

protein

structure

within

living

cells.

First,

knockout/knockdown/transgenic techniques can be used to create special cell lines that
remove interaction partners of the target protein. Using MESD as an example, siRNA
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could be used to knockdown the expression of LRP5/6 which are the interacting
partners. The structural information gained from this cell line can be compared to
structural information of a cell line that is overexpressing LRP5/6.
Another cell biology technique that can be utilized is the use of small molecule
inhibitors that will block transport from ER to the Golgi or vice versa. By using these
inhibitors, we could examine structural information of MESD within the ER only and
compare it to structural information of MESD within the Golgi only. MESD is known to
act as a chaperone and escort with two domains. At some point, there is a structural
change of MESD that switches its function from chaperone to escort. By confining the
protein to a specific compartment, these changes might be elucidated.
Another use for the in-cell FRET technique could be to observe the effects of
post-translational modification on a protein structure. A series of samples could be
created that would first allow for the collection of structural information immediately
following protein delivery. The following samples could be taken at increments of 30
minutes post-delivery. Structural changes might be seen throughout this time course
indicating either post-translational modifications or trafficking through various
intracellular compartments with varying chemical environments. In addition, special cell
lines can be generated to knockdown or knockout specific glycosylation enzymes and
these special cell lines can be used to study protein structure inside cells.
Another avenue of study using in-cell FRET is to study protein-protein
interactions. Two proteins can be delivered simultaneously or consecutively using the
QQ-protein delivery technique. One protein can be strategically labeled with a donor,
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while the other protein is strategically labeled with an acceptor. After QQ-delivery into
the cells, in-cell FRET can be performed on these proteins as they function in their
correct intracellular compartment.
The overall significance of this work will be the development of a structural
biology tool that can be used to determine atomic resolution protein structure in living
cells under a physiologically relevant concentration. The ability to gather structural
information from proteins within living cells may answer many currently unanswerable
questions. Therefore, the success of this new in-cell structural biology technology may
generate paradigm-shifting results for correctly understanding the intracellular events
of proteins in living cells at a high spatiotemporal resolution.
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TO STUDY PROTEIN STRUCTURE INSIDE LIVING CELLS
by
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Degree: Doctor of Philosophy
The goal of my thesis is to develop an in-cell fluorescence technique that allows
for measurement of the distances between fluorescence acceptors and donors within a
protein or between two proteins inside the correct intracellular compartment of living
cells. The successful achievement of this goal will allow us to obtain high-resolution
structural information from a protein, one key step towards high-resolution structural
biology of proteins inside the living cell.
To achieve this goal, we will apply the fluorescence resonance energy transfer
(FRET) technique to the specifically labeled proteins inside the cells. Our rationale is to
specifically label the protein(s) of interest in the test tube with a small molecule
fluorophore and then deliver the labeled protein(s) into the correct intracellular
compartment of living cells for in-cell FRET measurement. The QQ-protein delivery
technique can specifically deliver a protein to its intracellular destiny based on its signal
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sequence. This will result in special mammalian cells that contain a fluorescence labeled
target protein with unlabeled intracellular endogenous proteins as the background. The
FRET measurement will be performed on this specifically labeled protein and the
calculated FRET-distance will be between the donor and acceptor of the protein(s) of
interest, thus, high-resolution structural information of a protein inside living cells can
be obtained using this novel approach.
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